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Abstract 
The majority of conventional controlled release technologies tend to be based 
around encapsulant systems in which a polymeric binder or gel typically responds to 
changes in the local environment in which the delivery device has been placed. The 
contents are often released when the particle, capsule, film or droplet is exposed to 
the appropriate physico-chemical trigger (typically a change in pH) with the time-
release-dose delivery characteristics controlled through manipulation of the 
encapsulant formulation. The adaptation of this core strategy for use in the next 
generation of transdermal microdevices or smart patch is explored. The core 
rationale of this work relates to the development of microneedle patches and other 
delivery architectures, which upon activation by an appropriate electrochemical 
trigger, leads to the release of a drug. 
The methodology adopted herein focused on the use of cellulose acetate phthalate 
(CAP) as pH sensitive barrier films structured for use within a number of microscale 
(patch, implant, microneedle and microdroplet) devices. The barrier film was used as 
a means of entrapping a model drug with the controlled release of the latter achieved 
through the exploitation of the hydrogen evolution reaction. The application of an 
electrode potential resulted in an increase in the local pH thereby inducing the 
controlled dissolution of the barrier film and facilitating the release of the drug.  
A variety of approaches have been investigated leading from the use of standalone 
CAP films through to its direct incorporation as a component in the electrode 
material itself. The design and characterisation of the carbon composite material 
from a film to the development of conductive microneedles and electronic sutures is 
described.  The ability to electrochemically manipulate the structural integrity of the 
composite structures and the ability to affect the controlled release of model drugs 
is critically appraised.   
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Chapter 1 
 
Introduction and Summary of the Literature 
 
Abstract 
 
In recent years, there has been an emergence of novel smart devices that possess 
the ability to monitor a patient’s health without the presence of clinical staff.  At 
present, there is a wealth of research being targeted at the development of these 
technologies. A concise summary of the current and emerging research directed at 
the release of therapeutic agents from microscale devices is presented and a critical 
overview of the potential applicability evaluated. While conventional controlled 
release mechanisms are considered, the focus is on the provision of a detailed review 
of the current electrochemical developments for controlled release and serves a 
framework for the research being undertaken in this project.   
 
 
 
 
 
 
 
 
 
 
 
Part of the literature described in this chapter has been published in Anderson, A. and Davis, J. (2015), 
Electrochemical Actuators: Controlled Drug Release Strategies for use in Micro Devices. 
Electroanalysis, 27: 872–878.  
Design of Functionalised Materials for Use in Micro-Nanoscale Drug Delivery Devices and Smart 
Patches.  Nanostructures for Drug Delivery, Nanostructures in Therapeutic Medicine Series.  Editor(s): 
Grumezescu & Andronescu.  February 2017.  Elsevier, ISBN 9780323461436.  
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1.1    Introduction 
 
The concept of a ‘smart’ device that could routinely monitor a patient’s health 
with minimal clinical intervention has garnered considerable interest in recent years 
and, has evolved from significant advances in sensing and communication 
technologies.  A new generation of connected health systems offering discrete and 
prompt analysis of vital signs within smart phones and other wearable technology 
are already available and could be considered as opening up new opportunities in 
personalised healthcare. It can be anticipated that, as these systems mature, they 
will have a considerable impact on the future outlook of preventative screening 
measures within healthcare practices (Agboola et al., 2013; Valle, Tramalloni and 
Bragazzi, 2015).   In recent years, there has been an ambition to drive research 
towards the integration of electrical and chemical sensors for the detection of a 
particular disease or injury biomarker (Kumar et al., 2016; Bollella et al., 2017).  In 
their present incarnation, such devices offer a limited range of sensing capabilities, 
but this could be considered the first stepping stone on the journey to more 
integrated devices, which could provide a much more detailed biochemical picture 
of the wearer’s health. 
 
The rationale of the current formats rely on a “detect-alert” sequence,  which notifies 
either the patient or a central clinic (Chan et al., 2012).  In other situations, where 
perhaps urgent action is required, a more sophisticated substitution would be the 
development of a system that could act autonomously in response to information 
received from the sensing module and, where appropriate, deliver a drug therapy in 
an appropriate manner.  While the current approaches to sensing are well 
established, the development of “detect-respond” systems that can control the 
release of a drug is still in its relative infancy but is an area in which considerable 
effort is now being expended.  
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Project Aim 
The aim of the project undertaken was therefore to take up this challenge and 
investigate the design of new electrochemical approaches that can facilitate detect 
and respond delivery mechanisms which could eventually be employed within smart 
patch and microscale architectures. 
The focus of the present thesis is directed towards electrochemical approaches to 
drug delivery given the compatibility with modern electronics which should, in 
principle, provide opportunities for the delivery devices to become much smaller and 
less obtrusive with greater dose control and much more rapid response times.  
Through the development of functional materials whose properties can be 
controlled, it is possible to create advanced systems that could deliver a drug, 
antidote or treatment upon activation by an electrochemical trigger.  These “smart” 
materials could ultimately be incorporated into a micro device or smart patch that 
would be capable of acting autonomously to deliver a drug therapy.  A schematic of 
the idealised smart device / release mechanism is demonstrated in Figure 1.1.1, 
where drug release is achieved upon the detection of an appropriate biomarker. 
 
 
 
 
 
 
Figure 1.1.1 Combined sensor -actuator device 
 
A critical overview of present drug delivery strategies is considered along with the 
issues surrounding their application. The evolution of new electrochemical 
approaches to the controlled drug delivery are considered and the underpinning 
rationale for the present project is placed in context.  
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Conventional Drug Delivery Strategies 
At present, effective drug delivery can be achieved through several conventional 
approaches including: oral delivery (Choonara et al., 2014), injection (Prausnitz and 
Langer, 2008), inhaler (Illum, 2012; Casettari and Illum, 2014), and transdermal 
absorption (Margetts and Sawyer, 2007a; Maurya et al., 2014), which have allowed 
the successful treatment of a vast range of clinical conditions.  Some of the more 
common approaches are highlighted in Table 1.1.1. 
 
Table 1.1.1 Conventional drug delivery approaches and associated barriers 
 
Oral Delivery 
Oral delivery possesses many attractive attributes including; ease of use, control over 
dosage, design control over delivery system and the overall costings of manufacture 
are relatively inexpensive. In some cases, particularly where prompt delivery is 
needed, oral delivery would not be considered the most appropriate form of delivery, 
5 
 
particularly when the drug component could be degraded following interaction with 
gastrointestinal enzymes, resulting in low oral bioavailability (Choonara et al., 2014).  
Other negative side effects can present themselves when larger than desired dosages 
are administrated to ensure dosage is not lost, therefore selective delivery would 
ensure that only the desired amount of drug dosage would be delivered, thus 
eliminating the adverse effects.  At present, research is being directed at the 
reduction of negative side effects, particularly with the prevalence of chronic disease, 
in particular Crohn’s and Ulcerative Colitis (UC), where there is a pressing need to 
develop a more effective way of delivering drugs to the colon (Van den Mooter and 
Kinget, 1995; Philip and Philip, 2010). 
The use of encapsulated systems within oral drug delivery is well understood and 
extensively documented (Maroni, Zema, et al., 2013; Thanki et al., 2013; Choonara 
et al., 2014; Sattar, Sayed and Lane, 2014).  Slow release coatings are commonly used 
in oral delivery where, upon ingestion, the encapsulated system travels through the 
gastrointestinal (GI) tract, where the enteric coating surrounding the drug is 
breached by intestinal fluid.  The period of time for release depends on the residence 
time of the encapsulated system in the GI tract.  Gelatin capsules which offer 
instantaneous release are unsuitable for delivery to the GI tract, whereas slow 
release coatings can allow targeted delivery to the colon where uniform absorption 
can occur throughout the GI tract.  Slow release systems can offer progressive control 
over the release profile, more significantly these coatings can be modified with the 
addition of enteric coatings, for example cellulous acetate phthalate (CAP).  CAP is a 
commonly used pH sensitive polymer used to protect an entrapped agent in the 
stomach when presented with acidic conditions and then releases the entrapped 
components when exposed to more alkaline conditions within the intestinal tract.  
The use of CAP is the principal system investigated in this thesis.  The work involved 
will focus on exploiting the inherent properties of CAP within new devices.  The 
features of CAP will be outlined in Section 1.2.2 and further explored in Chapters 
4,5,6, and 7, where the properties of a CAP film will be researched and its application 
within a polymer composite film for electrochemical drug delivery will be 
investigated. 
6 
 
Injection Methods 
Drug administration via needle (typically subcutaneous injection) can alleviate some 
of the issues that limit oral efficacy but can also possesses a number of inherent 
drawbacks – particularly the degree of invasiveness which can engender an inevitable 
reluctance on the part of the patient to self-administer. There are also numerous 
concerns over health and safety in terms of use and disposal (Majumdar et al., 2015).  
In cases such as diabetes management where patients are required to self-administer 
insulin, this negative association can lead to further non-compliance and regression 
of the patient’s health.  Inadequate adherence by patients as a result of unwillingness 
to inject, or error in routine can adversely affect the dosage and concentration of a 
drug therapy. Therefore, it is possible that through insufficient adherence, health 
practitioners could easily assume that the treatment has been ineffective, resulting 
in a change in treatment or increase in dosage which can lead to further 
complications.  Delivery via hypodermic needle can overcome many of the issues 
associated with oral delivery, such as providing the possibility of much more accurate 
control over dosage. However, there are significant issues surrounding the 
appropriateness and invasiveness of an injection and it has been estimated that as 
much as 10% of the population suffer from a phobia related to needles (Sokolowski, 
Giovannitti and Boynes, 2010). 
Transdermal Methods 
Over the years, transdermal drug delivery systems have been proffered as prime 
candidates for effective drug delivery.  The development of transdermal patches and 
microneedle systems have allowed conventional drug delivery to be surpassed by a 
much more convenient route to delivery that has the capacity to reduce negative 
side effects that can be associated with traditional forms of drug delivery.  At present, 
most of the commercially available transdermal patches are passive systems, which 
do not offer the ability to control the release of the drug.  Undoubtedly, the most 
commercially available transdermal patches are nicotine patches which were 
approved by the Food and Drug Administration (FDA) in 1992.  Since they were 
released, the success of nicotine replacement therapy patches have been widely 
documented (Rose et al., 1985; Stead et al., 2012).  The success of nicotine patches 
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can be due to several factors which facilitate the cessation of smoking, including: 
discreetness of size and placement of patch, variation in nicotine strength, ease of 
use and handling.  While the nicotine patch may be considered the first of its 
generation within patch systems, there are also many more recent advantages within 
transdermal patch technology.  A summary of current transdermal delivery systems 
has been complied in Table 1.1.2.  
 
Table 1.1.2 Transdermal patch systems currently on the market 
Product Name Active ingredient Indication 
 
BuTrans® Transdermal  
Patch 
 
Buprenorphine 
 
Analgesia 
Catapres-TTS® Transdermal 
Therapeutic System  
Clonidine High Blood Pressure 
(hypertension) 
Evorel® Transdermal Patch Estradiol Hormone 
Replacement Therapy 
(HRT) 
EVRA® Transdermal Patch Norelgestromin 
(NGMN) and Ethinyl 
estradiol (EE) 
Female Contraception 
Exelon® Transdermal Patch Rivastigmine Alzheimer’s Disease 
Fencino® Transdermal Patch Fentanyl Analgesia 
Neupro® Transdermal Patch Rotigotine Parkinson's Disease 
Nicorette® InvisiPatch Nicotine Nicotine Replacement 
Therapy 
Nitro-Dur® Transdermal 
Patch 
Glyceryl trinitrate Prophylaxis of Angina 
Transderm Scop® 
Transdermal Patch 
Scopolamine Motion Sickness 
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The advancements and increasing popularity of fentanyl transdermal patches for 
chronic pain management has been widely documented (Margetts and Sawyer, 
2007b; Lane, 2013), but occurrences of abuse have been extensively reported (Moon 
and Chun, 2011; Mounteney et al., 2015).  Specific case studies have reported the 
extraction and intravenous injection of fatal doses of fentanyl (Tharp, Winecker and 
Winston, 2004).  It is important to be aware of the fact that the potency of fentanyl 
is around 100-200 times that of morphine, depending on the variety evaluated 
(Stanley, 2014). To combat this, research groups such as Cai et al. 2015, have recently 
made efforts to develop a nanostructured patch containing a tamper resistance 
fentanyl reservoir (Cai, Engqvist and Bredenberg, 2015).  Their approach employed 
geopolymers, a type of ceramic (typically composed of nanoparticulate Silica or 
Kaolin networks), where the fentanyl is embedded.  The physical properties of the 
nanoparticles can be controlled to regulate the release profiles as required.  The  
movement of drug molecules from most transdermal systems is by passive diffusion, 
this reduces the chances of success during the extraction processes necessary for 
acquiring sufficient quantities for abuse (Jämstorp et al., 2010).  When considering 
the widespread issues of delivery system tampering, could the emergence of smart 
devices reduce the potential for misuse? The answer will depend on the technologies 
involved and how the drug is sequestered within the system and, may involve a 
degree of tethering which can only be broken by the action of an electronic signal.  
In general, transdermal systems proffer several advantages for ease of treatment 
over conventional drug delivery strategies and the associated advantages and 
disadvantages of these systems have been highlighted in Table 1.1.3.   
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Table 1.1.3 Advantages and disadvantages of transdermal delivery  
 
 
 
 
 
 
 
 
Transdermal patches represent another emerging mode of drug delivery in the 
treatment or management of mild to moderate Alzheimer’s disease. Treatment 
regime adherence is a recurring issue for individuals being prescribed psychiatric and 
non-psychiatric medication.  Cholinesterase inhibitors are typically used by 40-70% 
of people being treated for Alzheimer’s (Alzheimer’s Society, 2010), where the most 
common cholinesterase inhibitor used is Rivastigmine.  Alzheimer’s patients who are 
prescribed rivastigmine often see improvements in memory/concentration, 
enhanced communication, restored confidence and independence to continue with 
daily activities (Adler, Mueller and Articus, 2014) .  Currently, Rivastigmine is the only 
drug of its kind available as a transdermal delivery system for the treatment of 
Alzheimer’s disease (Isaac and Holvey, 2012).  The need for further drug formulations 
to be incorporated into these kinds of delivery systems is evident, this will not only 
provide a niche method of delivery but will increase the availability of treatment 
therapies in a transdermal form.   
 
Further innovations of transdermal technologies include the development of 
microneedles for pain free drug administration.  Over the years, transdermal 
microneedles (MNs) have been heralded as the solution in overcoming the 
limitations of traditional transdermal devices.  One of the primary barriers against 
10 
 
effective delivery from the transdermal delivery system is the outermost layer (10-
15 m) of the stratum corneum (SC), which can prevent the efficient delivery of a 
drug therapy and limits the range of drugs that can be transported by the 
transdermal system.  Microneedle tips are generally much sharper than hypodermic 
needles and can be used with ease to pierce the SC.  Thus, allowing the transport of 
drug molecules from the delivery system and through micro channels created by the 
MNs, bypassing nerves and blood vessels.   
 
The development and interest in MN systems has increasingly grown over the years, 
and a number of preclinical studies have shown that MNs have performed favourably 
in applications such as: gene delivery (Dul et al., 2017), insulin delivery (Zhang et al., 
2018), allergen delivery (Kim et al., 2018), bio-signal monitoring (Ren et al., 2017) and 
blood sampling (Lee et al., 2018).  A number of research groups have developed a 
range of microneedles, whose structures vary from in-plane (Paik et al., 2004), where 
the MN is aligned parallel to the base plate, to out-of-plane where the MN is 
perpendicular to the base plate (Donnelly et al., 2010; Mansoor et al., 2013).   The 
desired pathway of drug release can also influence the structure of MN arrays which 
can be further subcategorised as either solid MNs (Gupta et al., 2011), hollow MNs 
(Lhernould, 2013), dissolving MNs (Ita, 2017a) and swelling MNs (Donnelly et al., 
2014). MN systems can be easily categorized by the range of materials that have been 
used to manufacture the technology and include: silicon (Ji et al., 2006; Yan et al., 
2013; Vinayakumar et al., 2014), glass (McAllister et al., 2003; Martanto, Moore, 
Couse, et al., 2006; Martanto, Moore, Kashlan, et al., 2006), sugar (Martin et al., 
2012; Loizidou et al., 2015), hydrogel (Donnelly et al., 2012, 2013, 2014), polymer 
(Park, Allen and Prausnitz, 2005; Lee, Han and Park, 2013; Ruggiero et al., 2018), 
metal and palladium composites (Kim and Lee, 2006; Badran, Kuntsche and Fahr, 
2009; McConville and Davis, 2016).  Regardless of the powerful drive to develop and 
implement MN platforms, there are still very few MN products available on the 
market, this can be largely attributed to the trouble with scale up of fabrication of 
such systems. 
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1.2    Barriers to Delivery 
 
The route to effective drug delivery can be limited by many challenges 
namely: response time and physical barriers to delivery.  As previously mentioned in 
Section 1.1, transdermal systems can address and overcome many of the drawbacks 
associated with traditional methods of drug delivery.  In many scenarios, it is 
common place for a health care professional or the patient themselves to administer 
treatments, which may have to be repeated over a period of days or weeks.  While 
in the short term, such actions can be completed with ease, it can become much 
more inconvenient when managing a chronic condition where treatment can be 
prolonged or last a lifetime.  The transdermal approach can provide many 
opportunities to improve patient compliance and co-operation by providing 
sustained release for a longer period of time without the need of intervention from 
clinical staff (Prausnitz and Langer, 2008).   
 
One of the main obstacles that can affect the success of a transdermal delivery 
system is transport of the treatment across the skin barrier. As a result, there are a 
limited number of drugs that have made the successful transition from traditional 
delivery into transdermal systems.  The skin consists of three major layers: the 
epidermis, dermis and the hypodermis as shown in Figure 1.2.1.  It can often be 
difficult to transport drugs across the skin barrier due to the low permeability of the 
skin tissue.  The stratum corneum (SC) is the first protective layer of the skin which 
shields the underlying layers from mechanical and chemical stress and acts a barrier 
to prevent water loss due to its hydrophobic nature.  The thickness of the SC layer 
measures around 10-20 µm in depth, this range varies at different anatomical sites 
and is comprised of around 25 layers of dead squamous cells which further restricts 
drug diffusion (Russell, Wiedersberg and Delgado-Charro, 2008; Escobar-Chávez et 
al., 2011).   
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Figure 1.2.1 Schematic demonstrating the layers of the skin. Adapted from (Tate, 2011). 
 
Despite the considerable permeability barrier presented by the stratum corneum, 
delivery through the skin still presents an attractive alternative to traditional drug 
delivery methods.  The drug permeability of transdermal systems can be significantly 
improved via the addition of microneedles which can overcome the issues 
surrounding the skin barrier.  The dimensions of an ideal microneedle system can 
range from 400 µm to 1500 µm thus allowing the delivery systems to easily bypass 
the protective layers of the stratum corneum and deliver the drug to a highly 
vascularized site.  Patient discomfort that is often associated with traditional 
approaches to drug delivery, such as hypodermic injection, can be minimised due to 
the size of the microneedles, where upon administration there should be little to no 
nervous stimulation or skin trauma (Indermun et al., 2014).   While the developments 
of transdermal systems have come a long way since their inception, there is also 
significant room for further improvement with regards to dosage control and 
controlled release.  The further development of transdermal systems will also see the 
addition of complex electronic systems into the device itself, where considerations 
surrounding power requirements and the finished product size will have to be 
considered for future ‘smart’ delivery systems to achieve their full potential.  
Microneedles systems will be further investigated in Chapter 6, where the 
development of an electrochemically controlled composite microneedle system is 
presented. 
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Issues in Delivery Technique: Compliance 
Each method must be carefully considered when determining the most effective 
route for the delivery of a particular drug - taking into account the physico-chemical 
characteristics of the latter but also its intended target.  Some of the issues that can 
arise include: poor response time, inadequate drug concentration, degradation. 
These can often be compounded by other factors such as: delivery invasiveness and 
errors in drug delivery site and variations in drug uptake due to premature release. 
As noted in previous sections, the treatment of chronic illnesses can be particularly 
troublesome where frequent dosing at constant concentrations is required to ensure 
optimal and successful drug action (Tiwari et al., 2012).  This aspect introduces yet 
another challenge to successful drug delivery: the patient. 
 
The ‘human factor’ and non-compliance (or adherence) is a substantial issue when it 
comes to ensuring the effectiveness of a drug therapy.  All too often treatment 
failures have been observed in patients with low drug concentration due to 
incomplete dosage resulting from the frequency of application rather than issues 
inherent to prescribed delivery method  (Dailey, Kim and Lian, 2001; Tarrants et al., 
2010). Inadequate adherence by patients to a treatment regime as a result of apathy 
in the administration of oral medicines, a fear or reluctance to inject subcutaneously 
or simple errors in routine can all adversely affect the dosage and concentration of a 
drug therapy. It is possible to envisage that through insufficient adherence, health 
practitioners could easily assume that the treatment has been ineffective.  The 
course of action which follows could lead to a change in the patient’s treatment – 
side effects associated with an increase in dosage can lead to further complications. 
This can significantly increase healthcare costs as a result of incorrect treatment 
regime adherence (NICE, 2007). There is overwhelming evidence corroborating the 
fact that patient compliance is a key issue which can interfere with treatment 
outcomes.   
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A qualitative review conducted by the National University of Singapore (Jin et al., 
2008) evaluated the issues surrounding patient compliance to specific treatments 
and the factors which can cause deviations from the prescribed regime.  While 
compliance with short term therapies was estimated at between 70% and 80%, it 
was found that, generally, the rate of compliance for long-term therapies typically 
fell to between 40% and 50%. In other compliance studies it has been estimated that 
the rate of compliance for the management of diabetes through the administration 
of insulin via hypodermic needle is around 20% (Bloom Cerkoney and Hart, 1980). 
 
It is important to consider patient compliance when considering outpatient care and 
the administration of drug treatments, therefore, for this kind of system, the most 
desirable outcome would be to completely remove patient intervention from the 
equation. The administration process is key when considering the overall success of 
a drug therapy and failure to maintain routine adherence can often compromise the 
effectiveness of the treatment.  The removal of responsibility from the patient, as 
shown in the smart system concept in Figure 1.1.1, would avoid delays in clinical 
assessment and treatment outcome.  It could also be predicted that through passive 
sensing, greater control over drug release and faster response time could ultimately 
be achieved.   
 
1.2.1 Existing Technologies 
 
Controlled Release Polymer Technologies 
 
Traditionally, oral capsules have been coated with thin films of water soluble 
polymer to mask taste and odour, to protect products from moisture degradation 
and provide increased mechanical resistance during handling.  These films remain 
intact only for a short time period and drug release is generally achieved soon after 
ingestion, making water soluble polymer films ideal for when drug release is required 
immediately.   Specific polymers that make ideal candidates for immediate release 
15 
 
coatings are cellulose ethers and can include: hydroxypropyl methylcellulose, 
polyvinyl acetate or polyvinylpyrrolidon.  Following from this, polymers can also be 
designed to be saliva resistant and only degrade when they reach the acidic 
environment of the stomach, an example is a methacrylic copolymer named 
Eudragit® E (Evonik Röhm GmbH, Darmstadt, Germany).  More recent advances in 
oral delivery have seen the addition of more sophisticated coatings which can protect 
the drug dosages from external stimuli and environments to achieve controlled drug 
release and optimum therapeutic outcome (Muheem et al., 2016; Lin et al., 2017; 
Ting et al., 2018). 
 
Controlled release systems have been of tremendous value to clinicians where they 
can enhance drug therapy through a variety of modes. These can include: protecting 
the drug from degradation, improving patient compliance, provide control over 
release mechanism and can, ideally, reduce the negative side effects that can come 
with aggressive treatment regimes.  Polymers used within controlled drug release 
applications can be categorized into the following sections: Diffusion controlled (non-
biodegradable), Chemically controlled (biodegradable) and Smart Polymers which 
are controlled by external factors (i.e. conducting polymers which will be discussed 
further in Section 1.4.2). 
 
Diffusion controlled systems are based on exogenous synthetic materials that are 
considered non-biodegradable.  In such instances, there is no immediate burst 
release, and the rate of release depends on the physical properties of the polymer 
i.e. the thickness and permeability, the area of release and the drug solubility.  The 
most commonly used non-biodegradable polymers that have been approved by the 
Food and Drug Administration (FDA) for safe use in the body are: crosslinked 
polyvinyl alcohol (PVA), ethylene vinyl acetate (EVA) and silicone (Yang and Pierstorff, 
2012).  PVA is often used a tunable membrane at the release area, due to its 
permeability to selective lipophilic drugs, also the thickness of the PVA membrane 
can be adjusted to achieve desired release rates.  EVA on the other hand is often used 
as a protective membrane encompassing the drug core and preventing early release.  
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Finally, silicone possesses both permeable and impermeable qualities subject to the 
grade used.  Non-biodegradable polymers continue to be developed for controlled 
release systems in drug delivery and include block co-polymers (vesicles and 
coatings) and parylene (films and coatings) (Kamaly, Yameen, Wu and Omid C 
Farokhzad, 2016). 
 
When comparing polymers used in controlled drug the release applications, it is 
evident that the most commonly used systems are biodegradable polymers.  These 
polymers are more suited to in vivo drug release due to their biocompatible nature 
of their degradation products and their ability to be either metabolised or excreted 
from the body.  Biodegradable polymers can be categorized as natural polymers or 
synthetic polymers.  Examples of well-defined biodegradable synthetic polymers are 
detailed in Table 1.2.1. Synthetic biodegradable polymers include Polyesters, 
Polyorthoesters, Polyanhydride and Polyamides.  The most commonly used are: 
Poly(lactic acid) PLA, Poly(lactic-co-gylcolic acid) PLGA and Poly(caprolactone).  
Commonly occurring natural biodegradable polymers are detailed in Table 1.2.2. 
 
In biodegradable systems, the rate of release is often determined by the degradation 
rate of the polymer.  When degradation rates are analysed, they can often be 
categorised into two different types of degradation: surface and bulk.  When the 
polymer membrane is gradually eroded from the surface of the system, the inside of 
the material does not degrade until the surrounding polymer matrix has worn away, 
this is known as surface degradation, this kind of degradation occurs in polyesters 
such as PLA and PLGA.  Bulk degradation on the other hand, occurs throughout the 
whole system and occurs in poly(ortho ester) and polyanhydrides.  Surface and bulk 
erosion both cause auto-acceleration where the degradation products advance the 
erosion process.  This means there is a preliminary surge and final release during the 
delivery process with biodegradable drug release mechanisms.  Furthermore, there 
are continuing efforts being developed to reduce surge effects and achieve zero-
order kinetics of drug release (Fu and Kao, 2010; Gokhale, 2014).  
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Table 1.2.1 Commonly used biodegradable synthetic polymers for controlled release 
 
Polymer Biodegradation Examples References 
Poly(esters) 
 
 
 
 
 
Hydrolysis or 
enzyme mediated 
degradation 
 
Poly(lactic acid) PLA 
(B. Liu et al., 2016; Tyler 
et al., 2016; Scaffaro et 
al., 2017) 
Poly(glycolic acid) 
PGA 
(Hurrell and Cameron, 
2002; Braunecker et al., 
2004) 
Poly(lactic-co-gylcolic 
acid) PLGA 
(Gasmi et al., 2016; 
Rodríguez et al., 2016; 
Terukina et al., 2017) 
Poly(caprolactone)  
PCL 
(Hyun, 2015; Genina et 
al., 2016; Sun et al., 
2016) 
Poly(ortho ester) Hydrolysis 
Dioxolane – based 
diketene acetals 
(Yang et al., 2003; 
Nguyen et al., 2008; 
Einmahl et al., 2016) 
Polyanhydride 
Hydrolysis 
 
Poly(sebacic 
anhydride) 
(Yin et al., 2013; 
Bagherifam et al., 2015; 
Ponnurangam et al., 
2015) 
Poly(adipic 
anhydride) 
(Albertsson, Carlfors and 
Sturesson, 1996) 
Polyamide 
 
Hydrolysis or 
enzyme mediated 
degradation 
Poly-γ-Glutamic Acid 
(Akagi et al., 2005; Zhang 
et al., 2013) 
Poly (l-lysine) 
(Askarian et al., 2016; 
Ren et al., 2016) 
 
 
Table 1.2.2 Naturally occurring biodegradable polymers 
 
 
Protein Based 
Polymers 
Example Reference 
Gelatin (Fan and Wang, 2016; Mahor et al., 2016) 
 
Collagen 
(Voicu, Geanaliu-nicolae and Pîrvan, 2016; 
Anandhakumar et al., 2017) 
Albumin (Woods et al., 2015; Wang et al., 2016) 
Casein 
(Luo, Pan and Zhong, 2015; Penalva et al., 
2015) 
Polysaccharide Based 
Polymers 
Cellulose (Svagan et al., 2016; Y. Liu et al., 2016) 
Chitosan (L. Liu et al., 2016; Constantin et al., 2017) 
Hyaluronic Acid 
(HA) 
(Agnello et al., 2016; Dosio et al., 2016) 
Alginate 
(Bhutani et al., 2016; Fan et al., 2016; Silva 
et al., 2016) 
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Polysaccharide based polymers have been previously used in tissue engineering and 
drug delivery applications.  One particular limiting factor that should be taken into 
consideration is their batch to batch variability and their variations of MW, in this 
case, synthetic polymers prove more suitable candidates due to their reproducibility 
(Kamaly, Yameen, Wu and Omid C. Farokhzad, 2016). 
 
1.3 Evolution of Smart Drug Delivery Devices 
 
In many cases, the conventional approaches to drug delivery work well, but as 
highlighted in the previous sections there are also many occasions where there is a 
need for more effective control over the drug therapy.  The latter may be due to 
issues of drug release or patient compliance. Both serve as motivation for developing 
smarter drug delivery technologies and devices that can autonomously respond in a 
predesigned way to specific instructions (i.e. from a smart phone, watch or tablet) or 
to changes in a particular biomarker profile.  A variety of electrochemical approaches 
have been examined to determine if they can offer greater control over drug release 
and critical evaluations of these emerging systems are explored in the following 
sections. 
 
1.4    Electrochemical Approaches to Drug Release 
 
Electrochemically controlled drug release systems are still in the early stages of 
their development, but a considerable number of systems have emerged in recent 
years and can be attributed to the growing interest in smart devices and the 
acknowledgement that electrochemical strategies are notably suited for application 
in microelectromechanical (MEMs) devices.  An abundance of electrochemical 
approaches have been exploited in controlled release applications and include: 
conducting polymers (Svirskis, Travas-Sejdic, et al., 2010a; Alizadeh and Shamaeli, 
2014), carbon nanotube composite structures (Riggio et al., 2009; Luo, Matranga, 
Tan, Alba and Xinyan T Cui, 2011; Prakash et al., 2011), redox gels (Dong, Wang and 
Du, 2006; Jin et al., 2012; Narayanan et al., 2012; Liakos et al., 2013),  and pump 
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systems (Ai et al., 2010; Li et al., 2010; Shin et al., 2011; Sheybani, Gensler and Meng, 
2013).  The electrochemical transitions and chemical structures which permit their 
adaption to drug release are assessed in the following subsections.   
 
1.4.1 Microelectromechanical Systems (MEMs) Devices  
 
Electrochemically adapted materials and electrochemically controlled drug 
delivery systems are being increasingly employed as the prime candidates for the 
development of microdevice release systems. Such systems prevail over stimuli-
responsive delivery methods as they can be easily miniaturised to be incorporated 
into MEMs devices that can control the delivery of a drug in a more precise manner.  
These microsystems have been shown to effectively deliver a drug in a highly 
controlled manner and electrochemically initiated release has been achieved 
through a microchip system as shown in Figure 1.4.1.  As discussed in the previous 
sections, patient compliance can be considered a major issue when it comes to 
assessing the therapeutic outcome of a drug therapy, especially for treatments that 
require daily injections or multiples dosages.  In cases such as this, implantable 
microdevices can significantly improve therapeutic outcomes by removing the 
potential for missed doses (Kleiner, Wright and Wang, 2014).  At present, implantable 
micro delivery systems are being developed using sophisticated microfabrication 
technologies.  Microfabricated drug delivery systems have been designed to be 
equipped with precisely measured geometry lending to the distribution of drug 
components in a highly favorable and regulated manner.   
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Figure 1.4.1 A Solid-state microchip drug delivery system. Adapted from (John T. Santini, Cima and 
Langer, 1999). 
 
The micro device shown in Figure 1.4.1 is a sloid-state microchip system that can 
deliver individual or multiple reagent release from the micro scale reservoirs located 
within the microchip (J T Santini, Cima and Langer, 1999).  The delivery reservoir is 
sealed with a gold anode membrane, which remains intact until the imposition of an 
electrochemical trigger, resulting in the controlled electrochemical dissolution of the 
gold thereby releasing its contents.  The application of an electrochemical potential 
(+1.04 V for several seconds) at the gold film anode triggers the oxidation of the gold 
and subsequent degradation of the film, allowing the entrapped drug molecules to 
move from the reservoir to the desired delivery site in a regulated manner.  Further 
development of microchip delivery systems that could be implanted into the desired 
tissue have great potential to lead research in the next generation of ‘smart’ drug 
delivery devices. 
 
MEMs drug delivery systems offer a substantial profile of benefits, however the 
invasiveness of implantable drug delivery systems is evident (Kleiner, Wright and 
Wang, 2014).  Of course, with any implantable device, a minor surgical procedure is 
necessary, this may cause distress among some patients.  One of the major 
advantages of micro implantable systems is that patient discomfort can be minimized, 
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this however raises questions regarding the quantity of drug agents that can be 
stored within the device during treatment before this supply is exhausted.   Other 
concerns with micro systems relates to issues of power – is there a need for a battery 
or can it be done wirelessly. If a physical power source is required – this raises issues 
over size, life and potential toxicity.  The battery inside the system can occupy a large 
volume which therefore limits the amount of space that can be used for drug storage. 
 
MEMs systems have also been developed for use in a wide range of other applications 
including: controlled release systems (Pirmoradi et al., 2011), lab-on-a-chip systems 
(Jung et al., 2015) and microfluidic devices (Yoon et al., 2014).  In some cases, it is 
essential that some drugs such as hormones, will have an enhanced therapeutic 
outcome if they are delivered in a manner that closely mimics how they would be 
produced naturally in the body.  Through the development and pursuit of micro 
fabrication technologies, the current prospects of drug delivery have been able to 
make significant steps forward from traditional techniques.  The miniaturisation of 
drug delivery devices has allowed new kinds of drug therapies, such as micro 
diffusion pumps (Meng and Hoang, 2012), to be successfully scaled down into more 
conveniently implantable delivery systems (Gensler, Sheybani, P. Y. Li, et al., 2012; 
Kleiner, Wright and Wang, 2014).  It should be noted however, that the intention of 
this literature review is not to consider the fabrication of the microsystems 
themselves but rather to explore and assess the controlled release strategies that 
they employ and the methodologies that could, in principle, be modified to the ever-
decreasing device formats. 
 
Micro device design considerations with regards to material properties are key when 
it comes to promoting interactions between a biological system and the interface of 
the device.  During material selection, analysis of physiochemical parameters will 
ensure that the device will respond in a manner that does not initiate an immune 
response from implantation, factors to be considered include: hydrophilicity, protein 
adhesion, electrical properties and electrochemical parameters.  Careful selection of 
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materials based on these considerations is enabling the further development of novel 
delivery systems that have the potential to become the new normal within treatment 
regimes. 
 
1.4.2 Conducting Polymers 
 
Historically, conducting polymers have been used in a wide variety of 
biomedical and sensing applications.   They have attracted increasing interest in the 
field of drug delivery due to their electronic and optical properties, high conductivity 
and tuneable qualities allowing the polymer to be made porous, biodegradable or 
biocompatible (Priya James et al., 2014; Kamaly, Yameen, Wu and Omid C Farokhzad, 
2016).   
 
The ability to have control over the redox state of polymers to allow for physical 
swelling or dissolution, via the capture or expulsion of anions (detailed in Figure 
1.4.2) provides an opportunity for drug loading or entrapment.   Typical examples 
can include the use of the following: neurotrophin (Richardson et al., 2009; Wise and 
Gillespie, 2012), dexamethasone (Leprince et al., 2010; Bohl et al., 2012), risperidone 
(Svirskis, Wright, et al., 2010) and several N-methyl-D-aspartate (NMDA) receptor 
inhibitors (Stauffer et al., 2011).  The polymer poly(phenylene-vinylene) (Tang et al., 
2009), has been previously established as effective candidate in controlled release 
applications (Wadhwa, Lagenaur and Cui, 2006).  Perhaps the most studied 
conductive polymer within electrochemical applications is the conjugated polymer 
polypyrrole (George et al., 2006; Svirskis, Wright, et al., 2010).  The stimuli responsive 
properties of polypyrrole lend it to be an excellent candidate for drug release 
applications, particularly within in vivo and in vitro biomedical applications due to its 
biocompatible nature (Wang et al., 2004; George et al., 2005). 
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Figure 1.4.2 A Polypyrrole system prepared with immobilized anions that swell and incorporate 
cations upon reduction; cations can then be expelled on oxidation. Adapted from (Svirskis, Travas-
Sejdic, et al., 2010b). 
 
It also possesses advantageous chemical attributes and good conductivity in 
biological environments.  The monomers of polypyrrole undergo oxidative 
polymerisation as shown in Figure 1.4.3 , where oxidation forms radical cations, and 
oligomers are formed via a head to tail coupling reaction resulting in a linear polymer 
chain (Svirskis, Travas-Sejdic, et al., 2010a). Oxidation can be achieved by either 
chemical or electrochemical synthesis via the application of an oxidative potential 
through an appropriate electrode substrate.   
 
 
 
 
Figure 1.4.3 Oxidative polymerisation of polypyrrole 
 
Electrochemical oxidation is often preferred over chemical oxidation in the 
preparation of intrinsically conducting polymer based drug delivery systems as they 
offer precise control of the electrical properties and the scaling of the polymer, which 
can be achieved by adjusting the rate and the quantity of charge that is circulated.  
Hard templates are involved in both chemical and electrochemical polymerization.  
With chemical polymerization, a hard template is submerged in a suspension 
containing an oxidant, monomers and a dopant.  On the other hand, electrochemical 
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oxidation involves a conductive electrode or a hard template with a conductive face 
where the polymer grows. 
 
Some of the first tunable polymer systems were drug loaded polymer films with the 
drug loaded as counter ions. The latter can then be released after a reducing 
potential is applied to the conductive film.  Electrochemically controlled drug release 
has been reported in a number of biomedical applications where traditional 
techniques can ultimately fail.  Conductive polymer coatings have been used in 
conjunction with neural prostheses to minimise the formation of an astro-glial sheath 
around implanted microelectronic devices, which can cause the electrode arrays to 
fail.  Wadhwa et al (2006), observed that by releasing the synthetic glucocorticoid 
anti-inflammatory drug Dexamethasone (Dex), they could reduce inflammation 
around the implantation site and therefore reduce the risk of the neural arrays 
failing.  Drug release was achieved using cyclic voltammetry where the voltage was 
swept from -0.8 to +1.4 V at a polypyrrole coated gold electrode that was loaded with 
an ionic form of dexamethasone.   
 
The approach to using polymer films as drug releasing actuators may be 
straightforward, however they have found success in many other biomedical 
applications including the treatment of Sensorineural Hearing Loss (SNHL).  SNHL 
occurs when the spiral ganglion neurons (SGNs) encounter damage, deterioration or 
when there is a loss of hair cells that send electrical signals, which have been 
converted from sound, to the brain (Wise and Gillespie, 2012).  A detailed diagram 
of a normal cochlea (A) and a deaf cochlea (B) are shown in Figure 1.4.4, there is a 
noticeable lack of hair cells in image B, where a cochlea implant electrode has been 
positioned.  Similar to the study with the polypyrrole coated neural prostheses, 
controlled deposition at the electrode surface of the cochlea implant can be 
achieved, again furthering the advantages and ease of using conducting polymers 
from drug release application.  This is of key importance when a high degree of 
deposition precision is required during the manufacture of microfabricated systems 
at the nano-scale. 
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Figure 1.4.4 (A) Normal cochlea (B) Deaf cochlea electrode array can be implanted to electrically 
activate SGN. Adapted from (Wise and Gillespie, 2012). 
 
It has been shown in existing research that the delivery of neurothrophin from 
implanted cochlea electrodes can protect the SGNs from damage and help to deliver 
electrical stimulation to the cochlea.  Richardson et al. previously demonstrated the 
successful delivery of neurothrophin to cochlea neurons from drug eluting 
polypyrrole coated electrodes (Richardson et al., 2009).  The study showed that the 
polypyrrole modified electrodes were able to aid in the protection and preservation 
of SGNs, without affecting the function of the cochlear implant.  Drug delivery that 
can be achieved from the device itself is particularly important in this case due to the 
restricted accessibility of the anatomy within the inner ear, where successful 
prolonged drug delivery is hard to achieve.  Drug loaded polymeric coatings allow full 
precise control over the release of the drug, along with other benefits over direct 
injection into the site which may cause fluid leakage resulting in variations and 
inconsistencies in drug dosage. 
 
One drawback of drug loaded polymer films is that they are limited by their volume, 
as the film itself is the primary drug carrier, therefore limiting the quantity of the drug 
molecules that can be loaded within the film.  Due to this, applications that can often 
require high dosages over a long timeframe may not be as feasible.  In recent years, 
there has been an emergence in the use of composites within drug release 
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applications, which have been favoured due to their larger drug loading capabilities 
within controlled release systems (Costache et al., 2010; Elliott Donaghue and 
Shoichet, 2015; Yassine et al., 2016).  This has led to a change in the way that 
polymers can be utilised and manipulated.  As an alternative to being used as a 
‘sponge’ that can be electrochemically controlled to release a drug, much more 
efficient and controllable polymer systems are being exploited as valve mechanisms.  
This mechanism functions to trap molecules in a drug reservoir until an appropriate 
electrical signal is triggered. Once the signal is received, the release of the trapped 
molecules is activated.  In previous work, dexamethasone has been electrochemically 
released from carbon nanotubes (CNT) that have been capped with polypyrrole (Luo, 
Matranga, Tan, Alba and Xinyan T. Cui, 2011).  The controlled release of the 
dexamethasone was achieved through the electrochemical reduction (-0.5 V) of the 
pyrrole caps, allowing the movement of the entrapped drug out of the CNT.  The CNT 
can be further manipulated through electrochemical oxidation (+0.5 V) which allows 
the polymer cap to be closed again when the desired level of drug release has been 
achieved as demonstrated in Figure 1.4.5.  Similar methodologies have also been 
employed in the research of chemotherapy treatments (Prakash et al., 2011; Vashist 
et al., 2011).  
 
 
 
 
 
 
 
Figure 1.4.5 Electrochemically controlled release of drugs from loaded nanotubes. Adapted from 
(Luo, Matranga, Tan, Alba and Xinyan T. Cui, 2011). 
 
By using similar approaches to the CNT application, the ability to tailor the properties 
of conductive polymer films have been demonstrated in the development of 
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transdermal microneedle systems.  As discussed earlier, transdermal systems 
typically operate on passive transfer, where the drug molecules are delivered from a 
reservoir and pass across the skin.  However, it is apparent that more sophisticated 
transdermal systems are being developed from smart stimuli responsive polymers.  
An example of this kind of transdermal technology has been developed by Valdes-
Ramirez and co-workers (2012).  The basic system is highlighted in Figure 1.4.6. In 
this case, polypyrrole is utilised as the electronic gate. A laser patterned membrane 
- possessing small micron sized holes is combined with a polypyrrole thin film to seal 
the drug reservoir.  In this particular case, the polypyrrole film acts as a barrier 
restricting the drug molecules within the reservoir, the film is then deposited onto 
porous polycarbonate film which has been sputtered with gold.  The patch is 
micromachined to create a surface of hollow microneedles and attached to the 
polypyrrole/polycarbonate composite layer.  Controlled release of the drug 
molecules occurs when a suitable redox potential is applied to the conductive 
polycarbonate layer, thereby causing a change in the redox state of the polypyrrole 
film and allowing the movement of drug molecules to pass up through the film 
(Valdés-Ramírez, Joshua R. Windmiller, et al., 2012).   
 
 
 
 
 
 
 
 
 
Figure 1.4.6 Microneedle patch with polypyrrole release film. (A) Before release (-1.1 V) and (B) 
After release (+0.5 V). Adapted from (Valdés-Ramírez, Joshua R Windmiller, et al., 2012). 
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While the transdermal system contains needles that are at the microscale, the 
reservoir where the drugs are stored is not however limited to the same scale. The 
increased capacity allows the device to be used for more sustained release 
applications where perhaps the patch may need to be worn for a prolonged length 
of time.  Another important observation with this kind of system is that it can be 
equipped with multiple individually addressable reservoirs which will allows multi 
reagent release to be achieved from a single patch. 
 
The conception of “artificial muscle” stemmed from early work on the 
electrochemical behaviour of  conducting polymers, in particular polypyrrole (Low et 
al., 2000).  However, in more recent research focused on drug delivery, the “artificial 
muscle” utilised a chemo mechanical actuator based on a hydrogel combined with a 
redox polymer equipped with electrochemical abilities.  Under the appropriate 
conditions, the polymer blend exhibits swelling properties when an electrochemical 
potential is applied, similar to the approach described above, thus resulting in the 
polymer creating open and close transitions behaving in a manner desirable to 
controllable valves (Low et al., 2000).   
 
1.4.3 Manipulation of Redox Hydrogels 
 
Alginates are naturally occurring biodegradable polymers found in brown 
marine alae.  They have been extensively used in a number of areas including 
thickeners in the food industry, binders in the pharmaceutical industry and as drug 
loaded hydrogels in drug delivery applications (Almeida and Almeida, 2004; Dong, 
Wang and Du, 2006).  Upon hydration, alginates form a viscous gel which can be 
chemically altered to change its mechanical and physical properties to perform 
favourably in many biomedical applications.  Alginate gels form a hydrogel matrix 
when they come into contact with cations such as calcium ions and have been used 
previously in controlled release applications (Liakos et al., 2013), wound dressings 
(Liakos et al., 2014), and tissue engineering (Venkatesan et al., 2014).   
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Crosslinking through interaction with metal ions such as Mg2+ and Ca2+ have long 
been exploited (Jin et al., 2012) but, from an electrochemical perspective, neither 
system offers an opportunity for electrochemical control.  However, electrochemical 
control can be achieved if Fe2+ is added to the gel as the crosslinking agent rather 
than calcium. The alginate/ferrous mixture can then be loaded with a therapeutic 
agent.  The presence of ferrous ion (Fe2+) has little effect on dissolved alginate but its 
electrochemical oxidation to the ferric state (Fe3+) induces crosslinking (Figure 1.4.7) 
and offers the possibility of controlling the nucleation of the hydrogel, its spatial 
location and the material entrapped within the 3D polysaccharide network.   
 
 
 
 
 
 
Figure 1.4.7 Electrochemical reduction of the ferric ions resulting in the disruption and dissolution of 
alginate layers 
 
The ferric ions (Fe3+) are characteristically viewed as hard metal cations, which attach 
preferentially to the negatively charged carboxyl groups within the alginate - 
effectively binding much more strongly compared to Fe2+.  On the other hand, the 
ferrous (Fe2+) ions bind preferentially to the neutral ligands and are considered “soft” 
metal cations.  When a reducing potential is applied to the crosslinked ferric 
component, gel disruption and dissolution will commence, resulting in the release of 
entrapped drug molecules.  These crosslinked hydrogels systems have the potential 
to be utilised as alternatives to the polypyrrole microneedle systems described in the 
previous section.  Thereby, proposing a new method for achieving a controllable, site 
specific drug delivery. 
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1.4.4 Control of Local pH 
 
One of the major concerns when delivering drugs to the colon is designing a 
drug formulation that remains stable during transit until it reaches the site of 
delivery. Drug delivery can be particularly problematic when we take into 
consideration the variation in pH/microbe composition present, which can cause 
drug degradation or perhaps premature release.  Traditionally, drug delivery to a 
specific part of the gut has been achieved using pH sensitive films that respond by 
releasing the drug therapy in response to the local pH.  The pH within the stomach 
can vary, during fasting the pH usually falls between pH 1 and 2. After eating, the pH 
tends to increase to around pH 6.6 or higher due to the movement of chime from the 
stomach to the small intestine (Evans et al., 1988; Philip and Philip, 2010).  During 
thin film manufacture, the pH resistance of a film can be accurately modified to 
protect the therapeutic agent until it reaches the delivery site.  Upon delivery 
however, there is little control over the release mechanism.  As discussed previously 
in Section 1.1, enteric coatings have been widely used in oral tablet formulation 
(Maroni, Del Curto, et al., 2013), where the drug content remains intact until the 
capsule reaches a site of higher pH causing rupturing of the film and consequent 
release of the drug.  Another approach, similar to the method described, uses 
biodegradable polymeric coatings which protect the drug during transit through 
environments of elevated pH, until it comes into contact with microbial enzymes 
located in the colon which trigger film degradation. This ultimately leads to the 
rupturing of the polymer back bone and the delivery of the drug (Karrout et al., 2009; 
Amidon, Brown and Dave, 2015).   
 
1.4.5 Electrochemical Pump Systems 
 
The methodologies described within the previous sections have largely 
focused on the diffusional movement of the drug from a reservoir to the delivery site 
– in most cases these approaches would not be appropriate when it comes to delivery 
to more complex or restricted anatomy (Ai et al., 2010). In order to achieve more 
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substantial and sustained movement of the drug, several methodologies have been 
developed to prompt the controlled movement of the drug during the release 
process.  Electrochemical investigations have established a sophisticated method for 
the manipulation of the local pH involving electrolysis (Cheng and Chang, 2011; 
Anderson and Davis, 2015). An associated limitation of the method is gaseous 
evolution, however, this product can be exploited for use in other scenarios to 
achieve drug release from pump systems (Sheybani, Gensler and Meng, 2013). 
 
The two approaches to this pump-like mechanism have been outlined in Figure 
1.4.8A and 1.4.8B. In the simplest case (A), the application of a suitable current 
induces water electrolysis at the electrodes which are in contact with the electrolyte 
which cause gaseous evolution. The formation of gas within the chamber increases 
the local pressure and forces the liquid containing the dissolved drug out of the 
delivery port. A more sophisticated approach (B) involves the use of bellows to 
prevent the degradation of the drug as a consequence of reaction at the electrode or 
changes in pH brought about by the electrolysis processes. The gas evolution within 
the parylene bellows (C) causes expansion which again forces the drug loaded 
solution to exit the port (Sheybani, Gensler and Meng, 2013).  This relatively straight 
forward approach has been applied to treat various conditions of the eye which 
require discrete continuous delivery as a result of the intricate anatomy of the 
delivery site, therefore proving electrochemical systems indeed prevail over 
conventional delivery techniques (Li et al., 2008; Uday B Kompella et al., 2013; Cima 
et al., 2014; Yasin et al., 2014).  Frequently, drug delivery to the eye is achieved 
through eye drops or direct injection, yet they do not have the benefit of a highly 
precise and controllable delivery mechanism.   
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Figure 1.4.8 Electrolysis pumps exploiting gaseous evolution to displace the drug from the device. 
Adapted from (Sheybani, Gensler and Meng, 2013). 
 
An implantable electrochemical micro device would proffer several advantages over 
the conventional approaches to drug delivery to the eye, which could allow sustained 
delivery from a micro sized system.  While the bellows system have been successful 
in their application, a further improvement would feature the use of electroosmotic 
pumping (Ai et al., 2010).  Drug release is achieved in a relatively simple manner from 
electroosmotic systems, which have no moving parts, by placing a porous layer such 
as alumina or silica, between two electrodes and allowing the drug to flow from the 
reservoir (Chen et al., 2010).  
 
Luft and colleagues were one of the first research groups to employ this approach for 
the development of one of the first electroosmotic insulin pumps in 1978 (Luft, Kuehl 
and Richter, 1978).  Since its inception, their approach has been used in several 
bioanalytical systems and microfluidic platforms (Bourouina, Bossebuf and 
Grandchamp, 1997; Pikal, 2001; Litster et al., 2007; Wang et al., 2009). Over time 
there have been concerns with the operational voltages, where water electrolysis 
can occur, leading to gaseous evolution.  The subsequent production of oxygen and 
hydrogen, can become trapped within the membrane layer, resulting in partial 
electrode insulation and irregular flow patterns (Litster et al., 2007; Ai et al., 2010). 
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1.4.6 Covalently Immobilised Drugs 
 
The methodologies that have been discussed above have generally involved 
the drug molecules being free – albeit enclosed within the drug reservoir.  The 
methodology employing covalently immobilised drugs aligns with the 
electrochemical cleavage of drugs covalently bound to the electrode surface.  By 
covalently attaching the drug molecules to the electrode surface it is possible to 
minimise the likelihood of gradual leakage.  Minimising leakage is a key issue if the 
long-term storage of an active component is necessary.  An innovative approach for 
the treatment of Inflammatory Bowel Disease (IBD) has utilised covalently 
immobilised drugs linked to the gel framework within a hydrogel via azoaromatic 
linkages.  Within the hydrogel there is an azo cross-linking agent along with a pH 
sensitive monomer, which ensure protection of the drug during digestion in the 
stomach and from degradation in the small intestine.  The reductive action of the 
azoreductases found in the colon, cause the breakage of the azo linkages resulting in 
drug release. The unfortunate side effects of the degradation of azo-polymeric 
matrices is the production of toxic by-products, rendering them unfit for long-term 
treatment therapies (Shantha, Ravichandran and Rao, 1995; Yamaoka et al., 2000; 
Stubbe et al., 2001).   
 
Following this research, an alternative method to the hydrogel system has been 
developed that is more equipped for use with systems at the micro – nano scale.  The 
technique involves covalent azo linkage, between drugs that possess diazonium salt 
functionalities, directly to carbon substrates.  Drug release can then be achieved 
through the electrochemical reduction of the azo functional groups at the surface of 
the carbon, as opposed to relying on enzyme induced degradation to release the drug 
(Wildgoose et al., 2005).  Further Investigation is still required to determine the 
toxicological consequences of the method; however, it does present a relatively 
uncomplicated means for functionalisation of carbon nanostructures such as carbon 
nanotubes and graphene nanoflakes. 
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1.4.7 Wound Healing Sutures 
 
In recent years there has been growing interest in the development of drug-
eluting sutures for a variety of clinical applications.  Traditionally, surgical sutures 
have been used to close wounds and facilitate the healing of wounds by holding 
tissue together to limit exposure to possible infections.  As sutures are placed within 
the immediate wound site, this makes them a prime candidate for drug delivery.  
There are a wide variety of suture materials available for clinical use.  The two main 
types are absorbable and non-absorbable.  Absorbable sutures lose around 50% of 
their tensile strength within 60 days of being in contact with tissue, on the other hand 
non-absorbable suture can maintain their tensile strength beyond 60 days (Dennis, 
Sethu, Nayak, Mohan, Y. Morsi, et al., 2016).  
 
Historically, suture materials have been derived from several sources including: gold 
and silver wires, silk, horse hair and plant fibres – including linen and cotton.  Sutures 
derived from naturally occurring materials can be easily broken down by proteolytic 
enzymes, thus allowing them to be absorbed within 70 days (Benicewicz and Hopper, 
1991; Dennis, Sethu, Nayak, Mohan, Y. Morsi, et al., 2016).  More recently, synthetic 
biomaterials such as polydioxanone and poly(lactic-co-glycolic acid) have been used 
as suture materials (Lee et al., 2013).  Degradation of synthetic absorbable sutures 
occurs via hydrolysis, whereby the polymers chains of the suture material are broken 
down when water molecules permeate into the polymer.  On the other hand, non-
absorbable sutures are mostly resistant to degradation within tissue as they are 
unaffected by hydrolysis and resistant to enzymatic action and consequently must be 
physically removed after wound healing.  
 
Despite the wide range of suture materials available, there is no one suture material 
that would be suitable for all types of surgical applications.  Many factors must be 
considered when choosing an ideal suture material, which can depend on the tension 
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across the wound, the depth of tissue at the wound site, expected duration of wound 
healing, and if it is likely that there will be an inflammatory response.  The mechanical 
properties of sutures can be tailored to meet the functional requirements of the 
wound site and can be achieved by braiding or coating the surface of the suture 
material.  The principle feature of a surgical suture is its tensile strength.  The tensile 
strength of the suture material depends on whether the suture is monofilament or 
multifilament.  Multifilament sutures tend to exhibit more desirable mechanical 
properties with superior flexibility over the monofilament varieties.   
 
In recent years, there has been considerable growth in the development of the next 
generation of sutures that possess additional modifications such as the addition of 
antimicrobial agents such as silver nanoparticles or triclosan which have been shown 
to reduce infection rates and promote wound healing. Historically, silver 
nanoparticles have been shown as ideal candidates for the coating of polymeric 
materials for the enhancement of their antimicrobial profile.  The antibacterial effect 
of the nanoparticles initiates the generation of reactive oxygen species which directly 
affects the cell membrane of infectious microorganisms while also reducing the rate 
of bacterial adhesion to the surface of the suture (Chaloupka, Malam and Seifalian, 
2010; Dennis, Sethu, Nayak, Mohan, Y. Y. Morsi, et al., 2016a).  The advantages 
proffered with the addition of silver nanoparticles are particularly important given 
the increasing concerns over antimicrobial resistance.  In addition to the coating of 
sutures with antimicrobial agents, the loading of drug agents has been shown to 
reduce infections and promote wound healing.  Drug coating can be achieved 
through dip coating (Joseph et al., 2017), radiation grafting (Gupta, Jain and Singh, 
2008), or by electrospinning (Chen et al., 2012).  One of the main challenges faced 
during the manufacture of drug eluting sutures is to obtain the necessary drug 
concentration without affecting the mechanical properties of the suture, this can be 
achieved by controlled release mechanisms.   
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Controlled release mechanisms that can be incorporated into electronic sutures that 
are capable of sensing and wound monitoring have garnered immense interest in 
recent years (Kim et al., 2012a; Dennis, Sethu, Nayak, Mohan, Y. Y. Morsi, et al., 
2016b).  While still in their infancy, electronic sutures have the potential to monitor, 
sense and mimic biological responses in the body.  The ability to monitor the local 
temperature and pH from within a wound site could provide early diagnostics that 
could potentially alert the patient to infection.  This type of suture will be further 
explored in Chapter 7, where electrochemically driven drug release can be controlled 
through a suture, and the further investigation of the potential for such electronic 
sutures within biomedical applications will be investigated.   
 
1.4.8 Summary 
 
Advances in conventional drug delivery using oral, topical and injectable drugs 
have allowed the treatment of an extensive range of diseases.  However, even with 
these improvements, many boundaries still need to be confronted.  The effectiveness 
of traditional drug delivery can often be highly variable at treating chronic illnesses 
which are dose dependent and require frequent, precise and targeted drug delivery.  
The development of electrochemical strategies for controlled release would enable 
the further progression of drug delivery technologies resulting in improved patient 
outcome. 
 
 
1.5   Electrochemical Enteric Coatings – New Directions 
 
Conventional drug delivery systems still have fundamental issues over release 
time, drug suitability and delivery environment. The addition of enteric coatings can 
offer a more effective approach to delivery by controlling the release of the drug 
contents. With these coatings, the barrier film is designed to protect the drug 
molecules in the low pH environments and is then ruptured or eroded when it 
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encounters higher pH environments found in the duodenum.  In order to function as 
an effective enteric coating, the polymers contain many carboxylic acid groups with 
a pKa value of 3-5 (Lehmann, 1994) .  The most widely used enteric polymers are 
cellulose acetate phthalate, polyvinyl acetate phthalate, hydroxypropyl 
methylcellulose phthalate, Eudragit® L and Eudragit® S.  Slow release polymers are 
suitable for drug release applications, but the work within this project will focus on 
the development a controlled release system utilizing cellulose acetate phthalate 
(CAP) adapted for a range of electrochemical purposes.  CAP is an ideal candidate 
for enteric coatings as it contains many carboxylic acid groups (Figure 1.5.1) and has 
a pKa of around 5.28 (Rando et al., 2006).  This means that when it is exposed to the 
lower pH conditions of the stomach, the carboxylic acid groups will not be fully 
dissociated and therefore the CAP will be resistant to dissolution.   
 
 
 
 
 
 
 
 
 
 
Figure 1.5.1 Chemical structure of cellulose acetate phthalate 
 
An alternative approach has been developed as part of the work described in this 
thesis.  The rationale has been to exploit the CAP enteric coating as a means of 
retaining a model drug but exploit the electrochemical manipulation of pH to induce 
the breakdown of the protective film and release the drug. Its objective is to enable 
a more refined release profile. The base system used throughout is based on 
conductive carbon composites which have been patterned into films or 
microneedles. Irrespective of formation, the presence of the carbon particles allows 
control over the local pH through controlling the potential applied at the interface. It 
was anticipated that holding the potential at the negative end of the potential 
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window (i.e. -2 V, 60 seconds) would result in the reduction of protons leading to an 
increase in the pH.  As the pH rises to the alkaline region – it was expected that the 
dissolution of the CAP film should occur resulting in pores that allow the transfer of 
the drug molecules.  As  the change in pH would only be in the immediate vicinity of 
the holes in the membrane and thus won’t affect the surrounding tissue. (Grozovski 
et al., 2017).  As polyesters are unstable in alkaline solutions we can then control the 
release of the drug at a predetermined time and rate, which can be initiated by the 
carbon components.  
 
1.5.1  Project Objectives 
The project objectives are: 
1. To develop a microscale pH measurement system to monitor the pH 
manipulation capabilities of the functional materials. 
2. To develop new functional materials capable of electrochemically controlled 
release. 
3. Characterise drug release profiles. 
4. Investigate the manipulation of local pH using electrolytic methods. 
5. To develop microneedle patch systems that can deliver a drug agent 
electrochemically. 
6. Optimise the design and assess the efficacy of prototype drug release 
systems 
 
Ultimately, the rationale would be to provide the preliminary ground work for the 
development of a micro device that could control the release of a drug.  It is 
envisaged that the drug could be stored within a micro reservoir or could be 
potentially embedded into the system itself.  The opening of the reservoir or the 
release of the entrapped drug molecules could be achieved by applying an 
electrochemical potential upon receiving an appropriate biomarker response, 
inducing a change in configuration of the smart membrane and therein release the 
drug in a controlled manner. 
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Chapter 2 
 
Materials and Experimental Methodologies 
 
 
Abstract 
 
A concise overview of the experimental materials, techniques and system 
parameters used throughout the project are presented in this chapter.  Technical 
details of the underpinning theory behind each experimental technique is discussed, 
as is the way in which data is presented and analysed.  Specific details of each 
experimental technique are further examined within the Experimental Procedure 
sections within each chapter. 
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2.1  Materials and Instrumentation 
 
Unless stated otherwise, all reagents used during experimental procedures 
were purchased from Sigma-Aldrich (UK) and were of the highest grade available.    
Electrochemical measurements were conducted at 22 °C ± 2 °C in stock solutions 
prepared in Britton-Robinson buffer (acetic, boric and phosphoric acids – each at a 
concentration of 0.04 M) and then, through the addition of concentrated sodium 
hydroxide, the pH was adjusted to the appropriate value.  All buffer solutions have a 
specified amount of potassium chloride (0.1 M) added in order to provide sufficient 
electrolyte and, in cases where a silver wire is used as the reference, define the 
reference potential.  Solutions were prepared in deionised water from an Elgastat 
(Elga, UK) water system and refrigerated when not in use. 
   
Electrochemical analysis was performed utilising a µAutolab Type III computer 
operated potentiostat (Eco-Chemie, Utrecht, The Netherlands) and a three electrode 
configuration was employed unless stated otherwise In some instances, a two 
electrode configuration was used whereby a silver/silver chloride coated wire was 
used as a combined counter/reference electrode.  Throughout the experimental 
investigations, several materials were employed as the working electrode and 
included: glassy carbon, carbon fibre, palladium, gold, and carbon/cellulose acetate 
phthalate composites.  In most cases, a platinum wire was employed as the counter 
electrode and a commercial Ag|AgCl (3 M KCl) half cell reference electrode (BAS 
Technicol, UK) completed the cell assembly.  Further details of electrochemical 
configuration and measurements are described in each chapter. 
 
 
2.2  Electrochemical Instrumentation 
 
 
Electrochemistry is the study of the chemical process that causes electron 
transfer between electrodes and reactant species in a solution.   Electrochemical 
analysis can be used to provide both qualitive and quantitative data, as well as 
ascertaining the thermodynamics and transfer kinetics of a particular reaction.  
41 
 
Analytical electrochemistry is often employed for the detection or analysis of specific 
biomarkers, where investigation begins with the oxidation or the reduction of the 
analyte of interest at suitable potentials.  It is often common practice from an 
electrochemical stand point, to modify the working electrode by either chemical or 
physicals means.  Modification is often undertaken to ensure specificity in 
multifaceted biological media due to the number of species that are considered 
electrochemical interferences.  In this work, a number of electrode surface 
modification techniques have been employed and will be detailed within the relevant 
sections.  Overall, electrochemistry proffers many advantages over traditional 
laboratory analysis, it has considerably lower cost of instrumentation compared to 
spectroscopic instrumentation, proffers many options for the choice of electrode 
materials and enables control over system design lending to its widespread 
applicability for incorporation into a large number of applications including: 
biomedical, industrial and environment fields of research. 
 
 
 
 
2.3  Electrochemical Cells 
 
 
 
When undergoing electrochemical investigation, the most commonly used 
set up is a three electrode system as shown in Figure 2.3.1.  A three electrode system 
consists of a working electrode (WE), where the reaction of interest takes place, a 
reference electrode (RE) which provides a stable and well-known potential and a 
counter electrode (CE) which controls the flow of current through the working 
electrode and not the reference.  In some experiments including within this work, a 
two electrode system was employed, whereby a combined counter/reference 
electrode is utilised. Details of cell setup will be further described in the relevant 
experimental subsection.   The instrumentation that maintains the potential of the 
working electrode with respect to the reference is a potentiostat.   
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Figure 2.3.1 Diagram of a typical electrochemical system utilising a three electrode setup and a 
nitrogen inlet 
 
 
2.3.1 Reference Electrodes  
 
 
The purpose of a reference electrode is to provide a fixed and stable potential 
which serves to regulate the potential at the working electrode.  The reference 
electrode’s potential is independent of the current density and is generally 
unaffected by the sample solution of interest, but only in cases where the half cells 
contain their own reference solution.  Throughout this project, a conventional silver-
silver chloride (Ag | AgCl) half-cell reference electrode was employed during 
electrochemical investigations and the electrode fabrication is shown in Figure 2.3.2.  
The silver/silver chloride reference electrode consists of a silver wire (Ag) coated with 
a layer of silver chloride, typically immersed in a glass cylinder system which contains 
a solution of 3 M KCl in order to define the potential.  Located at the bottom of the 
Ag/AgCl reference electrode is a porous frit which allows the gradual outflow of KCl 
to induce electrical conduction within the sample solution.  
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Figure 2.3.2 Commercial reference electrode and corresponding electrode process 
 
 
The chemical reaction taking place within the cell can undergo two processes namely 
oxidation and reduction.  The difference in potential between the two processes is 
the emf of the cell.  The electrochemical activity that takes place inside the half cell 
can be defined by the Nernst equation: 
 
 
 
 
 
 
 
AgCl(S) + e   ↔   Ag (s) + Cl-(aq)  E0 = +0.222 V 
  
 
…Eq.2.1 
Where: 
E is the electrode potential (Volts); 
Eo is the standard electrode potential for the redox couple (Volts); 
R is the gas constant (8.314 JK-1 mol-1); 
T is temperature (Kelvin); 
n is the number of electrons transferred to the electrode during reaction; 
F is Faraday constant (96485 C mol-1) 
[A] and [B] are activities of the oxidised and reduced species. 
 
 
Cl-(aq) | AgCl(s), Ag(s) 
AgCl(s) + e   Ag(s) + Cl-(aq)  E0 = + 0.222 V 
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As mentioned above, some experiments utilised a chloridised silver wire, further 
details of specific set up can be found in the electrochemical configuration section of 
each chapter.  The chloridised silver wire was prepared by oxidising the wire at +1 V 
for a defined length of time in the presence of KCl (process detailed below) by 
following an already established technique (Huang and Dasgupta, 1997). 
 
 
Ag(s) → Ag+ (aq) + e 
Ag+ (aq) + Cl- (aq) → AgCl(s) 
 
 
…Eq.2.3 
 
This process causes the initial stripping of silver, resulting in the rapid deposition of 
a silver chloride layer which behaves in a similar way to that of a standard commercial 
Ag |AgCl reference electrode.  In contrast with the commercial system, the Ag|AgCl 
wire does not incorporate its own internal chloride solution.  Therefore, during 
investigations where a silver wire reference was used, it was necessary to add a 
known concentration of chloride (0.1 M KCl) to the test solutions to maintain a 
constant reference potential.  
 
 
2.3.2 Working Electrodes 
 
 
During electrochemical investigations, the reaction of interest takes place at 
the working electrode.  A potential is applied between the working electrode and the 
reference through a computer controlled potentiostat.  Due to the constant potential 
at the reference electrode, it can be determined that any changes in the electrode 
potential are as a result of changes at the working electrode. 
 
 
 
 
 
…Eq.2.4 
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Where: 
E = Electrode Potential 
∅M = Electrical 
∅S = Solution 
 
 
In some cases where a two electrode system was used during investigations, 
Equation 2.3 would no longer be appropriate as the current may now pass through 
the reference, thus altering (∅𝑀 − ∅𝑆)𝑟𝑒𝑓𝑒𝑟𝑒𝑛𝑐𝑒.  To determine the electrode potential 
for a two electrode system, the equation would now be replaced with: 
 
 
 
 
 
…Eq.2.5 
Where: 
IR = electrical resistance of the bulk solution between RE and CE 
 
 
Within this set up, any variations in the potential (E) would result in unspecified 
changes in IR along with (∅𝑀 − ∅𝑆) 𝑤𝑜𝑟𝑘𝑖𝑛𝑔. In this case, the current flowing through 
the working electrode is no longer regulated.  However, in situations where the 
working electrode is a microelectrode, this does not apply.  The current that passes 
through these electrodes is very small due to their micron dimensions.  Small 
currents will therefore have little effect on the electrolytic change within the 
reference and the IR will be small enough to disregard (Compton and Banks, 2011). 
 
Throughout experimental procedures, several substrates where chosen as working 
electrodes, depending on their suitability to the applications.   The materials 
investigated included: carbon, palladium and carbon composites due to their inert 
chemical properties.  Choice of electrode material can be dependent on how well the 
electrode will exhibit fast electron transfer kinetics, as well as performing in a manner 
that will yield reproducible results. The sensing area of each working electrode is 
defined within each results chapter, this was achieved by using a laminate assemble 
with a specified window, this approach is used to accurately interpret voltammetry 
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results.  Specific details of their composition, pre-treatment and electrode assembly 
are detailed within the electrode design section within each chapter. 
 
 
 
 
2.3.3 Counter Electrodes 
 
 
Within a three-electrode system, the auxiliary electrode, or the counter 
electrode as it’s more commonly referred to, serves to prevent the surge of large 
currents from flowing through the reference electrode and triggering changes in its 
potential.  A counter electrode should not interfere with the reaction at the working 
electrode, therefore they are usually made from inert materials which are inherently 
conductive.  Due to these desirable characteristics, common materials chosen as 
counter electrodes are platinum, carbon, steel and nickel.  It is important to take into 
consideration the size of a counter electrode, as to reduce the amount of current 
density gathered at this electrode it must be as large as possible (Pletcher, 2009).  
Unless stated otherwise, a platinum wire was chosen as a counter electrode 
throughout experiments due to its inert nature and high conductivity.  
 
 
 
2.3.4 Buffer Solution 
 
 
The background solution of a standard electrode electrochemical chemical 
cell is comprised of one or more analytes which are dissolved in a conductive 
electrolyte solution therefore allowing current to flow through the cell thus allowing 
electrochemical measurements to be undertaken.  The conductive electrolyte 
solution should be inert so that specific measurements can be directed at the analyte 
of interest.  Variations in pH at the electrode surface can also be minimised by used 
buffer solutions, this can be particularly influential if the electrode process undergoes 
the production or depletion of H+ (or OH-) (Pletcher, 2009).  Throughout the duration 
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of experimental procedures, Britton-Robinson buffer was used, and its composition 
is detailed in Section 2.1 above. 
 
 
 
The Nernst equation shown (shown below) an be rearranged to determine the 
change in potential (E) as a consequence of taking the log change in the 
concentration of hydrogen ion (1 pH unit).  Therefore, if a process behaves in a 
Nernstian manner, where a change of 1 pH unit occurs, the potential shift would be 
59.1 mV under standard conditions (i.e. 25 ˚C, and where n=1) This electrochemical 
principle is the underpinning theory behind electrochemical pH sensing concepts 
(Compton and Banks, 2011). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
…Eq.2.2 
 
2.4  Mass Transport 
 
The types of molecular movement are described below, their importance in 
analytical electrochemistry is key as molecules can be chemically altered during the 
measurement process at the electrode-solution interface.  The three main types of 
molecular movement in solution are: diffusion, migration and convection. 
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2.4.1 Diffusion 
 
 
When molecules move from areas of high concentration to areas of low 
concentration the motion is known as diffusion.  Diffusion can occur at an electrode 
surface when a chemical change is initiated for example, when a reaction at the 
electrode triggers the transitional change of the original material to the product.  
When in solution, the concentration of the original material is less concentrated at 
the electrode surface than the concentration of that in the bulk of the solution, while 
the opposite of this applies to the product.  Therefore, when a reaction takes place 
at the electrode, diffusion drives the starting material toward the electrode sensing 
area, and the resulting product will then diffuse out into the bulk solution (Pletcher, 
1982).  The product can be defined quantitatively by Fick’s laws of diffusion.  Fick’s 
first law (Equation 2.5) expresses that the rate of diffusion, goes from an area of high 
concentration to an area of low concentration and is directly proportional to the 
steepness of the concentration gradient. 
 
 
Flux =  −𝐷 
𝑑𝑐
𝑑𝑥
 
 
 
…Eq.2.6 
Where: 
D = diffusion coefficient in cm2/s 
dc / dx = the concentration gradient at distance x 
 
 
 
Fick’s second law of diffusion describes how diffusion causes the concentration to 
change with time and is shown in Equation 2.7.  The equation dictates that the 
concentration is now a function of both distance and time (Pletcher, 2009). 
 
 
𝜕𝑐
𝜕𝑡
= 𝐷 
𝜕2𝑐
𝜕𝑥2
 
 
 
…Eq.2.7 
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4.4.2 Migration 
 
 
Migration is the transport of charged molecules due to electrostatic-
attraction and electrostatic-repulsion.  The transport of these charged molecules 
across a potential gradient is the motion by which charge transfers through the 
electrolyte solution.  During electrochemical analysis, there is little effect on the mass 
transport of the electroactive compound as the background solution contains a large 
quantity of inert electrolyte (typically 0.1 M) which transports most of the charge, 
meaning there is limited movement of the electroactive compound by migration 
(Pletcher, 1982). 
 
2.4.3 Convection 
 
 
Convection is the physical transport of molecules within a solution and can 
occur naturally due to density gradients, or mechanically by stirring or through forced 
flow through a channel. If mechanical induced convection, in the form of stirring the 
solution or using a rotation disc electrode is used, this will be the principal form of 
mass transport (Pletcher, 1982). 
 
 
2.5  Voltammetry 
 
 
Voltammetry is a commonly used electrochemical technique which involves 
varying the potential (voltage) between the working and reference electrodes, the 
resulting current flow (amps) is quantified and presented relative to the potential 
producing a voltammogram.  A variety of commonly used voltammetric techniques 
were used throughout this project and are detailed in the sections below. 
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2.5.1  Cyclic Voltammetry 
 
 
One of the most frequently used voltammetric techniques is cyclic 
voltammetry (CV).  Usually, cyclic voltammetry is the technique that is used initially 
to define and understand the electrochemical processes, this is due to the rate at 
which scans can be completed and the swift collation and interpretation of data 
(Pletcher, 2009).  A triangular waveform is generated by sweeping the potential of 
the working electrode linearly as shown in Figure 2.5.1.  The starting position of the 
potential applied to the working electrode is E1, where there is generally no chemical 
reaction taking place and is swept linearly to E2.  The potential E2 is generally larger 
than the potential needed for the oxidation or reduction process of interest thereby 
allowing the reaction of interest to be recorded.  As detailed in Figure 2.5.1, it can be 
identified that the first half of the triangular waveform is alike to that used in Linear 
Sweep Voltammetry, however, the direction of the sweep is reversed once E2 is 
reached, allowing the potential to be scanned back to its primary state (E1). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.1 Triangular waveform used in cyclic voltammetry 
 
 
After the scan has been completed, with regards to specific scanning parameters, a 
voltammogram is generated whereby the current is presented against a function of 
the applied potential.  A characteristic cyclic voltammogram presenting the response 
observed for a reversible reaction in shown in Figure 2.5.2. 
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Figure 2.5.2 An example cyclic voltammogram showing reversible redox peaks 
 
The voltammogram presented for a reversible system exhibit some well-defined 
features: 
 
• The interpeak distance between the oxidation and reduction peak potentials 
are detailed in Equation 2.8 and are not aligned with the scan rate. 
 
 
 
 
 
…Eq.2.8 
 
• The peak ratio of the forward and reverse scans will be equal to one 
(Equation 2.9). 
 
 
 
 
 
 
…Eq.2.9 
 
• Lastly, the peak currents iap / icp are proportional to the square root of the 
scan rate in a diffusible system. 
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From Figure 2.5.3, we can observe that the current response increases as the scan 
rate is increased.   The change in current can be considered by analysing the size of 
the diffusion layer along with the length of time taken to complete the scan.  
Therefore, it can be observed that by increasing the scan rate we will see a quicker 
rate of scan completion (Figure 2.5.3 A).  The size of the diffusion layer is then 
dependant on the scan rate.  When the scan rate is increased, the distance the 
diffusion layer moves away from the electrode will lessen, i.e. a reduced amount of 
diffusion will happen within the time frame, when compared to a slower scan rate.  
As a result of increasing the scan rate, there will be a surge in the flux to the surface 
of the electrode where the current is related to the flux in the direction the electrode.  
As a result, the size of the current will then be larger at faster scan rates and will be 
smaller at smaller scan rates (Figure 2.5.3 B). 
 
 
Figure 2.5.3 (A) Triangular waveforms used in cyclic voltammetry displaying different scan rates. (B) 
A series of cyclic voltammograms recorded at increasing scan rates 
 
 
A graph detailing the peak current against the square root of the scan rate presents 
a linear relationship and by applying the Randles-Ševčik equation (Equation 2.10) the 
diffusion coefficient can be calculated. 
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…Eq.2.10 
Where: 
jp = current density (A) 
n = number of electrons 
D = diffusion coefficient (cm2/s) 
c = concentration (mol/cm3) 
v = scan rate (V/s) 
 
 
Electrochemical reactions that are reversible tend to demonstrate fast electron 
kinetics and ensure the equilibrium of concentrations of the oxidised and the 
reduced species are maintained.  This equilibrium can only be maintained if there are 
sufficient electron kinetics, if the kinetics are not adequate then the reaction is 
irreversible.  The importance of the peak potential of the oxidation and reduction 
peaks in a standard CV are detailed in Figure 2.5.4. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.4 Cyclic voltammogram detailing the electron kinetics involved in a reversible, quasi 
reversible and irreversible system 
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As previously detailed in Equation 2.8, the ideal peak separation for a categorically 
defined reversible couple would be 59 / n mV, where the rate of transfer of electrons 
between the working electrode and the redox species is fast and is not affected by a 
change in scan rate.  When the rate of electron transfer kinetics is slower, the 
oxidation and reduction peaks move away from each other.  In this case, the 
overpotential needed to oxidise the species becomes greater with growing current 
density, thus resulting in the shift of the oxidation peak to more positive potentials 
where the peak itself appears broader and elongated in comparison to the sharp 
peaks of a reversible system.  A similar effect is observed in the reduction peak which 
will appear more drawn out towards more negative potentials. These observations 
are characteristic of a quasi-reversible couple. 
 
 
When the rate of transfer of electrons between working electrode and redox species 
is slow, the oxidation and reduction peaks are much smaller than those observed in 
a reversible system and are widely separated, this is indicative of an irreversible 
system.  As a result, there is effectively no reconversion of the product back to the 
reactant.  The time it takes for depletion of the surface concentration of the reactant 
is now much longer, therefore decreasing the flux of the reactant at the peak 
potential (Pletcher, 2009). An additional observation between reversible and 
irreversible reactions is that the irreversible couple is reliant on the scan rate. 
 
 
When the peak current is plotted against the square root of the scan rate a linear 
relationship is observed when investigating a reversible system, however this is not 
the case for an irreversible system where the peak current density now must take 
into account the transfer coefficient (α) and is now defined as: 
 
 
 
 
 
 
…Eq.2.11 
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The voltammetric profile and shape of the CV as detailed above is typical of linear 
diffusion at a macroelectrode. As the dimensions of the electrode with regard to the 
diffusion layer thickness shrinks, the diffusion layer transforms into a hemispherical 
shape thus resulting in a noticeable change in the CV profile. The CV shown in Figure 
2.5.5 illustrates near steady-state conditions where the distinctive peak has now 
disappeared (Compton and Banks, 2011).  
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.5 Relationship observed between the size of the electrode (with respect to the diffusion 
layer thickness) and the contribution of convergent diffusion and its observed cyclic voltammograms. 
Adapted from Compton and Banks,2011   
 
 
Electrodes which dimensions are measured in micrometers are categorised as 
‘microelectrodes’. When the dimensions of an electrode exceed this size, they are 
usually termed ‘macroelectrodes’.  As illustrated in Figure 2.5.5, microelectrodes 
perform in different ways from macroelectodes, especially in terms of non-planar 
diffusion which gives rise to faster rates of mass transport. Furthermore, 
microelectrodes possess reduced capacitance in contrast to macroelectrodes as the 
capacitance is directly proportional to the area of the electrode.  Decreasing the 
dimensions of the electrode immediately reduces the capacitance (Compton and 
Banks, 2011).  
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From an analytical perspective, microelectrodes are becoming more popular and are 
often preferred over macroelectrodes as they offer comparable magnitude 
voltammetric response with less capacitance background (Davies and Compton, 
2005). The production of reproducible microelectrodes can be easily achieved 
through lithography - typically in cubic or hexagonal arrays or via an easier method 
implemented by Fletcher and Horne (1999) by facilitating a random distribution 
(array) of microdisc electrodes into an insulating substrate (RAMTM electrodes) 
(Stephen Fletcher and Horne, 1999).  As mentioned previously, the diffusion profile 
of microelectrodes differs in comparison to macroelectrodes.  Individual diffusion 
layers will arise in microelectrode arrays, and the subsequent voltammogram is 
subject to two influences: the dimensions of the diffusion layers in comparison to the 
area of the individual microelectrode and the dimensions of the diffusion layers 
against the size of the insulating substrate or the separation between each 
microelectrode. In accordance with these two influences, Davies and Compton 
(2005) determined that microelectrode arrays can be allocated to one of four classes 
which are detailed in Figure 2.5.6. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.6 Schematic diagram of the four categories of diffusion profiles to which a microelectrode 
array may belong (Davies and Compton, 2005).  Reproduced with permission from Elsevier 
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Traditionally, the majority of microelectrodes that are developed fall into the second 
category, as this is where the maximum current density is obtained.  Steady-state 
behaviour is achieved within this category where the diffusion layers are greater in 
size than the microelectrode, but more significantly are smaller than the space 
between the microelectrodes reinforcing independence.  If the distance between the 
microelectrodes was reduced, as showing in categories 3 and 4, the neighbouring 
diffusion regions will overlap and therefore give rise to linear diffusion as observed 
in a microelectrode (Compton and Banks, 2011).   
 
 
2.5.2 Square Wave Voltammetry 
 
 
Although cyclic voltammetry can provide qualitative information during 
electrochemical investigations, square wave voltammetry (SWV) can be used to 
achieve further quantitative analysis of a sample solution.  Unlike CVs - where the 
potential of the working electrode is swept linearly to form a triangular waveform, 
with SWV the current is recorded as the potential of the working electrode is swept 
in a staircase manner and is demonstrated in Figure 2.5.7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.7 (A) Detailed waveform and parameters used in square wave voltammetry. (B) Full 
profile of the staircase waveform used in a square wave scan 
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The chief principles for SWV are described in Figure 2.5.7 A.  The duration of one 
complete square wave cycle or one staircase step is termed the square wave period 
(τ).  The square wave is categorised by two features, the amplitude (Esw) and the pulse 
width (tp).  The pulse width can also be classified in terms of frequency which is 
described as f = 1/τ or f = 1/2tp.  The step height ΔE is the step height is applied to 
determine the scan rate for a square wave voltammetry experiment (Equation 2.12). 
 
 
 
 
 
 
…Eq.2.12 
 
With the method, during a square-wave period the current is logged twice, this 
happens as each pulse finishes, which is detailed as the green and blue dots seen in 
Figure 2.5.7A.  These are located at the end of the forward current scan - if (green 
dot) and is repeated when the reverse current has been completed - ir (blue dot).  
When the forward and reverse currents are recorded, the output is unidirectional 
sweep as shown in Figure 2.5.8. The critical difference between CV and SWV is that 
the latter is generated from the difference current (Δi)  (Bard and Faulkner, 2001). 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.8 The difference current displayed in a typical square wave voltammogram 
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The peak show in Figure 2.5.8 is positioned at around +0.3 V is representative of 
redox processes and the size of the peaks in SWV are proportional to the 
concentration of the analytes present corresponding to Equation 2.13. 
 
 
 
 
 
…Eq.2.13 
Where:  
Δip = differential peak current (A) 
n = number of electrons 
F = Faraday constant 96485 C mol-1 
A = electrode area (cm2) 
D = diffusion coefficient (cm2/s) 
C = concentration (mol/cm3) 
tp = pulse width in s 
Δψp = dimensionless peak current 
 
 
Square wave voltammetry is often chosen as a more appropriate method over cyclic 
voltammetry especially when a high degree of sensitivity is required along with 
minimal background interface.  This is due to the timing of the current measurement.   
During a CV, current measurement begins directly following the change in potential 
step, however, during SWV the sensitivity is enhanced as the current is logged twice 
during each square-wave period at the completion of each pulse, thus resulting in a 
delay (a few milliseconds) of the recorded current.  This delay is significant as upon 
changing the potential of the electrode surface, there is a reorganisation of ions at 
the interface which in turn leads to an increase in capacitance current.  The current 
is of greater interest on account of the electron transfer to or from the target 
biomarker, termed as the Faradaic current.  As a consequence of the current 
measurement delay in square wave voltammetry, the input to the current signal 
following on from capacitance current is marginal while with cyclic voltammetry, the 
current measured is the addition of these two current measurements.  For this 
reason, much smaller concentrations can be tested by SWV in contrast to CV since 
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the small Faradaic current can frequently be masked by the capacitance effects and 
consequently, by pausing to allow the capacitance dissipate, an improved signal to 
noise ratio can be achieved and as such greater detection limits can be attained (Bard 
and Faulkner, 2001). 
 
 
 
2.5.3 Amperometry 
 
 
 
  Amperometric measurements involve stepping the potential of the working 
electrode, from one potential where there is usually no reaction taking place (E1) and 
then stepped to another (E2) where it is fixed at that potential for a predetermined 
amount of time as shown in Figure 2.5.9.  The step in potentials can be used to induce 
either oxidation or reduction.    
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.9 Potential step procedure used in amperometry 
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For the duration of this process, the current is measured as a function of time and a 
typical current response during amperometry is shown in Figure 2.5.10.  When using 
a potential step, the performance of the current can be explained by Equation 2.14. 
 
 
 
 
 
 
 
…Eq.2.14 
 
Where: 
i = current (A) 
E = electrode potential (V) 
e = electronic charge (C) 
t = time (s) 
Rs = solution resistance in ohms 
Cd = differential capacitance of the double layer in F 
` 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.10 Example of the current response in amperometry 
 
The current-time response reflects the transformation in the concentration gradient 
in the electrodes vicinity (Figure 2.5.11) as a result it has substantial use in acquiring 
62 
 
physical parameters (electrons transferred, effective electrode areas, diffusion 
coefficients etc.) of the system under investigation but has limited diagnostic use. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.11 Concentration profiles for various times into an amperometry experiment 
 
 
In section 2.4.1, Fick’s second law was addressed, which details how diffusion effects 
the concentration gradient with time.  During an amperometric investigation, the 
potential is stepped from one potential to the next in an effort to stimulate an 
electrode process; such as oxidation or reduction.  The shift in potential will bring 
about an adjustment in the concentration of the reactant at the electrode surface, 
causing variation in the reactant concentration close to the electrode surface. This 
results in the diffusion of the reactant in the direction of the electrode, in doing so it 
generates concentration differences around the electrode and the extension of the 
diffusion layer into the bulk solution (Pletcher, 2009). As shown in Figure 2.5.9 the 
diffusion layer expands with time along with the concentration gradient and the flux 
of the reactant towards the electrode surface reduces with time causing a drop in 
current density versus time (Figure 2.5.10). 
 
 
The falling current density versus time transient will follow the Cottrell equation 
(Equation 2.15) which is essentially a test for diffusion control and is shown in 
Equation 2.15: 
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…Eq.2.15 
 
Where: 
j = current density (A) 
n = number of electrons 
F = Faraday constant 96485 C mol-1 
D = diffusion coefficient (cm2/s) 
c = concentration (mol/cm3) 
t = time in (s) 
 
 
2.5.4 Potentiometry 
 
 
Unlike all other previously described voltammetric methods, potentiometry 
measures the potential of the working electrode relative to the reference electrode 
under zero current and is monitored as a function of time (Figure 2.5.12). As zero 
current is passing through the cell, the configuration of the solution remains 
unaffected thus allowing quantitative measurements of the solution’s composition. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.5.12 The potential of the working electrode is measured in relation to the reference 
electrode and recorded as a function of time 
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2.6  Surface / Physical Characterisation Methods 
 
The next section will describe a number of surface and physical 
characterisation techniques that were used throughout the project, these techniques 
can provide key information regarding physical and chemical composition and 
surface morphology.   
 
 
 
 
2.6.1 Scanning Electron Microscope 
 
 
The Scanning Electron Microscope (SEM) is one of the most commonly used 
surface characterisation techniques.  To produce an image, the technique utilises 
electrons instead of light for imaging.  During experimental procedures, materials 
chosen for electrochemical consideration where first characterised using the SEM to 
observe surface morphology and structural defects that may be present on the 
surface of electrode materials.   The sample material is scanned using a high energy 
focused beam of electrons (ranging from 0.5 keV to 40 keV) where the incident beam 
is scanned in a raster pattern.  An electron detector identifies the emitted electrons 
in each position within the scan area.  On the output screen, the brightness of the 
electronic signal is based on the intensity of the emitted electrons. 
 
 
An electron gun, equipped with a tungsten source filament, produces a stream of 
monochromatic electrons.  Tungsten can operate with very high voltages and is 
chosen for this application due to its high melting point and low cost.  The filament 
functions as a cathode, which begins to heat up when a potential is applied, 
generating an electron beam which travels in the direction of the anode.  When the 
sample is placed onto the sample stage and the entry drawer is sealed, the sample is 
held under vacuum, where the incident beam moves in a downward motion towards 
the sample and then towards the detectors.  When the focused beam is directed at 
the sample, backscattered a variety of signals are generated – such as electrons and 
X-rays.  The course taken by the electrons is shown in Figure 2.6.1.  
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Figure 2.6.1 Diagram of a scanning electron microscope showing the pathway taken by the electrons 
 
 
When the beam of electrons reaches the sample stage, several signals are generated 
such as backscattered electrons, secondary electrons, X-rays and auger electrons 
which are shown in Figure 2.6.2.  Backscattered electrons originate from the incident 
beam and are reflected against the sample through elastic scattering.  These signals 
can provide information on the atomic number of the material being examined, 
where higher atomic number materials absorb more electrons.  Secondary electrons 
arise due to inelastic collisions between primary electrons (the beam) and loosely 
bound electrons in the outer shells of the sample atoms are ejected due to a transfer 
of energy from the primary electrons displacing secondary electrons from the 
sample.  Characterisation X-rays are released as the incident beam disconnects an 
inner shell electron from the sample, triggering a higher energy electron to take its 
place and emit energy.  The released energy is acquired by another electron which is 
released form the atom.  The released electron is known as the Auger electron, 
together the Auger electron and X-rays provide diagnostic information relating to the 
surface composition of the sample. 
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Figure 2.6.2 Several types of signals are produced when an electron beam hits the sample 
 
 
The SEM has a large depth of field, which allows a large amount of the sample to be 
in focus at one time, and the technique produces an image which is a reasonable 
good representation of the 3D topography of the sample.  The combination of higher 
magnification, larger depth of field, greater resolution, compositional and 
crystallographic information makes the SEM a greater tool for studied surface 
morphology compared to a traditional light microscope.  Samples should be prepared 
carefully to withstand the vacuum inside the microscope.  Because the SEM 
illuminates the sample with electrons, samples should be made to conduct electricity 
(insulating samples produce charging). Thin layers of conducting material are sputter 
coated onto samples where the most commonly used metals are: Au, Au/Pd, Pt, Cr 
and carbon.  
 
 
2.6.2 X-Ray Photoelectron Spectroscopy 
 
 
X-Ray Photoelectron spectroscopy (XPS) is a technique used to characterise 
the chemical and elemental composition of the uppermost surface regions of a 
material in the range (30 – 50Å). X-rays from a low energy source (typically Mg K 
(1253.6 eV) or Al K (1486.6 eV) X-rays) are directed towards the sample and give 
rise to the emission of the core and valance electrons from atomic shells of the 
elements present on the uppermost surface by the photoemission process. The 
photoelectrons produced possess energies characteristic of the element and the 
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molecular orbital from which they were emitted. They have measurable kinetic 
energies. 
Valence levels, refer to those electrons that interact with those equivalent valence 
levels of other atoms to form chemical bonds. Their character and energy will be 
changed markedly by such interactions. The core levels contain electrons, which are 
not involved in direct chemical bonding and, so they have energies that are 
independent of the chemical species in which the atom is bound. Therefore, the 
identification of the core level binding energy (B.E) is a unique signature for each 
elemental species. 
 
All elements in the periodic table, except for hydrogen and helium, which do not have 
core levels, can be identified using this. Quantitative analysis, which yields the atomic 
concentration of each of the elements detected, requires the measurement of the 
area under the most intense photoelectron peak for each species, combined with a 
knowledge of the . Typically, the XPS spectrum is plotted as B.E. (x-axis) versus peak 
intensity in counts/second (y-axis). B.E. is substituted for K.E. to give a direct 
experimental determination of the electronic energy levels of the different atoms 
present in the sample. 
 
In Figure 2.6.3 the electrons emitted from the sample are focused at the entrance of 
a hemispherical electron energy analyser (HEA) by an electrostatic lens column. A 
voltage applied across the hemispheres, called the pass energy, allows electrons of 
specified energy only to travel around the analyser where they are detected by a 
suitable device such as a channeltron electron multiplier or a channel plate array. 
Electrons emitted by the sample are slowed to this pass energy by applying a 
retarding voltage in the region immediately before they enter the electron energy 
analyser, thus improving the energy resolution. Scanning the voltage across the 
analyser produces a spectrum of the electron energies detected at each energy value, 
which corresponds to the elements on the surface of the analysed sample. 
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Figure 2.6.3 Diagram of an X-Ray Photoelectron Spectroscopy system 
 
The photoelectrons emitted from the surface region are focussed between inner and 
outer hemispheres of a Hemispherical Energy Analyser (HEA) via an electrostatic lens 
assembly. Retarding voltages are used to direct the electrons onto the detector. Peak 
intensities of the electrons emitted from different orbitals of the same element are 
not the same because the probability for photoemission, i.e. the photo-ionisation 
cross-section (), from each orbital is different. The probability is also different for a 
given orbital in a different atom. Thus, the spectral peaks correspond to the number 
of occupied energy levels in the atoms whose B.E. is lower than the incident X-ray 
energy (h). The position of the peaks then provides a measure of the B.E. of the 
electrons in the orbitals and identifies the atoms concerned. Correspondingly, the 
intensities of the peaks depend upon the number of the atoms present and on the 
value of  from each orbital concerned. A typical spectrum for carbon is shown in 
Figure 2.6.4. 
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Figure 2.6.4 A typical carbon spectrum obtained from an XPS system showing different binding 
energies for different chemical states 
 
2.6.3 UV-Vis Spectroscopy 
 
 
Ultraviolet/visible spectroscopy involves passing electromagnetic radiation 
through a sample which is placed in a spectrometry cell – typically a quartz cuvette 
(path length 1cm) held inside the spectrometer.  The fundamentals of UV-vis 
spectroscopy begin when light is passed through the compound, the energy from the 
light is used to stimulate an electron from a bonding or non-bonding orbital towards 
one of the vacant anti-bonding orbitals as illustrated in Figure 2.6.5. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6.5 Electron stimulation from a bonding or non-bonding orbital towards the vacant anti-
bonding orbitals 
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Within each example, an electron is excited from a fully occupied orbital into a vacant 
antibonding orbital.  The energy from each jump is taken from the light, where the 
larger the jump, the energy required will be bigger.  Each specific wavelength of light 
has a certain energy related to it.  If the specific amount of energy is enough to fulfil 
one of the energy jumps, then the wavelength will be absorbed – as its energy will 
have been utilised in promoting an electron. 
 
 
A conventional UV-vis spectrometer functions in a range from around 200 nm (near 
ultra-violet) to 800 nm (very near infra-red). It is important to note that larger jumps 
require more energy and therefore absorb light with a shorter wavelength.  The most 
significant jumps are from pi bonding orbitals to pi anti-bonding orbitals, and from 
non-bonding orbitals to sigma anti-bonding orbitals.  Therefore, for light absorption 
to occur in the area from 200-800 nm, the molecule must possess pi bonds or atoms 
with nonbonding orbitals.  Light absorbing groups that are present in a molecule are 
known as chromophores. 
 
An example of a typical UV-visible absorbance spectra using Methyl Salicylate is 
shown in Figure 2.6.6.  The vertical axis represents absorbance of light, where the 
larger the value the more of a particular wavelength is being absorbed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6.6 UV Spectra detailing the additions of methotrexate (2 mM stock, pH 7 buffer) 
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UV-vis spectroscopy is often used to obtain the absorbance spectra of a particular 
compound in a solution or solid.  The data that is collected spectroscopically is the 
absorbance of light energy or electromagnetic radiation, which promotes electron 
excitation from the ground states to the first singlet excited state of the compound 
of interest.  If we consider the electromagnetic spectrum, the area that covers the 
UV-Visible region spans 1.5 – 6.2 eV which is associated to the wavelength range from 
800 -200nm.  The theory behind absorption spectroscopy is defined by the Beer-
Lambert Law as described in Equation 2.16. 
 
A = ε l c 
…Eq.2/16 
Where: 
A = Absorbance  
ε = Molar absorptivity of the compound or molecule in solution (mol-1 L cm-1) 
l = Path length of the cuvette or sample holder (usually 1 cm) 
 c = Concentration of the solution (mol L-1). 
 
There are two types of absorbance spectrometers: single beam and double beam.  
Each spectrometer has a light source (deuterium or tungsten lamp), a sample 
container and a detector.  A single beam spectrometer contains a monochromator 
placed between the light source and the sampled to analyse one wavelength.  The 
single beam instrument has a filter or a monochromator between the source and the 
sample to analyse one wavelength at a time and is demonstrated in Figure 2.6.7. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.6.7 Schematic of a typical single beam instrument 
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UV-vis analysis can retrieve both qualitative and quantitative data from the 
compound sample. In both cases it is necessary to use a reference cell to zero the 
instrument before the analysis can be undertaken.  When quantitative information 
is required from the sample, calibrating the instrument can be achieved by additions 
of the compound of interest at known concentrations to the same solvent used in 
the sample. If confirmation of a compounds presence is only required, it is not 
necessary to create a calibration graph.  Specific scanning parameters for each 
experiment can be found within the relevant chapter where spectrometry 
techniques have been used for analysis. 
 
 
 
 
2.7  Surface Modification Techniques 
 
 
A number of techniques were used throughout the project to improve 
substrate response or modify the surface of electrode materials.  The methods 
employed are described in detail in the following sections. 
 
 
 
2.7.1 Electrochemical Anodisation 
  
 
Electrochemical anodisation involves the use of the amperometry technique 
detailed in Section 2.5.3.  Within this project, electrochemical anodisation has been 
employed to alter the electrode surface in order to improve the electrode response 
towards a number of analytes as previously demonstrated by (Dutt et al., 2005). The 
electrochemical anodisation and subsequent enhancement of electrode substrates 
was achieved by amperometric oxidation (+2 V) for various amounts of time (typically 
5-300 s) in 0.1M NaOH, where the working electrode acts as the anode (the positive 
electrode).  As a result, hydrogen is released at the cathode (the negative electrode) 
and oxygen at the surface of the working electrode, which leads to a build-up of 
hydroxide.  This process give rise to the creation of oxygen functionalities (carbonyl, 
carboxy, hydroxy and quinoid) on the electrode surface, changing the microscopic 
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texture of the surface as well as the crystal structure of the layers as show in Figure 
2.7.1 (Banks and Compton, 2005a). 
 
 
Figure 2.7.1 Effect of electrochemical anodisation on the immediate surface of the graphite 
particle 
 
By increasing the oxygen functionalities at the electrode surface, fracturing of the 
carbon is observed leading to the increase in the amount of edge plane sites where 
faster electron transfer is observed, this gives rise to enhanced electrode 
performance together with greater voltammetric resolution and sensitivity. 
 
 
 
2.7.2 Laser Ablation  
 
 
 
Laser ablation of the conductive composite films to create pores was achieved 
using a 25W CO2 computer-controlled laser cutter (FB400 series CadCam Technology 
Ltd, Nottingham, UK).  Control over the direction of the laser, speed and output 
power was controlled via ApS-Ethos software.  The laser was typically patterned 
across the x and y directions of the applicable substrates with a spacing of 2 mm 
between each pass in order to create a porous network, which will be further detailed 
in the following chapters.  Within this project, controlled laser ablation was used to 
pattern the surface of the conductive carbon film described in Chapter 1 to create 
micron sized pores, though which the drug molecules can permeate. 
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2.8  Film Deposition methods 
 
2.8.1  Solvent Casting 
 
   Composite free-standing films were composed of carbon nano powder and 
cellulous acetate phthalate (CAP) at 1:1 w/w ratio.  Cellulose acetate phthalate was 
first dissolved in acetonitrile and left under continuous stirring until a homogenous, 
fully dissolved solution was achieved.  Following dissolution, the CAP solution was 
added to the carbon nano powder while mixing with further additions of acetonitrile 
added until the desired viscosity was achieved.  The solution was then free cast onto 
a flat silicone substrate using a glass pipette and allowed to dry at ambient 
conditions. Once dry, the film was gently peeled from the silicone substrate and then 
cut to the required size (typically 0.8 mm x 0.6 mm). The carbon-CAP film sections 
were thermally sealed within a laminate system to define the electrode area -  the 
full procedure is further detailed in the materials section within the relevant chapters 
where composite films have been used.  
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Chapter 3 
 
 
Electrochemical Manipulation of pH to Aid Controlled Release of Reagents from 
Barrier Films 
 
 
 
 
 
Abstract 
 
The development and characterisation of a nanostructured conductive film capable 
of facilitating the controlled dissolution of enteric coatings is described.  Laser 
treatment of the conductive surface was used to create defined pores.  
Electrochemical manipulation of the local pH within laser etched pores is shown to 
initiate the hydrolysis of an attached cellulose acetate phthalate film and facilitate 
the controlled release of a model drug.  Moreover, an innovative approach to the 
design and operation of microfiber pH probe is critically appraised.  X-ray 
photoelectron spectroscopy of the electrode surface after electrochemical 
anodization presented an increase in the population of endogenous quinone 
moieties.  The redox profile obtained from the electrochemically anodised microfiber 
probe was exploited and its application to the prototype drug release system 
demonstrated. 
 
 
 
 
 
 
 
 
 
Part of the research described in this chapter has been published in Anderson, A. & Davis, J., 
2015. Next generation transdermal drug delivery – An electrochemical approach to pH 
manipulation for controlled release within smart patch technologies. IFMBE Proceedings: 
World Congress on Medical Physics and Biomedical Engineering. Volume 51, pp 919-922. 
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3.1  Introduction 
 
  The development and manufacture of conventional controlled release 
technologies to date have been largely based around encapsulant systems in which 
a polymeric binder or gel typically responds to changes in the local environment in 
which the delivery device has been placed. The delivery agents are typically released 
when the particle, capsule, film or droplet is subjected to the appropriate physio-
chemical trigger (typically a change in pH) with the time-release-dose delivery 
characteristics controlled through manipulation of the encapsulant formulation 
(Bertz et al., 2013; Hassan, Shakeel Laghari and Rashid, 2016; Kamaly, Yameen, Wu 
and Omid C. Farokhzad, 2016). Gradual dissolution of the coating leads to the release 
of the therapeutic agent (Maroni et al., 2016, 2017; Pérez-Ibarbia et al., 2016; Pole 
et al., 2016).  One of the most common formulations is cellulose acetate phthalate 
(Figure 3.1.1), which is stable in acidic environments but dissolves in mild alkaline 
conditions (Felton and Porter, 2013). The film is designed to protect oral tablet drugs 
from the acid environment of the stomach and enable safe passage to the colon, 
where the higher pH induces the dissolution of the film and release of the drug.   
  
 
 
 
 
 
Figure 3.1.1 Chemical structure of cellulose acetate phthalate (CAP) 
 
In this chapter, an adaptation of this core strategy for use in the next generation of 
transdermal microdevice or smart patch is explored. A key feature of the approach is 
the ability to electronically trigger the release of the drug on demand.  
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The strategy within this methodology relies on the electrochemical properties of a 
carbon-polycarbonate (C-PC) composite film, in which micro-nanoscale pores 
(typically 0.5 mm diameter) are created through controlled laser ablation. Laser 
treatment of the film removes small amounts of the encapsulating polymer resulting 
in greater exposure of conductive carbon around the edges of the pore.  In addition, 
laser ablation causes fracturing of the carbon particles which leads to an increase in 
the proportion of edge plane sites within the pores, thereby increasing the electron 
transfer kinetics.  This approach has been successfully demonstrated though previous 
work on carbon fibre electrodes  (Ezekiel et al., 2008). 
 
The porous carbon layer was then combined with a conventional pH responsive 
barrier film (cellulose acetate phthalate) to complete the prototype patch as 
indicated in Figure 3.1.2.  Under normal conditions, the enteric coating will remain 
intact with no diffusion of the drug to the bulk of the solution.  Electrolysis of the 
solution within the latter can be used to raise or lower the pH (Davis and Cooper, 
2002; Fomina et al., 2016) and upon imposing a reducing potential to the carbon film 
top layer, it was anticipated that the local pH within the pores would be dramatically 
increased, such that hydrolysis of the ester occurs with dissolution of the protective 
barrier thereby releasing the drug.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1.2 Proposed configuration of the electrochemical release system 
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An additional challenge facing this approach was how to determine the pH from 
within the pore, when the size of the latter is only 0.5 mm in diameter.  The problem 
with using conventional pH measuring systems in this application is not just their 
incompatible size, they also would have to respond in a rapid manner in determining 
the pH of the local area and not just the bulk pH.  As such, the strategy taken in the 
present methodology was to use carbon microfiber electrodes (10 µm diameter) 
encased within thermally sealed laminates, in order to monitor the pH from within 
the pore. The presence of the pH sensitive quinone functionalities on the surface of 
the microfiber can be used for the indirect voltammetric sensing of pH in accordance 
with the Nernst equation (59 mV / pH for a 2 electron-2 proton reaction).  Previous 
methodologies have been able to modify the surface of the electrode via the 
chemical attachment of quinones (Streeter et al., 2004; Lafitte et al., 2008; Makos et 
al., 2010; Park and Kim, 2013), however, carbon fibre itself already possess a number 
of endogenous quinone groups as indicated in Figure 3.1.3 which could be expected 
to shift in a similar manner with a change in pH.    
 
 
 
 
 
 
 
 
Figure 3.1.3 Possible redox transition of endogenous quinone functionalities 
 
 
3.2  Experimental Details 
 
3.2.1 Materials 
 
Chemical reagents were of the highest grade available and used without any 
additional purification.  All electrochemical measurements were carried out at 22oC 
± 2oC in Britton Robinson (BR) buffer (pH 3-9, adjusted to the appropriate pH value 
via the addition of sodium hydroxide).  The composite carbon-polycarbonate(C-PC) 
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films, carbon fibre (10 µm diameter filaments) and silver wire (50 µm) reference 
electrode were supplied by Goodfellow Research Materials.  Cellulose acetate 
phthalate, sodium nitrite and dexamethasone where obtained from Sigma Aldrich. 
 
 
3.2.2 Electrochemical Setup 
 
 
Electrochemical analysis and set up was performed using a µAutolab 
computer controlled potentiostat (Eco-Chemie, Utrecht, The Netherlands).  The 
initial electrochemical arrangement included a three electrode set up comprising of 
carbon (composite film or microfiber probe, detailed in Section 3.2.3) working 
electrode, a platinum wire was used as the counter electrode and a standard 
silver/silver chloride (3 M NaCl) reference electrode.  Further measurements used a 
two electrode configuration comprising a carbon fibre working electrode and a 
combined counter -reference electrode in the form of a chloridised silver wire.  The 
silver wire (50 µm) was prepared by applying +0.5 V in 1 M KCl for a total of 60 
seconds resulting in the deposition of a silver chloride layer.  Cyclic voltammetry 
measurements were conducted at 50 mV/s and square wave voltammograms were 
scanned from -0.8 V to +0.8 V unless otherwise stated. 
 
 
3.2.3 Configuration of Release System and Modification 
 
The carbon fibre electrodes were electrochemically anodised by applying a 
fixed potential of +2 V for varying amounts of time (10-300 seconds) in a solution of 
0.1 M NaOH. This process has been shown to increase the presence of carboxyl 
functionalities on the surface of the carbon (Banks and Compton, 2005b).  The carbon 
microfiber electrode was assembled within a resin backed polyester laminate, 
modelled to the design shown in Figure 3.2.1, which was thermally sealed using a 
commercial laminator and then cut at the end of the probe to expose a cross section 
of anodised carbon fibres.  A similar approach was utilised for the combined counter 
silver wire reference, however, a 10 mm length of the chloridised silver wire was 
exposed.   
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Figure 3.2.1 Schematic of the laminated carbon fibre and reference electrode 
 
Laser enhancement of the conductive C-PC film was achieved using a 25 W CO2 laser 
air-cooled computer controlled laser-cutter (FB400 series CadCam Technology Ltd, 
Nottingham, UK) which created pores on the surface (typically 0.5 mm diameter) and 
is shown in Figure 3.2.2.  Controlled laser ablation to pattern the surface also 
fractures carbon particles increasing the amount of edge plane sites.  Before laser 
enhancement the conductive film is a flat, non-porous structure whereas after laser 
ablation the surface is modified to create a mesh like interface though which the drug 
molecules can permeate. 
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Figure 3.2.2 Fracturing of carbon through laser ablation 
 
It is imperative to note that providing the device is small, the pH will only change at 
the interface of the pore within the C-PC electrode and will not affect the bulk and 
hence should not cause any irritation or complication to the patient.  Also, crucially 
as the device is using a negative potential it is unlikely to degrade the drug once 
released – this may be an issue however if the drug contains nitro functional groups 
which could, in principle, be converted to the nitroso, hydroxylamine or amine group.  
The pH sensitive polymer film used in Section 3.3.5 below, was assembled by 
dissolving cellulose acetate phthalate (CAP) in acetonitrile, which was then cast onto 
a polyethylene substrate and carefully removed.  As part of the overall device 
schematic, a pH sensitive layer can then be placed below the conductive film along 
with the drug molecules.  The production of the model drug loaded films is described 
in the following sections. 
 
 
3.2.4 Film Construction 
 
 
Sodium Nitrite Loaded Polycarbonate Film 
 
In order to demonstrate model drug release, a polycarbonate film loaded with 
sodium nitrite (90:10 %w/w) was constructed and placed below the lasered working 
electrode, where it was possible to monitor the release of a reagent after the 
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initiation of a negative electrochemical potential.  Polycarbonate granules were 
dissolved in Dichloromethane (DCM) and left to stir for 2 hours.  NaNO2 was ground 
into a fine powder and added to the polycarbonate and left to stir until full 
integration of the nitrite into the polycarbonate was achieved.  A polyethylene sheet 
was used as a substrate for casting the Polycarbonate/NaNO2 films which were left 
to dry until the solvent had evaporated.  
 
 
Dexamethasone Loaded Cellulose Acetate Phthalate Film   
 
A CAP (90%) film loaded dexamethasone (10%) was manufactured in a way similar to 
the method outlined above.  An accurately weighed out amount of dexamethasone 
was first dissolved in cyclohexane and then added to the CAP and left to stir until the 
CAP was fully incorporated within the solution.  The solution was then cast onto a 
silicone substrate which, as a consequence of its chemical inertness, was determined 
to be the most successful route for film removal once the solvent had evaporated.  
 
3.2.5 UV-Visible Spectroscopy 
 
  Reagent release from films was monitored using UV-Vis spectroscopy.  
Spectra were recorded using a Jenway 67 Series spectrometer.  Absorbance spectra 
for the reference and sample solutions were measured in a quartz cuvette (1 cm path 
length) cell.  For each standard solution, a sample was taken and scanned from 200 
to 800nm, in order to determine the optimum absorbance.   
 
 
3.2.6  Model Drug Release 
 
Sodium Nitrite Release 
A standard stock solution of 1 mM NaNO2 was prepared in H2O along with a solution 
of phloroglucinol (10 mM, pH 3 buffer).  A sample of the phloroglucinol solution (3 
mLs) was measured into a quartz cuvette and an aliquot of NaNO2 (25 µL) was added 
to the acidified phloroglucinol.  The solution within the quartz cuvette was scanned 
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from 200 to 500nm were the optimum absorbance selected within an aqueous 
solution was 319 nm.   
 
Dexamethasone Release 
A stock solution of 1 mM Dexamethasone was prepared in methanol and scanned 
from 200 nm to 500 nm were the ideal absorbance was found to be 243 nm. 
 
 
3.2.7. XPS Analysis 
 
  X-ray photoelectron spectroscopy (XPS) of the carbon fibre probe before and 
after anodisation was performed using an Axis Ultra DLD spectrometer (Kratos 
Analytical, Japan) using monochromated Al Ja X-rays (15 kV and 10 mA) with an 
operating pressure lower than 6x10-8 Pa. A hybrid lens mode was used throughout 
examination and charge neutralisation was achieved using an immersion lens with a 
filament current of between 1.7 and 2.1 mA at a charge balance voltage of between 
3.0 and 3.6 V. Three spots were studied for each sample and wide energy survey 
scans (0–1300 eV binding energy) as well as high resolution spectra for C1s (272.5–
297.5 eV) and O1s (519.5–544.5 eV).   C-PC films were also analysed, including high 
resolution spectra for C1s.  Pass-energy was 160 eV for the wide energy survey scans 
and 20 eV for the high-resolution spectra. Quantification of the atomic % oxygen at 
the surface from the high-resolution spectra was conducted by subtracting a linear 
background and calculating the area under the peaks on the C1s spectra using Vision 
2.2.8 software (Kratos Analytical, Japan). 
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3.3  Results and Discussion 
 
 
3.3.1 Microfibre pH Probe Operation and Optimisation 
 
 
Square wave voltammograms detailing the response of an unmodified carbon 
fibre electrode under a range of pH conditions are shown in Figure 3.3.1A.  It can be 
seen that the voltammetric profile does change with pH, though there are no clearly 
discernible peaks from which it would be possible to calibrate a range for assessing 
the pH.  The absence of a defined peak for each scan can be attributed to the small 
number of redox groups present on the surface of the unmodified carbon fibre.  In 
order to improve the electrode response, the carbon fibre electrode was 
electrochemically anodised with the aim of increasing the population of quinone 
redox species (Figure 3.1.3) and thereby lead to the appearance of a distinct redox 
peak. The response of the electrode in pH 3 buffer before and after varying the 
anodisation times are compared in Figure 3.3.1B, whereby a noticeable change in 
the voltammetric profile compared to the unmodified carbon fibre is observed.  
Significantly, it is now possible to discern a single and unambiguous peak within each 
of the voltammograms. The magnitude of the peak current is greatly increased and 
can be associated with a massive increase in quinone population on the carbon 
surface. The latter is aided by the fact that the anodisation process fractures the 
carbon – increasing the effective area onto which the quinones can be generated.  
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Figure 3.3.1 (A)Response of an unmodified carbon probe to buffers of varying pH. (B) Response of 
the carbon fibre probe to pH 3 buffer solution before and after varying degrees of anodisation 
 
 
As the square wave scan commences at -0.8 V, the quinone groups present will 
immediately be reduced to the corresponding hydroquinone (indicated in Figure 
3.1.3, I→II). As the scan is swept forward to +0.8 V, the hydroquinone moieties are 
consequently reoxidised (II→I) thus leading to the appearance of a large oxidative 
peak process as shown in Figure 3.3.1B.  
 
The response of the modified carbon fibre probe was tested in buffer solutions across 
a range of pHs and the scans are detailed in Figure 3.3.2.  In comparison to the 
response observed by the unmodified carbon fibre (Figure3.3.1A), the 
electrochemically modified probe presents much more defined (albeit broad) 
oxidation peaks and, as a result, the peak potential can now be accurately recorded. 
It can also be observed that as the pH increases, the oxidation peak position moves 
towards the negative region and is reflective of that observed by previous studies 
that have used quinones as indicators of pH (Wildgoose, 2003; Lafitte et al., 2008).  
As the scans progress to more alkaline conditions, the oxidation peak becomes 
broader and the peak height reduces, this drop in peak height can be due to the 
deprotonation of the quinones moieties as the background pH solution becomes 
greater than the pKa which corresponds with earlier work (Abiman et al., 2007).  A 
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calibration graph is showing the peak position against pH is detailed in Figure 3.3.3. 
The peak potentials assigned to each oxidation peak were found to shift with pH (pH 
3-9; Epa /V = -0.056 pH + 0.2257; N = 7; R2 = 0.9916) in manner that is near Nernstian 
(the ideal being 59 mV / pH) and verifies its suitability for pH measurement.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.2 Square wave voltammograms detailing the response of the anodised carbon fibre probe 
in buffer solutions of varying pH 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.3 A plot detailing the linear response found between the peak position and pH 
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The measurements were recorded three times and the full analysis of the peak 
position values are recorded in Table 3.3.1.   
 
 
Table 3.3.1 Full analysis of the peak positions obtained during a pH range 
 
pH 
Peak Position / V 
Mean 
Standard 
Deviation 
Standard 
Error / mV Scan 1 Scan 2 Scan 3 
3.03 0.063 0.063 0.064 0.063333 0.0005774 0.0003333 
3.96 0.013 0.015 0.022 0.016667 0.0047258 0.0027285 
4.98 -0.035 -0.025 -0.025 -0.02833 0.0057735 0.0033333 
5.96 -0.069 -0.063 -0.07 -0.06733 0.0037859 0.0021858 
6.95 -0.131 -0.128 -0.128 -0.129 0.0017321 0.001 
8.35 -0.222 -0.216 -0.213 -0.217 0.0045826 0.0026458 
 
 
It must be noted that during anodisation, exfoliation of the carbon fibre will produce 
several structural defects and it has be inferred that this would include a large 
proportion of oxygen functionalities.  The anodisation process is an aggressive, 
nonspecific weapon and, as a result, it is inevitable that a multitude of quinoid 
species will occur – each possessing their own unique redox properties.  This is 
displayed in the voltammetric profile detailed in Figure 3.3.1. B where it is evident 
that the broad oxidative peak is liable to comprise of many overlying processes.  
 
 
3.3.2 XPS Analysis   
 
  The influence of the anodisation process on the surface chemistry of the 
carbon was further investigated using XPS spectroscopy.  The spectra obtained for 
the carbon fibre pre anodisation is comprised of mainly sp2 carbon as shown in Figure 
3.3.4A, this can be attributed to the basal nature of the unmodified fibre.  Once the 
carbon fibre has undergone anodisation, there is a marked increase in carbonyl 
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functionality accounting for 55% of surface carbon moieties. The latter are key 
elements of the quinone groups (Figure 3.1.3) which can be attributed to the 
observed enhancement in the electrode response highlighted in Figure 3.3.1B.  There 
is also an increase in intercalated water which could be expected given the exfoliation 
of the carbon fibre. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.4 XPS profiles for the C1s peak obtained from a carbon fibre bundle before (A) and after 
(B) anodisation 
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3.3.3 Characterisation of Carbon-Polycarbonate Composite Film 
 
   
The conductive C-PC film in its unmodified state is a flat, non-porous structure 
impermeable to the transfer of drug molecules. Laser ablation was therefore used to 
cut pores within the film as indicated in Figure 3.3.5. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.5 Pore created on the surface of the conductive film. (A) Result of laser ablation.  (B)  SEM 
of pore 
 
The spatial pitch of the pores was 150 µm with an average diameter of 115 µm. It can 
be seen from the electron micrographs that the pores are not as uniform as 
anticipated, with a lot of uneven edges.  This, however, presents an opportunity for 
increased surface area of the electrode, from where the pH will be increased.  It was 
also observed that is a small tear in the Y direction, this is attributed to an 
instrumental artefact and may be due the drag of the laser across the film due to the 
small distance between each pore. The morphology of the lasered pores should not 
present any detrimental effects during experimental as the main purpose of the 
pores are to function as a pathway for drug release.   
 
The electrochemical properties of the C-PC film before and after the various 
modification steps was assessed through examining the cyclic voltammetric profile 
of ferrocyanide (2 mM, 0.1 M KCl).  Ferrocyanide was selected as a model redox 
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probe on the basis that it exhibits nearly a reversible electrode reaction without any 
impediments of proceeding or post chemical reactions. Due to this, ferrocyanide has 
been chosen as a model redox probe through the years to demonstrate CV. 
 
Cyclic voltammograms detailing the response of an unlasered C-PC electrode to 
ferrocyanide before and after anodisation are shown in Figure 3.3.6.  The 
electrochemical response to C-PC pre anodisation was found to be very poor, where 
there are no observable oxidation or reduction peaks shown in Figure 3.3.6A.  The 
unmodified C-PC contains many basal plane sites where slow electron transfer takes 
place.  In contrast, anodisation (Figure 3.3.6B) results in a dramatic change in which 
the voltammetric profile is characteristic of a microelectrode response.  
 
 
Figure 3.3.6 Cyclic voltammograms presenting the results of the unmodified polycarbonate aluminium 
electrode towards 2 mM potassium ferrocyanide with variations in scan rate from 10 mV/s to 500 
mV/s. Before (A) and after (B) electrochemical anodisation 
 
Similar responses were observed when comparing the lasered C-PC before and after 
anodisation (Figure 3.3.7). The laser etch does increase the initial (pre anodisation) 
response to ferrocyanide and this can be attributed to the greater exposures of the 
encapsulated carbon particles. The response is still far from reversible with a large 
A B 
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overpotential required to elicit any current response. The post anodisation response 
however is analogous to that recorded with the unlasered C-PC (Figure 3.3.6B) where 
the response is typical of a microelectrode system.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.7 Cyclic voltammograms presenting the results of the laser modified polycarbonate 
electrode towards potassium ferrocyanide with variations in scan rate from 10 mV/s to 500 mV/s. 
Before (A) and after (B) electrochemical anodisation 
 
The anodised electrode responses (irrespective of laser modification) are similar to 
those expected of a microelectrode system, but as the electrode consists of a 4 x 4 
mm square there is clearly a discrepancy. In this case, the electrode consists of 
particles which are immersed in a sea of polymer, as demonstrated in Figure 3.3.8, 
with only small islands of carbon visible at the surface. Thus, despite a high loading 
of carbon, the amount of interfacial, and hence electrochemically accessible surface 
is very limited. This is confirmed when comparing the unanodised responses before 
and after lasering, where there is a moderate increase in the current as a 
consequence of more carbon surface being exposed.  The microelectrode response 
can be explained by the occurrence of hemispherical diffusion to the electrode rather 
than planar diffusion. As the dimensions of the electrode shrink, the diffusion process 
changes - it becomes much faster and results in a steady state response (sigmoidal 
shape).  Normally, such behaviour is only observed when the electrode dimensions 
A B 
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are at the low micron scale, typically 10 µm in diameter, yet the film substrate being 
tested is 4mm square.  It is also important to note that the current is very large which 
is to be expected for a large electrode. There is a clear discrepancy in the observed 
results – the explanation lies in the fact that the film is composed of micron sized 
particles.  Instead of one microelectrode, the film contains a high number of 
independent micro electrodes, therefore the results present the sigmoidal shape, but 
also the high current is observed from the cumulative addition of these individual 
electrodes. The current response is representative of RAMTM electrodes, similar to 
that observed by Fletcher and Horne (S Fletcher and Horne, 1999).  Thus, the 
interfacial carbon is effectively acting as a random array of microelectrodes (RAM 
electrode), which were previously introduced in Section 2.5.1.   
 
 
 
 
 
 
 
 
Figure 3.3.8 Schematic of carbon particles within a polycarbonate binder 
 
XPS Analysis of CPC Films 
 
During investigations, the surface composition of the C-PC film was assessed. When 
we consider the structure of polycarbonate shown in Figure 3.3.9, there is very little 
sp3, however there are two benzene rings therefore it is expected that there will be 
a significant sp2 peak present. It is also important to remember the composition of 
the film at the interface is largely composed of polycarbonate, with a scattering of 
carbon (Figure 3.3.8). In contrast to the anodisation of the carbon surface, it is 
unlikely that the electrode process would lead to the destruction of the 
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polycarbonate backbone and therefore, as polycarbonate is the main component, it 
is unlikely that there would be much change in the sp2 peak.  
 
 
 
 
 
 
 
Figure 3.3.9 Structure of polycarbonate 
 
The spectra obtained for the carbon polycarbonate before anodisation (Figure 
3.3.10) is, as expected comprised of an sp2 peak attributed to the phenyl ring. Post 
anodisation, there is an increase in the C=O and COOH groupings – the latter being 
the more significant as this originates from the exfoliation of the carbon particles. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.10 High resolution spectra for the C1s peak of C-PC  
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The peak increase at 291 eV is characteristic of carboxylic and carbonate 
functionality.  The formation of these groups is expected after anodisation, with 
reported literature values of 288.9 eV for carboxylic groups and 290.6 eV to 
carbonates (Nevskaia and Martin-Aranda, 2003). 
 
 
 
3.3.4 Manipulation of Local pH 
 
  The next step was to measure the voltammetric behaviour of the carbon fibre 
probe to assess its suitability for measuring the localised pH.  In contrast to earlier 
investigations employing a single working electrode, this approach required the use 
of two working electrodes, where the carbon fibre probe was positioned directly 
above the lasered pores of the carbon-polycarbonate (C-PC) film as demonstrated in 
Figure 3.3.11.  A standard Ag|AgCl reference electrode was also used at the same 
position of the working electrodes.  A reservoir was created from the site of the 
working electrode to a platinum wire, this ensured the level flow of fluid from the 
working electrode to the counter.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.11 Microfiber probe arrangement for monitoring changes in pH brought about by 
electrolysis at the carbon-polycarbonate film 
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The potential of the C-PC film was held at -2 V for a period of 12 minutes. This had 
the effect of electrochemically reducing protons within the C-PC pore structures 
according to Equation 3.1. 
 
H+(aq) + e    ½ H2 (g)                                                       
  …Eq.3.1 
 
The removal of H+ from within the pore would have the effect of increasing the pH.  
The microfibre probe was scanned at 60 s intervals with the resulting scans shown in 
Figure 3.3.12.  It can be seen that the oxidation peak associated with the endogenous 
quinoid moieties is distinct and the peak potential can be assigned without 
ambiguity.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.12 Voltammograms presenting the response of the probe to change in pH as a result of 
electrochemically increasing the pH 
 
By recording the position of the quinone oxidation peak, the resulting pH within the 
micro pore can be determined using the calibration equation (Epa = -0.056 pH + 
0.2257) as previously shown in Figure 3.3.3.  Before the commencement of 
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electrolysis, the pH within the pore was found to be pH 2.78 and post electrolysis 
over a conditioning period of 12 minutes the resulting pH was pH 12.65.   
 
 
The effect of the controlled electrolysis potential applied to the C-PC electrode is 
shown in Figure 3.3.13 where by the local pH within the micro pore can be 
electrochemically controlled over time to produce a steady rise in pH.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.13 Influence of film electrolysis time on the local pH recorded by the microfiber probe 
 
 
3.3.5 Cellulose Acetate Phthalate Dissolution 
 
 
  During the investigations described in the previous section, it was confirmed 
through voltammetric profiling that it is possible to control and monitor the local pH 
using the conductive carbon electrode and the carbon fibre micro pH in concert.  The 
next step was to assess the ability of the approach for controlling the dissolution of 
a cellulose acetate phthalate (CAP) barrier film which protects a model drug film. In 
this case the CAP film is acting much in the same way as it would be applied to protect 
oral tablet formulations. 
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The initial investigations employed sodium nitrite as a model drug and it was selected 
on the basis of its high solubility in aqueous solution and insolubility in acetonitrile 
(the solvent used to cast the protective phthalate ester over layer).  The preparation 
and construction of the NaNO2 loaded polycarbonate film is detailed in Section 3.2.4 
above.  A calibration spectrum for sodium nitrite was generated by analysing a series 
of 25 µL additions of the NaNO2 stock solution into a 3 mL sample of phloroglucinol 
and is shown in Figure 3.3.14.  The resulting absorbance values of each addition 
where plotted against the concentration of each NaNO2 to produce the calibration 
graph in Figure 3.3.15.  The calibration graph was then used to determine the 
concentration of the NaNO2 released from the loaded polycarbonate film.  The 
determined concentration was then converted to a mass of the NaNO2 released from 
the film.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.14 Spectra of NaNO2 additions to phloroglucinol 
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Figure 3.3.15 Calibration graph of NaNO2 additions to phloroglucinol 
 
Before the commencement of electrolysis, the CAP film was tested under the same 
conditions (-2 V, 20 minutes), as the drug set up to confirm that the hydrolysed CAP 
itself had no effect on the UV spectrum containing the model drug.  The spectra of 
the reduced CAP results are shown in Figure 3.3.16, where there are no ambiguous 
absorbances associated with CAP in comparison to the pre- electrolysis solution.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.16 Reduction of the control CAP film (no NaNO2 present) 
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Following this, the NaNO2 loaded polycarbonate film acting as the drug reservoir was 
placed below the protective CAP film and sealed. The lasered carbon-polycarbonate 
electrode was placed onto the CAP film as shown in Figure 3.3.17. 
 
 
 
 
 
 
 
 
 
Figure 3.3.17 Electrochemical set up featuring a NaNO2 loaded film below the C-PC working 
electrode and CAP barrier film 
 
An aliquot of KCl (200 µL, 0.1 M) was deposited onto the conductive polycarbonate 
electrode, the top layer of the system. A sample of KCl was extracted and placed into 
the spectrometer in 3 mL of phloroglucinol (10 mM, in pH 3) and a scan was run to 
confirm that there was no sodium nitrite present at this point.  The conductive film 
was held at -1.5 V, initiating a change in the local pH within the pore. The subsequent 
dissolution of the CAP film was observed, allowing the surrounding sample of KCl to 
encounter the NaNO2 loaded film.  The solution was then sampled every 5 minutes 
for nitrite after the commencement of hydrolysis, with the nitrite determined 
spectroscopically through its reaction with the acidified phloroglucinol.  It was found 
that after commencing electrolysis the nitrite was found to emerge (detected at 319 
nm) as indicated in Figure 3.3.18. 
 
The inset within Figure 3.3.18 is the control test where the NaNO2 loaded film was 
placed in a solution of KCl for two hours and 25 µL additions where sampled from the 
control solution to demonstrate that the film is stable in aqueous solutions and 
leeching of the model drug NaNO2 does not occur in solution.  A comparison of the 
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response achieved before and after the commencement of electrolysis is shown in 
Figure 3.3.19. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.18 UV-vis spectra detailing the response of the phloroglucinol towards nitrite – released 
as a consequence of the electrochemical dissolution of the cellulose phthalate film 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.19 UV-vis spectra comparing the response before and after the commencement of 
electrolysis  
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During electrochemical investigations palladium was also investigated as another 
ideal candidate for catalysing the reduction of protons and hence electrochemically 
raising local pH (Zhang et al., 2016a; Cardoso et al., 2017a).   Due to this ability, the 
hydrolysis of the CAP film would be achieved more rapidly owing to the rapid increase 
in pH leading to the release of more nitrite.  This was demonstrated by utilising a 
similar set up to the C-PC electrode, this time substituting the C-PC for a lasered 
palladium counterpart and applying a reducing potential.  As shown in Figure 3.3.20, 
we can determine that during the same amount of applied electrolysis time, utilising 
a similar sample removal method as used previously, the reducing potential applied 
to palladium set up results higher concentrations of release NaNO2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.20 UV-vis spectra detailing the response of the phloroglucinol towards nitrite – released as 
a consequence of hydrolysis of the CAP protective film initiated at the palladium working electrode 
  
The merit of using such conductive thin films, lies in the ease from which such thin 
film can be easily incorporated into systems.  The size of the thin films also allows for 
the facile modification through laser ablation to improve the overall film sensitivity.  
When used in drug delivery mechanisms as demonstrated above, the pathway to 
drug release is short and could in principle, be easily incorporated within thin film 
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transdermal drug delivery systems allowing for the controlled release of 
therapeutics.  
 
3.3.6 Controlled Release of Dexamethasone From pH Sensitive Film 
 
Dexamethasone, 9α-fluoro-16α-methyl-11β, 17α, 21-trihydroxy-1,4-
pregnadiene-3,20-dione, is a synthetic glucocorticoid hydrocortisone which has anti-
inflammatory and immunosuppressive properties.  The structure of dexamethasone, 
shown in Figure 3.3.21,  and has been widely used in clinical applications to treat a 
variety of conditions such as: rheumatoid arthritis, asthma and ocular diseases 
(Zilberman, 2005; Saraiya and Goldstein, 2011; Plontke et al., 2014; Kalam, 2016).  
More notably it is used to suppress an immune response in transplant patients 
(Wadhwa, Lagenaur and Cui, 2006; Coutinho and Chapman, 2011; Webber et al., 
2012).  For these reasons, dexamethasone is an ideal candidate for incorporation into 
transdermal patches as it has the potential to limit skin adverse reactions or irritation 
that is often associated with puncturing the stratum corneum in order to deliver a 
drug.  
 
 
 
 
 
 
 
 
 
Figure 3.3.21 Structure of dexamethasone 
 
While the approach in Section 3.3.5 utilised a polycarbonate film as an effective drug 
loaded film, it would be much more effective to control the physical state of the film 
in a controlled manner to release an entrapped drug, rather than rely on a passive 
response of releasing the drug from the film as demonstrated by the polycarbonate.   
Therefore, when hydrolysis is initiated as previously described, the control of the 
local pH at the site of the drug loaded film could control how much of the drug is 
released through monitoring the hydrolysis time.  Therefore, the next stage was to 
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transfer the strategy developed with sodium nitrite to the release of dexamethasone. 
In this scenario, UV-Vis detection was again used to monitor the electrochemically 
driven release directly from a dexamethasone loaded CAP film, omitting the PC film.  
A calibration graph was constructed by obtaining the absorbance values from a series 
of additions of 25-375 µL aliquots from the 1 mM dexamethasone stock solution into 
a background solution of 0.1M KCl as shown in Figure 3.3.22, with accompanying 
calibration graph Figure 3.3.23. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.22 Calibration spectra of dexamethasone 
 
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.23 Calibration graph of stock dexamethasone 
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The amount of dexamethasone released from the drug loaded CAP film was 
determined by measuring the absorbance of the dexamethasone into the 
background solution (0.1 M KCl) and sampling 25 µL of the released solution every 5 
minutes into a quartz cell containing a blank solution of 3 mL 0.1 M KCl as shown in 
Figure 3.2.24.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.3.24 Release of dexamethasone 
 
 
 
3.4  Conclusions 
 
 
  A new approach to pH measurement has been demonstrated and the surface 
chemistries of several materials characterised.  The applicability of the probe was 
established through measuring variations in the local pH of a novel drug delivery 
device. The latter permits greater control over the release mechanism and could be 
used to exploit the more conventional uses of enteric coatings – potentially as 
transdermal/microneedle patches. 
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Carbon-polycarbonate films were selected as the base substrate for the 
electrochemically driven release mechanism.  Preliminary investigations sought to 
control the release of sodium nitrite which had been entrapped within a 
polycarbonate binder.  The use of enteric coatings within conventional drug release 
is widely established within oral drug formulations and thus the CAP component was 
chosen to act as a barrier membrane, which served to protect the drug loaded film 
until the electrochemical trigger was initiated.  The application of the electrochemical 
trigger reduces protons and leads to the removal of H+ resulting in the increase of 
local pH.  The controlled manipulation of pH within the C-PC pore was shown to lead 
to the rupture and dissolution of the pH sensitive CAP barrier layer, thereby releasing 
the sodium nitrite in a controlled but rapid manner, the presence of which was 
successfully confirmed through spectroscopy.  
 
During electrochemical investigations, palladium was also investigated as another 
ideal candidate for catalysing the reduction of protons and hence electrochemically 
raising local pH.  From the literature it is known that palladium is commonly used to 
catalyse hydrogen.  This would mean that it would be possible to reach higher pH 
conditions much quicker.  It was postulated that due to this ability, the hydrolysis of 
the CAP film and subsequent drug release would be achieved much faster than the 
other conductive component explored.  It was determined that conductive 
polycarbonate film would be used hereon as is proffered a number of advantages 
over the palladium substrate; including its fairly inexpensive component cost and its 
ability for successful surface modification (laser ablation and electrochemical 
anodisation) in order to enhance electrode performance.   
 
The methodology was further developed by encapsulating dexamethasone – a 
commonly used drug to treat inflammatory diseases, within the CAP layer.  This 
approach was much more effective, as it proffered the opportunity to control the 
physical state of the film in order to release the entrapped drug.  The stability of the 
film was tested within aqueous solutions and results determined that the CAP binder 
suitably protected the dexamethasone from leeching into the solution. It was 
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successfully demonstrated that the application of a suitable reducing potential to the 
C-PC film, leads to the subsequent swelling and dissolution of the CAP thereby 
releasing the entrapped dexamethasone.   
 
The main challenges facing drug delivery is device size and response time.  Therefore, 
a device capable of these demands would result in optimal patient outcome.  It is 
imperative to note that providing the device is small the pH will only change at the 
interface and will not affect the bulk and hence should not cause any irritation or 
complication to the patient.  The response time of the device needs to be improved 
as part of the development profile, in order to improve response time, the conductive 
film could be improved by the addition of metals such as platinum or palladium 
nanoparticles which would catalyse the reduction of protons quicker.  The 
development of the micro pH probe proffers a whole host of advantageous 
applications, within this project it was used with microtiter plate however it also has 
the ability to be used in vivo in the future. 
 
 
 
 
 
 
 
 
 
 
 
 
  
107 
 
Chapter 4 
 
Electrochemical Bubble Rip: A New Approach to Controlled Drug 
Release 
 
 
Abstract 
 
The controlled dissolution of a cellulose acetate film using electrochemical methods 
was further investigated. A novel approach employing hydrogen bubble generation 
has been developed to enable the rapid rupture of barrier film and release of the 
drug. The ability of the film to be used as a controllable gateway for the release of 
candidate drugs is critically assessed.  
 
 
 
 
 
 
 
 
 
 
 
Part of the research described in this chapter has been published in:  Anderson, A., 
McConville, A. & Davis, J., 2015. Electrochemical bubble rip: A new approach to controlled 
drug release. Electrochemistry Communications, 60, pp.88–91. 
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4.1 Introduction  
 
It was demonstrated in Chapter 3 that the imposition of a negative potential 
could result in the gradual dissolution of a cellulose acetate phthalate film (CAP) and 
thereby lead to the release of a therapeutic agent. The rate of dissolution can be 
relatively slow (depending on applied potential and resulting current) and therefore 
an alternative strategy was sought to enable rapid release of the drug. Rather than 
simply relying upon the change of pH at the interface, the next stage was to 
determine if the hydrogen evolution reaction (HER) could be exploited to yield a 
mechanical force on the CAP barrier film. 
 
The intention was to fix the film onto a porous carbon fibre (CF) mesh as indicated in 
Figure 4.1.1. The carbon mesh performs a number of functions: it acts as a support 
for the CAP film, as a gate for a drug reservoir and, as the fibre is conductive, an 
electrode. The CAP film is impermeable in acidic/neutral pH and thus the drug is 
effectively entrapped behind the CF mesh.  The release methodology was based on 
employing a suitable reducing potential to the CF electrode, that will initiate the 
reduction of water, resulting in the production of hydrogen bubbles at the CAP-CF 
interface. 
 
 
 
 
 
 
 
 
Figure 4.1.1 Schematic of the cell configuration 
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The reduction of water at electrodes to form hydrogen is well established and the 
“hydrogen evolution reaction” is a foundation in many electrochemical fuel cells 
(Lasia, 2010; TONG et al., 2016; Grozovski et al., 2017). In this instance, it was 
envisaged that the production of gaseous hydrogen and its coalescence into bubbles, 
would cause sufficient mechanical stress to rupture and dissolve the thin barrier CAP 
film. Upon fracturing the film, it could be expected that there would diffusion of the 
drug from the reservoir section of the device through the carbon mesh. 
 
The release strategy is highlighted in the schematic in Figure 4.1.1 in which 
ferrocyanide was used as a model drug.  The application of the reducing potential 
will result in an increase in local pH at the working electrode/CAP film interface which 
will lead to steady dissolution of the film - similar to the solubilisation process that 
enteric films undergo in their conventional applications. Critically, the solubilisation 
of the CAP will act in concert with the electrogenerated bubbles, with the dissolution 
of the film further weakening the mechanical integrity of the film. 
 
The development of electrolytic processes in small scale microdevices has been 
previously explored and include: dissolution of metallic wrappers (Langer, Santini and 
Cima, 1999) and the inflation of parylene micro pumps (Gensler, Sheybani, P.-Y. Li, et 
al., 2012; Uday B. Kompella et al., 2013) but this is the first description of the 
controlled physical rupture of an impermeable organic seal that could be useful for 
incorporation within drug delivery devices. 
 
4.2      Experimental Details  
 
4.2.1   Materials  
 
Chemical reagents were of the highest grade available and used without any 
additional purification.  All electrochemical measurements were carried out at 22 oC 
± 2 oC in Britton Robinson (BR) buffer (pH3-9, adjusted to the appropriate pH value 
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via the addition of sodium hydroxide).  Carbon fibre mat (Toray) was supplied by 
Goodfellow Research Materials.  Methotrexate, (2S)-2-[(4-{[(2,4-Diaminopteridin-6-
yl)methyl] (methyl)amino}benzoyl) amino] pentanedioic acid, cellulose acetate 
phthalate (CAP) and phenolphthalein were obtained from Sigma Aldrich.   
   
 
4.2.2  Electrochemical Setup  
   
 
Electrochemical analysis and set up was performed using a µAutolab 
computer controlled potentiostat (Eco-Chemie, Utrecht, The Netherlands).  The 
initial measurements employed a three electrode configuration comprised of a mat 
carbon fibre working electrode, a counter electrode in the form of a platinum wire 
and a standard silver/silver chloride reference electrode.  Cyclic voltammetry 
measurements were recorded at 50 mV/s unless otherwise stated.  
 
 
4.2.3  Sensor Design and Modification  
 
The carbon fibre mat (Toray) working electrodes (10 µm fibres compressed 
into a mesh, sheet thickness measured 110 µm and the electrical resistivity through 
plane is 80 mΩcm2) were prepared by sandwiching the conductive mesh between 
polyester laminate sheets that had been pre-patterned to reveal a square window 
on either side.  Circuit connection to the carbon fibre was accomplished though the 
addition of adhesive copper tape.  Cellulose acetate phthalate (Sigma) thin films were 
prepared by dissolving appropriate number of pellets in acetonitrile solution (10 mg 
/ mL) and solvent cast onto a carbon polyethylene substrate (Goodfellow). These 
were allowed to dry at ambient conditions until the free-standing CAP film could be 
carefully removed as shown in Figure 4.2.1A.   
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Figure 4.2.1 (A) Mat carbon fibre electrode alongside a free-standing CAP film.  
(B) Microscope image of CAP after it has been thermally sealed within a CF electrode. (C) Scanning 
electron micrograph detailing the surface of carbon fibre electrode 
 
The CAP film was carefully removed and placed on top of the unmodified carbon fibre 
(CF) and both were thermally sealed between polyester laminate sheets.  The mat 
CF/CAP electrode configuration is shown in Figure 4.2.2. The basic approach has been 
described previously (Dutt et al., 2006) but in this instance, rather than have carbon 
exposed on both sides of the window, the CAP film completely blocks and insulates 
one side.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.2 SEM image and configuration of mat carbon fibre CAP electrode  
A 
C 
CAP film on top of 
CF electrode 
CF electrode 
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4.3  Results and Discussion 
4.3.1  Characterisation of Carbon Fibre Electrode 
 
 
In order to evaluate the initial electrochemical performance of the bare 
carbon fibre, it was necessary to test the CF in the presence of a model redox probe 
such as ferrocyanide (Fe(CN)64-), and to benchmark the electrode against a 
commercial glassy carbon (GC) electrode.  A GC electrode is often chosen as a primary 
substrate in electroanalytical testing, however within this work a GC electrode would 
be considered too bulky and expensive. Its primary use in this instance is to be 
employed as a comparison for the evaluation of new electrode materials such as the 
carbon fibre composite.  The response of an unmodified carbon fibre in the presence 
of 2 mM ferrocyanide is compared against an electrochemically anodised CF 
electrode and a commercial GC electrode in Figure 4.3.1. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.1 Cyclic voltammograms comparing the response of a glassy carbon electrode (GC) against 
carbon fibre electrodes (before and after anodisation) in the presence of ferrocyanide (2 mM, 0.1 M 
KCl, 50 mV/s) 
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The response of the GC carbon electrode towards ferrocyanide shows behaviour 
typical of a reversible system, where there are well defined oxidation and reduction 
processes with peak separations (Ep = 79 mV) close to the 59 mV predicted by 
Nernst. The peak current ratio is also close to 1 which corroborates the reversibility 
of the system. In contrast, the unmodified carbon fibre electrode presents broad 
oxidation (+0.38 V) and reduction (+0.12 V) peaks giving a peak separation of 263 mV 
and indicating relatively poor electron kinetics.  The carbon fibre electrode was 
electrochemically enhanced by anodising the electrode surface (+2 V, 900 s).  
Electrochemical modification increases the electrode surface area as it causes 
exfoliation of the carbon particles and increases the population of edge plane sites, 
where faster electron transfer can occur (Banks and Compton, 2005).  The clarity of 
the resulting peaks is greatly improved, and the peak current magnitude is greatly 
increased. The latter can be attributed to the increased surface area arising from the 
anodisation process. The peak separation is also greatly improved (Ep = 65 mV) and 
is in close agreement with responses from the GC electrode.   
 
 
4.3.2  Effect of Hydrolysis on CAP Film 
 
 
The methodology within this chapter relies on the electrochemical initiation 
of a reducing potential to a CAP modified carbon fibre electrode that has been placed 
in between two reservoirs, as indicated previously in Figure 4.1.1.  The CAP side of 
the electrode acts as an insulating barrier preventing the contact of the detection 
analyte (2 mM ferrocyanide) with the carbon fibre. The exposed side of the carbon 
fibre electrode faces to the receiving / delivery reservoir. As the latter contains 0.1 
M KCl (adjusted to a lower pH to minimise dissolution of the film) it was anticipated 
with the CAP barrier in place - there would be effectively no faradaic signal – only the 
buffer sweep.  The application of a reducing potential initiates the production of 
hydrogen bubbles within the electrode as demonstrated in Figure 4.3.2. The 
consequent removal of protons also causes an increase in local pH within the carbon 
fibre network. Both events ultimately lead to the disruption of the protective CAP 
film, allowing the ferrocyanide to travel and then once at the exposed porous CF 
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electrode, become oxidised to ferrocyanide (Fe(II)(CN)64-  Fe(III)(CN)63- + e) 
generating a faradaic signal at the electrode. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.2 Mechanism for initiating hydrolysis leading to the evolution of hydrogen bubbles 
Both the reference and the counter electrodes were placed in the delivery chamber 
and completed the electrochemical cell.  A cyclic voltammogram was initiated before 
reduction to confirm that the CAP barrier was intact and there was no leakage of 
ferrocyanide. This effectively served as the blank response.  The carbon fibre 
electrode was then subjected to a reducing potential -2 V for 30 seconds. As 
expected, the generation of hydrogen bubbles commenced at the surfaces of the 
electrode almost immediately. Cyclic voltammograms detailing the response 
obtained at the carbon fibre electrode after timed intervals - post reduction are 
shown in Figure 4.3.3.  The peak responses can be seen to increase with time as, in 
the absence of the CAP barrier, the ferrocyanide passes through the fibre network 
and is oxidised to ferrocyanide. 
 
-V  
Independently  
Addressable 
Arrays 
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Figure 4.3.3 Cyclic voltammograms detailing the responses recorded at the carbon fibre electrode 
after electrolysis (−2 V, 30 s) and subsequent rupture of the cellulose acetate phthalate film. Scan rate: 
50 mV/s. Inset: schematic of the cell configuration 
 
 
Confirmation that the film was indeed ruptured by the formation of the bubbles is 
provided in Figure 4.3.4, where video stills capture the effect of electrolysis process 
pre and post reduction.  It can be seen from Figure 4.3.4B that a minor tear emerges 
in the film as the hydrogen bubble emerges from the carbon fibre network.   
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Figure 4.3.4 Pictures of the CAP-CF film before and after commencing the electrolysis 
 
As mentioned previously, the hydrogen evolution reaction will also lead to the 
increase in the local pH at the carbon fibre interface. The next challenge was to 
confirm that the latter occurs and to determine the extent to which the pH shifts with 
the application of a reducing potential.  
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Assessing Changes in Local pH 
 The shift in pH at the electrode interface was confirmed through observing the peak 
position of the quinoid species on the surface of the anodised carbon fibre electrode 
(Anderson et al., 2014; Lu and Compton, 2014).  The carbon surface is populated by 
a variety of chemical functionality – many of which are electrochemically invisible. 
Quinoid structures, in contrast, give rise to faradaic processes (Figure 3.1.3) which 
can be observed when conducting voltammetric sweeps. Ordinarily, these species 
are present at very low concentration, but their population is dramatically increased 
after anodisation processes and their peak processes can be easily identified 
(Anderson et al., 2014). 
 
The peak position of these quinone species on the surface of the carbon fibre are pH 
dependent, this makes them an identifying marker of the local pH.  During the 
present investigation, the carbon fibre was anodised as described previously, and a 
calibration graph detailing the position of the electrochemically generated quinoid 
oxidation peak to a range of pH (3-10) is detailed in Figure 4.3.5. 
 
 
 
 
 
 
 
 
 
Figure 4.3.5 Square wave voltammograms detailing the response of the anodised carbon fibre probe 
at various pH regimes 
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The response was found to be linear (E/V = −0.069 pH + 0.428; N = 8; R2 = 0.994) 
although the gradient is larger than Nernstian predictions (Anderson et al., 2014; Lu 
and Compton, 2014).  In order to assess the change in pH within the carbon fibre 
network during electrolysis, the anodised electrode was scanned in the KCl 
electrolyte which had been adjusted to pH 3 in accordance with the previous study 
highlighted in Figure 4.3.3.  Square wave voltammograms were recorded before and 
after the imposition of the electrolysis conditioning step (-2 V, 5 s) and are detailed 
in Figure 4.3.6.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.6 Square wave voltammograms detailing the influence of local pH on the carbon-quinoid 
moieties peak position pre and post electrolysis 
 
 
After the application of the reducing potential (-2 V, 5 s), there is a distinct shift in 
the peak process towards more negative potentials which, from the results 
highlighted in Figure 4.3.5, are consistent with a change in the local pH to more 
alkaline conditions. The peak returns to the pre-conditioning position shortly after 
the electrolysis has finished as the bulk solution dilutes the local concentration of 
hydroxide and returns the pH to the initial state.  From the calibration equation it is 
possible to determine the pH of the solution directly at the CF interface by using the 
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calibration equation (Figure 4.3.5) and the peak position of the post electrolysis 
quinone peak (Figure 4.3.6). The localised pH was found to have increased from pH 
3.19 to pH 8.26 based on holding the electrode at -2 V for 5 s. 
 
The effect of electrolysis was visually investigated through testing the CF electrode 
in the presence of the pH indicator phenolphthalein.  Phenolphthalein is a useful 
indicator in this study as it remains colourless in acidic conditions, sharply changing 
colour to pink in alkaline conditions.  A reducing potential (-2 V, 60 s) was applied at 
the CF electrode, where it was envisaged that the onset of a negative potential would 
increase the local pH environment resulting in a colour change.  Although this is not 
an accurate representation of the true pH change at the electrode, it does however 
provide a visual indication that the CF electrode does undergoes a change in localised 
pH.  The CF electrode was placed into to a solution of phenolphthalein (1 mM, 0.1 M 
KCl) along with the reference and counter electrodes.  The reducing potential was 
initiated (-2 V, 60 s) and an image was recorded after every 10 seconds during 
electrolysis as shown in Figure 4.3.7. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.7 Mat CF with CAP film under varying times of electrolysis 
 
 
In addition to this, a screen-printed carbon electrode (SPCE) was used in a similar 
configuration as described above in order to project a visual change in pH using 
universal indicator paper.  A small section of indicator paper was placed on top of a 
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SPCE electrode and secured in place.  An aliquot of 0.1 M KCl was added, along with 
the reference electrode and counter wire.  A reducing potential (-2 V, 30 s) was 
initiated at the SPCE, this leads to a colour change within the indicator paper as more 
basic conditions are achieved - as indicated in Figure 4.3.8.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.8 Application of various electrolysis times to a screen-printed electrode visually 
monitored with pH indicator paper 
 
 
It is known that the dissolution of protective CAP films occurs at pH environments of 
8 or above and therefore the fact that the pH at the interface of the CF-CAP modified 
electrode can be manipulated, proffers an alternative approach to controlled release. 
The electrochemical approach proposed offers two modes of action: rapid release - 
as a consequence of the mechanical force exerted by the generation of the hydrogen 
bubbles, and the controlled application of a reducing potential that will lead to more 
gradual change in local pH and ultimately film dissolution. 
 
 
 
4.3.3  Electrochemically Controlled Release of Methotrexate 
 
In order to determine the efficacy of this approach for controlled release 
systems with an authentic drug, the system utilising ferrocyanide - as described in 
Section 4.3.2 , was replaced with methotrexate - a common chemotherapeutic agent 
(Cipriani et al., 2014; Favalli, Biggioggero and Meroni, 2014).  The electrochemical 
behaviour of the drug is not as distinct as ferrocyanide – it does not exhibit reversible 
oxidation because of the tertiary amino group.  The transport of the drug from 
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reservoir, through the CF network and into the receiving/delivery reservoir was 
therefore monitored using UV-Vis spectroscopy.  In order to assess the spectral 
properties of the molecule, a series of additions from a stock solution of 
methotrexate (1 mM, pH 7 buffer) is shown in Figure 4.3.9.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.9 UV Spectra detailing the additions of methotrexate (2 mM, pH 7 buffer) 
 
A calibration graph detailing influence of concentration on absorbance at 260 nm is 
shown in Figure 4.3.10.  The calibration equation was then used to determine the 
amount of methotrexate that had been displaced from the drug reservoir into the 
receiving/ delivery reservoir.   
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Figure 4.3.10 Relationship observed between peak height and increasing methotrexate 
concentration (8.3 µM to 62.5 µM, pH 7) 
 
Methotrexate (0.2 mM) was dissolved in pH 7 buffer and placed in the CAP facing 
drug reservoir) (replacing the ferrocyanide).  The delivery reservoir again contained 
only 0.1 M KCl.  Rather than relying on the electrode to detect the transfer of the 
drug between the reservoirs, samples from the receiving / delivery reservoir were 
extracted at given time periods. The movement of the methotrexate from the drug 
reservoir into the delivery reservoir was confirmed by repetitively sampling the 
delivery reservoir and examining the uv-spectrum. Typical spectra obtained from the 
investigations are shown in Figure 4.3.11. Samples were withdrawn from the delivery 
reservoir after the initiation of hydrolysis (rupture of the CAP film) every 5 minutes. 
The spectra show the continued transport of the drug though the carbon fibre gate 
by diffusion transport.   
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Figure 4.3.11 UV spectra detailing the emergence of methotrexate through the ruptured CAP-CF 
gate into the delivery chamber. Solution sampled at 5 min intervals following the electrolysis. Inset 
from calibration additions 
 
 
The structure of methotrexate is somewhat complex and encompasses several 
electrochemically active groups and it could be suggested that electrochemical 
manipulation could lead to the drug being changed and its bioactivity compromised.  
It must be considered that the electrolysis potential is only applied for a matter of 
seconds until dissolution or rupture of the film is achieved, therefore, with the 
exception of the materials directly at the interface, it is unlikely to modify the bulk of 
the material within the drug reservoir. During hydrolysis, the production and 
subsequent release of hydrogen - as the bubble rip initiator, must be considered with 
a small degree of caution, but it must be remembered that the intention is for its 
application within a microdevice and not at the macro scale. As a result, the amount 
of hydrogen generated will be very small (assuming 0.18 mm3 per bubble from visual 
inspection of the bubble diameter – provides an estimate of some 8 nmol / L) and, 
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ironically, there have been a number of studies that have demonstrated the 
beneficial aspects of the gas within physiological systems (Xie et al., 2010; Lekic et 
al., 2011; Qu et al., 2012) - albeit at low levels.  The presence of hydrogen at such 
levels should not directly impede its consideration. 
 
4.3.4  Modification of Mat CF Electrode Using Iron Oxide Nanoparticles 
 
 
Nanoparticles designed for biomedical applications have performed 
favourably in various sensing and diagnostic environments.  The use of several metal 
and metal oxide nanoparticles have been researched, particularly in the fields of 
regenerative medicine and tissue engineering (Ito and Kamihira, 2011; Khan, Saeed 
and Khan, 2017; Parveen et al., 2018).  The accessibility of magnetic nanoparticles 
(MNPs) has provided the opportunity to develop conductive composites by utilising 
much smaller particles than which have been available in the past.   
 
In order to perform favourably within biomedical systems, MNPs should exhibit 
superparamagnetic properties (SPIONs).  SPIONs are small particles containing either 
a magnetite (Fe3O4) or maghemite (γ-Fe2O3) core, which have been coated with a 
biocompatible polymer (Markides, Rotherham and El Haj, 2012).  The suitability of 
iron (Fe) oxide-based MNPs within biological settings is apparent due to their 
superparamagnetic nature, along with their biocompatibility. The 
superparamagnetic properties ensure that the nanoparticles will not be attracted to 
each other and hence the risk of agglomeration in a biological system is reduced.  
Ferritin is a naturally occurring protein in the human body that stores and release 
iron in a controlled manner, therefore, nanoparticles containing iron can be 
considered biocompatible as the body can easily metabolise the particles into its 
elements, which can be used by the body in subsequent metabolic processes 
(Markides, Rotherham and El Haj, 2012; Elmas et al., 2018).   
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The anodised CF electrode was modified through the selective deposition of iron 
oxide nanoparticles (1 mg/mL, H2O, Sigma).  Iron oxide nanoparticles (0.1 mg) were 
drop cast onto the surface of an anodised CF electrode and left to dry.  The Fe3O4 
modified electrode was then placed in pH 3 buffer and the resulting square wave 
voltammogram is compared against an anodised CF electrode in the absence of Fe3O4 
in Figure 4.3.12.  The modified electrode contains not only quinoid species native to 
the carbon fibre but also the addition of the Fe3O4 (both Fe2+ and Fe3+ ions).  As the 
square wave scan commences at the Fe3O4 modified electrode, it is possible that as 
the quinone undergoes oxidation, the iron particles are being reduced leading to a 
larger and much sharper than the peak recorded for its unmodified counterpart.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.12 Anodised CF electrode compared against a Fe3O4 modified CF electrode 
  
 
Incrementing additions (0.02 mg – 0.1 mg) of the Fe3O4 were added onto the 
anodised CF electrode which was investigated in the presence of pH 7 buffer.  It was 
observed in Figure 4.3.13, that the peak position in the presence of pH 7 buffer was 
in the more negative region of the potential window which aligns with previous 
experimental investigations in Section 4.3.2. 
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Figure 4.3.13 Square wave voltammograms highlighting the additions of Fe3O4 onto modified CF 
electrode in pH7 buffer 
 
 
 
The next step looked at the electrochemical behaviour of the unmodified and Fe3O4 
modified CF electrodes in the presence of ferrocyanide (2 mM, 0.1 M KCl).  The 
response of the unmodified and Fe3O4 modified CF electrodes towards ferrocyanide 
are shown in Figure 4.3.14.  Unlike the SWV (Figure 4.3.12) which shows a distinct 
peak, and an increase in electrochemical signal as the additions of Fe3O4 are 
increased, when the Fe3O4 modified (0.03 mg) electrodes are tested in ferrocyanide 
(Figure 4.3.14), the resulting CV is much broader in comparison to the unmodified CF 
electrode (Ep = 220 mV).  While the response to ferrocyanide may not be slow, it 
does not necessarily follow that the response to hydrogen evolution will be likewise. 
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Figure 4.3.14 Cyclic voltammograms comparing the response of the Fe3O4 modified electrode to an 
anodised carbon fibre electrode towards ferrocyanide (2 mM, 0.1 M KCl, 50 mV/s) 
 
Linear sweep voltammograms detailing the response of the modified CF electrodes 
(anodised CF and IO modified CF (0.1 mg Fe3O4)) are shown in Figure 4.3.15.  The 
addition of iron oxide nanoparticles onto the CF surface displayed superior HER 
activity compared to the unmodified CF due to the high dispersity and conductivity 
of the iron oxide nanoparticles deposited on the surface of the CF.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.15 Linear sweep voltammograms of the unmodified CF and IO modified CF (0.1 M KCl, 
under nitrogen) 
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It can be seen that the presence of the Fe3O4 particles significantly improves the 
response to hydrogen reduction and could, in principle, enable the imposition of 
smaller cathodic potentials to induce more subtler pH changes.  The benefit of using 
the iron oxide is that the system is inherently biocompatible (Markides, Rotherham 
and El Haj, 2012; Ling and Hyeon, 2013) and could potentially be incorporated into a 
variety of electrochemically initiated drug release mechanisms.  
 
 
Graphene Oxide 
 
Graphene research has received a huge amount of attention in the past decade (Nag, 
Mitra and Mukhopadhyay, 2018).  The use of graphene materials - in particular, 
Graphene Oxide (GO) within electrochemical devices has garnered substantial 
interest (Ambrosi et al., 2011).  Its unique two-dimensional lamellar structure and 
desirable properties include; high electron conductivity, a fast heterogeneous 
electron-transfer (HET), a large surface area, and edge reactivity (Zubir et al., 2014; 
Farooqui, Ahmad and Hamid, 2018).  GO is typically formed by the exfoliation of 
graphite oxide, and possesses a large number of oxygenated functional groups, 
where, hydroxyl and epoxides reside on the basal plane and carbonyl and carboxyl 
groups are found at the edges (Zubir et al., 2014).  
 
The addition of GO was employed to assess whether or not its presence would 
improve the overall performance – both in terms of sensing application but, more 
importantly, as a means of enhancing the HER process which would be required to 
initiate an increase in local pH.  The optimisation of the unmodified carbon fibre 
electrodes was further investigated via the deposition of graphene oxide (GO 1 mg / 
mL H2O).  Additions of the suspended GO solution (0.005 mg – 0.03 mg) were 
deposited onto the anodised CF and left to dry before their response towards a 
model redox probe – ferrocyanide, was assessed (Figure 4.3.16).   
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Figure 4.3.16 Cyclic voltammograms detailing the response of the GO modified CF towards 
ferrocyanide (2 mM, 0.1 M KCl, 50 mV/s) 
 
 
The additions of GO onto the CF electrode display inherent electrochemistry.  By 
examination of the peak separations in Table 4.3.1, it is evident that the 
electrochemistry of the unmodified CF presents very slow electron transfer of the 
ferrocyanide couple as shown by the large peak separation values.  The values of the 
GO modified electrodes are much improved with much smaller peak separation 
values.  The better response of the GO modified CF to ferrocyanide can be attributed 
to the edge plane effects of the GO particles and the structure of GO itself which has 
quinoid components present (Figure 4.3.17) 
 
 
 
 
 
 
 
 
Figure 4.3.17 Structure of graphene oxide 
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Table 4.3.1 Analysis of peak separation after modification with GO 
 
GO Modifier Peak Separation 
Unmodified CF 353 mV 
0.3125 µg /mm2 101 mV 
0.625 µg /mm2 112 mV 
1.25 µg /mm2 103 mV 
1.875 µg /mm2 105 mV 
 
 
The influence of the GO on the electrode was found to improve the electrochemical 
performance as indicated by the improvement in the peak definition and separation. 
Linear sweep voltammograms detailing the response of the modified CF electrodes 
(anodised CF, IO modified CF (0.1 mg) and GO modified CF (0.1 mg)) are shown in 
Figure 4.3.18, where it is clear that the addition of both the IO and GO has a dramatic 
impact on the relative processes. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3.18 Linear sweep voltammograms of the unmodified CF and IO and GO modified CF 
electrodes (0.1 M KCl, under nitrogen) 
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While the Fe3O4 nanoparticles are considered to be the most common and effective 
biocompatible magnetic nanoparticles for use in biomedical applications – there are 
still questions over the toxicology of GO.  Although the results from the GO 
modification step demonstrate an improvement in peak separation, there are still 
questions over the unsatisfactory biocompatibility of GO materials which restricts 
their use within biological systems (Ambrosi et al., 2011; Guo and Mei, 2014).   
 
 
4.4  Conclusions  
 
Protective coatings are widely used in conventional drug release systems, but 
it has been shown in this chapter that electrochemical activation through the 
imposition of a sufficiently negative potential can induce controlled rupture of a 
cellulose acetate phthalate film. Electrochemical generation of hydrogen bubbles 
and the subsequent mechanical strain can enable rapid, on demand, release rather 
than relying on the gradual solubilisation of the film in solutions of higher pH. It has 
been demonstrated that potential control of the carbon fibre electrode can not only 
control the local pH but also enable the dissolution and fracture of protective CAP 
films. It is possible to exploit this mechanism to selectively control the movement of 
model drugs from a reservoir to the receiving target.  Two approaches have been 
investigated: electrochemical generation of hydrogen bubbles can enable rapid 
rupture of the protective film and lower potential dissolution.   Proof of concept for 
the release strategy has been demonstrated using methotrexate as a model drug. 
Moreover, routes through which the hydrogen evolution reaction could be optimised 
further were investigated using the immobilisation of iron oxide and graphene oxide 
nanoparticles. Although preliminary in nature, the results indicate that these systems 
could be versatile catalysts for further development.  
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Chapter 5 
 
Controlled Electrochemical Dissolution of pH Sensitive Carbon Composite 
Electrodes 
 
 
Abstract 
 
 
In previous sections, cellulose acetate phthalate (CAP) was employed as a separate film with 
the electrochemical induced pH dissolution facilitated by electrodes placed near to the film. 
The methodology proposed herein focuses on integrating the CAP component directly within 
the electrode substructure – essentially using the former as a pH sensitive binder. The design 
and fabrication of a novel nanostructured conductive film, based on a composite of carbon 
nanoparticles and cellulose acetate phthalate (CAP) is presented and its ability to serve as 
drug releasing actuator is explored.  
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5.1  Introduction  
 
 
The work described within the previous chapter exploited a conductive 
carbon fibre electrode combined with a pH sensitive barrier film applied as a separate 
layer.  The assembly can be complicated due to the need for precise alignment 
between the carbon fibre, cellulose acetate phthalate (CAP) film and the 
encapsulating laminate. The next stage was to simplify the process and determine if 
the CAP component could be directly incorporated within the conductive element.  
Rather than using carbon fibre filaments - the central design rationale here revolved 
around using the CAP polymer to bind together nanoparticulate carbon particles to 
form a conductive sheet. In contrast to conventional carbon films, a novel element 
was to be introduced whereby the CAP component could be eroded under the 
imposition of a reducing potential. In this respect it shared similar principles to the 
approach investigated in Chapter 4. The core methodology relating the film to 
controlled drug release is highlighted in Figure 5.1.1. It was envisaged that the 
carbon-CAP composite film would retain conductivity and thus the imposition of a 
suitable cathodic potential would begin to generate hydrogen. The pH would be 
expected to increase at the film interface and induce the solubilisation of the CAP 
film. The end result would be the removal of the CAP binder allowing the passage of 
the drug through the pores left behind. 
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Figure 5.1.1. (A) Stable carbon-CAP film before the commencement of reduction (B) Application of 
reducing potential leads to hydrogen generation (C) The pH at the interface of the film increases, 
leading to gradual film solubilisation (D) The removal of the CAP binder results in the transportation 
of the drug through the film pores 
 
The application of a reducing potential was once again used as the rational towards 
the development of an electrochemically controllable gate and, in this instance, the 
system could be considered to be more readily capable of being integrated into micro 
drug delivery reservoirs.   
 
5.2  Experimental Details  
 
5.2.1  Materials  
 
Chemical reagents were of the highest grade available and used without any 
additional purification.  All electrochemical measurements were carried out at 22 oC 
± 2oC in Britton Robinson (BR) buffer (pH 3-9, adjusted to the appropriate pH value 
via the addition of sodium hydroxide).  Nano carbon powder with a mean particle 
size of 100 nm and cellulose acetate phthalate (CAP) were obtained from Sigma 
Aldrich.   
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5.2.2  Electrochemical Setup  
 
Electrochemical analysis and set up was performed using a µAutolab 
computer controlled potentiostat (Eco-Chemie, Utrecht, The Netherlands).  The 
initial measurements involved a three electrode configuration comprising of CAP-C 
composite working electrode, a counter electrode in the form of a platinum wire and 
a standard silver/silver chloride (3 M NaCl, BAS Technicol UK) reference electrode.  
Cyclic voltammetry measurements were conducted at 50 mV/s unless otherwise 
stated. 
 
5.2.3  Sensor Design and Modification  
 
The construction of the carbon loaded films was generally achieved through 
the simple mixing and dispersion of the carbon nano powder within the CAP (50 / 50 
wt %) that had previously been dissolved in a suitable solvent, such as acetonitrile.  
The composite solution was then cast onto a silicone substrate and allowed to dry. 
After drying, the films were carefully removed from the substrate and assembled into 
the electrode configuration. Electrical connections to the carbon composite films 
were made via the addition of strips of adhesive backed copper shielding tape (100 
µm thick) available from RS Electronics, UK.  Small sections of the CAP-C film were 
assembled between sleeves of a resin polyester lamination pouch with a film 
thickness of 75 µm (Rexel, UK).  The laminate sleeves were pre-patterned to reveal a 
square window on either side and were sealed using a standard office laminator.  The 
final electrode configuration is shown in Figure 5.2.1. To improve the conductivity of 
the composite films for electron microscopy, the CAP-C electrodes were sputtered 
with a thin layer of Palladium using an 80:20 Pd/Au target at 30 mA for 3 minutes 
(Emitech K500X Sputter Coater, Quorum Technologies Ltd, England).  Iron (II, III) 
oxide (Fe3O4) - which contains a mixture of Iron2+ and Iron3+ ions and graphene oxide 
(GO) were employed as chemical modifiers during experiments. 
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Figure 5.2.1 Schematic of the CAP-C electrode configuration along with electron micrographs of the 
cellulose acetate phthalate-nano carbon composite microstructure 
 
5.2.4 Biocompatibility Studies 
 
The biocompatibility of the nano carbon-cellulose acetate composite was 
assessed in relation to skin irritation (DIN EN ISO 10993-10:2014) and cytotoxicity 
(DIN EN ISO 10993-5:2009) and were conducted by Bioserv Analytik Un 
Medizinprodukte GMBH (Rostock Germany) under GLP conditions.  A summary of 
the procedure undertaken is described: 
Skin irritation assessments were conducted using healthy young female albino 
rabbits with a weight not less than 2 kg (as per ISO recommendations). The rabbits 
were kept caged for at least 5 days prior to the test to enable acclimatisation and 
were immunised against myxomatosis and RHD. The fur on the back of the rabbits 
was closely clipped on both sides of the spinal column (10 x 15 cm) 4 hours before 
the test procedure was initiated. The test material (CAP-C) was applied directly to the 
clipped skin along with gauze patches that served as a control (25 x 25 mm). The sites 
were then covered with a non-occlusive gauze patch and then wrapped with an 
occlusive bandage for a period of 4 hours. At the end of the test, the dressings were 
removed, and any residual substances were washed with warm water and the skin 
blown dry. The application sites were typically monitored at 1, 24, 48 and 72 hours 
137 
 
after removal of the material and scored in terms of extent of erythema, eschar and 
edema formation. The results indicated that there was no skin irritation at any point 
in the course of the 72 hour observation. 
Cytotoxicity studies were conducted using 6 cm2 samples of the CAP-C material. 
Polypropylene and DMSO were used as the negative and positive control samples 
respectively. Extracts were prepared in accordance with ISO 10993-12:2012 using 
Dulbecco’s Modification of Eagle Medium with 10% fetal calf serum (DMEM-FCS). 
The extraction processes were run with gentle shaking for 24 hours at 37oC. Cell 
cultures were prepared using L 929 cells (ATCC CCL 1, NCTC clone 929, connective 
tissue mouse) as per recommendations in 10993-5:2009. Cells were grown in DMEM-
FCS at 37oC and 5% CO2 in a humidified incubator. Cells were harvested 24 hours 
before determination of cytotoxicity using a trypsin / EDTA solution and re-
suspended in fresh DMEM-FCS. The cell density was adjusted to 1.75x105/ mL. The 
wells of a tissue culture plate were then inoculated with 1 mL of the cell suspension 
and incubated for 24 hours - during which the cells formed a subconfluent 
monolayer. Serial dilutions of the CAP-C extract were prepared to give a 
concentration range of 100, 66, 44, 30 and 20% using DMEM-FCS as diluent. Each 
dilution extract was then tested through triplicate pipetting of 1mL aliquots into the 
respective cell culture wells (after removal of the culture medium). The well plate 
was then incubated for 24 hours prior to assessment.  The cell culture plates were 
examined microscopically and graded according to their reactivity (0: no growth 
inhibition/no cell lysis through to 4: almost complete destruction of the cell layers).  
The cell layers were also quantitatively assessed through staining with 0.25% crystal 
violet, washed, dried and the cell bound stain extracted with 33% glacial acetic acid. 
The dissolved stain samples were read by microplate reader at 550 nm. The 
absorbance for each sample was determined in triplate with the mean value of the 
negative polypropylene estimated at 100% cell growth. The relative inhibition of cell 
growth (ICG) was calculated as %ICG= 100-(100 x A550 test / A550 negative control) 
whereby, in accordance with ISO 10993-5, an ICG of more than 30% is regarded as a 
cytotoxic effect. The extract solutions all fell below this threshold and along with the 
overall assessment indicated that the material did not cause any relevant 
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toxicological or biological damage to the subconfluent monolayer of L929 cells under 
the test conditions of DIN EN ISO 10993-5:2009. 
 
5.3  Results and Discussion 
5.3.1  Preliminary Characterisation of CAP-C Films 
 
The primary batch of composite electrodes were comprised solely of CAP and 
carbon nanopowder (CAP-C). The electrochemical performance of the CAP-C 
electrodes in the presences of ferrocyanide (2 mM, 0.1 M KCl) – a model redox probe, 
is shown in Figure 5.3.1 A.  The CAP-C electrode displays very poor electrode kinetics 
with a poorly defined oxidation peak. No reduction peak was observed on the reverse 
scan. This is in contrast to the responses observed with a Glassy Carbon electrode 
and the carbon fibre systems detailed previously in Figure 4.3.1. The response of the 
CAP-C film was then tested in Ruthenium hexamine (Ru(NH3)62+/3+ (2 mM, 0.1 M KCl) 
under nitrogen (Figure 5.3.1 B).  There is a marked improvement in electrochemical 
response towards the ruthenium hexamine in comparison to the ferrocyanide. The 
disparity can be attributed to the difference in the nature of the compounds and their 
interaction with the carbon surface. The ferrocyanide probe is a classic negatively 
charged inner sphere complex whereas the ruthenium hails from a positive charged 
outer sphere system (Brownson et al., 2011) and it could be that electron transfer is 
preferentially faster at the latter. 
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Figure 5.3.1 Cyclic voltammograms detailing the response of the cellulose acetate phthalate-nano 
carbon films towards ferrocyanide (A) and ruthenium hexamine (B). Each redox probe present at 2 
mM in 0.1 M KCl. Scan rate: 50 mV/s 
 
It is clear from the voltammograms highlighted in Figure 5.3.1 that the background 
current is very large and can, at least in part, be attributed to uncompensated 
resistance within the film and the capacitive background associated with the surface 
area arising from the nanoparticle interface. The is due to the composite nature of 
the film, in which the carbon content has to be reduced in order to have sufficient 
polymeric binder that the film integrity is not compromised. Going beyond the 50:50 
ratio of carbon : CAP has the effect of either increasing resistance (too much binder) 
or the film becomes too powdery (too much carbon).  
While in previous chapters it was possible to improve the electroanalytical response 
to ferrocyanide through anodisation of the carbon surface and thereby increasing the 
edge plane/quinoid functional group population, the same option is not possible in 
this case.  Electrochemical anodisation is not appropriate as due to the pH sensitive 
nature of the CAP binder.  The highly alkaline anodisation solution (0.1 M NaOH) 
would immediately compromise the structure of the CAP-C films resulting in 
immediate dissolution and destruction of the film.   
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5.3.2 Controlled Electrochemical Dissolution of CAP-C Electrodes 
 
 Exploitation of the pH sensitivity of the polymer for use in electrochemically 
controlled drug release has been described previously in Chapter 4, but in the context 
of its use as a film encapsulating a drug loaded reservoir with a distinct/separate 
conductive element.  The stability of the CAP-C composite film was first assessed in 
the presence of ruthenium hexamine (2 mM, 0.1 M KCl) and is shown in Figure 5.3.2.   
The addition of 150 µL of 0.1 M NaOH to the ruthenium hexamine solution yield a pH 
of 11.55 and it was envisaged that as the bulk pH was dramatically increased, 
dissolution of the CAP-C electrode begins. This would ultimately decrease the 
electrochemical signal of the ruthenium hexamine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.2 Response of the CAP-C electrode towards 2 mM ruthenium before and after pH 
adjustment using NaOH. Scan rate: 50 mV/s 
 
It was observed that soon after change the pH of the bulk ruthenium (30 s) that the 
signal becomes much more amplified (green scan) compared to the scan that was 
initiated before the addition of NaOH.  An explanation for the increase in 
electrochemical signal can be that when the NaOH is initially added to the solution, 
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it leads to the dissolution of the surface CAP thereby exposing more of the carbon 
resulting in a greater signal.  After the time intervals, it was observed that this initial 
spike in signal then begins to decrease as more and more of the CAP is dissolved and 
the carbon is also lost when the electrode begins to disintegrate.  To prove that this 
result was indeed a result of the dissolution of the CAP-C and not a consequence of 
the pH changes to the ruthenium, a commercial glassy carbon electrode was exposed 
to the same conditions as shown in Figure 5.3.3.   
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.3 Response of the GC electrode towards 2 mM ruthenium before and after pH adjustment 
to pH 11.55 using NaOH. Scan rate: 50 mV/s 
 
The glassy carbon response remains constant; therefore, it was concluded that the 
response of the CAP-C was not just simply a case of a pH effect of the solution on the 
ruthenium hexamine, rather a response to the presence of lots of hydroxyl ions 
dissolving the CAP binder – and therein compromising the structural integrity of the 
film as indicated in Figure 5.1.1.  Visual confirmation that electrochemical control of 
the potential (-2 V, 30 s) and hence the local pH can induce the dissolution and 
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subsequent failure of the film is highlighted in Figure 5.3.4). It could be anticipated 
that were drugs to be entrapped within the network at the time of formulation, then 
the electrochemically induced swelling could allow control over their release. 
 
 
 
 
 
 
 
 
 
Figure 5.3.4 Dissolution of the CAP-C film before and after the initiation of electrolysis 
 
The next step was to assess the ability to control the swelling or dissolution of the 
CAP-C film in the presence of ruthenium hexamine.  The CAP-C electrodes where 
assembled into the laminate assembly, where a filter paper sleeve was placed on 
either side of the CAP-C film and thermally sealed within the electrode.  The 
incorporation of the filter paper into the system was used to ensure that residual 
particles of carbon and CAP were entrapped after the application of the reducing 
potential yet allowing redox transitions of the ruthenium hexamine to be detected 
through the porous membrane. Voltammograms were recorded before the 
application of a cathodic potential to serve as a control. Again, it was envisaged that 
the imposition of a cathodic potential would increase the pH and lead to the swelling 
or dissolution of the CAP binder within the core of the film, as such, the surface area 
of the electrode would change. The latter could therefore be assessed through 
changes in the peak magnitude of the ruthenium hexamine. Thus, the ruthenium 
hexamine voltammograms were recorded before and after each cathodic step.  Cyclic 
voltammograms detailing the response of the CAP-C filter paper electrodes to 
ruthenium hexamine (2 mM, 0.1 M KCl) before and after the imposition of a potential 
of -2 V are detailed in Figure 5.3.5.  Before the cathodic potential is applied, the 
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voltammetric response of the CAP-C film to ferrocyanide is consistent with that 
observed in Figure 5.3.1B.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.5 Cyclic voltammograms detailing the response of the CAP-C filter paper electrode to 2 mM 
Ruthenium before and after holding the electrode at -2 V for given time periods. Scan rate: 50 mV/s 
 
Upon the initiation of hydrogen evolution, the profile changes dramatically, where 
the scan recorded after 30 s of reduction at -2 V appears much larger with a more 
defined peak.  This aligns with the previous result shown in Figure 5.3.2, where after 
the first period of reduction the resulting scan presents a much larger signal – again 
this can be related back to the fact that as the local pH is increasing, the surface CAP 
is being removed therefore exposing more carbon particles resulting in a greater 
signal.  This trend continues 60 s post reduction; however, the peak begins to lose 
definition, becoming much broader. After 90 s of an applied reducing potential the 
electrode losses much of its response as full dissolution of the electrode has been 
achieved and the conduction between the carbon particles is significantly reduced.  
The results from above (Figure 5.3.5) were repeated without the filter paper within 
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the electrode configuration in order to draw a comparison.  It was predicted that the 
local pH within the filter paper configuration would give rise to greater changes in pH 
as the local sensing area had been confined within the filter paper, therefore leading 
to more rapid dissolution.  Cyclic voltammograms detailing the response of the CAP-
C electrode without filter paper before and after the imposition of a potential of             
-1.5 V are shown in Figure 5.3.6. The voltammetric response of the CAP-C electrode 
to ruthenium hexamine is consistent with that observed in Figure 5.3.2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.6 Cyclic voltammograms detailing the response of the CAP-C electrode (without filter 
paper) to 2 mM Ruthenium before and after holding the electrode at -1.5 V for given time periods 
Scan rate: 50 mV/s 
 
After imposing the reducing potential for 30 s, a large well-defined peak is observed 
which is much larger in comparison to the electrode with filter paper.  This can be 
attributed to the fact that the diffusion of the ruthenium hexamine to the electrode 
surface is faster in the absence of the filter paper. The latter also means that diffusion 
of the CAP away from the electrodes is also more rapid and hence the drop in the 
signal is much more pronounced. 
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To demonstrate that the signal drop is, in fact, due to the dissolution of the CAP-C 
electrode as a result of hydrolysis, a mat CF electrode was exposed to the same 
conditioning potential as the CAP C.  Cyclic voltammograms detailing the response of 
a carbon fibre towards ruthenium hexamine before and after the commencement of 
hydrolysis are shown in Figure 5.3.7.   It was observed that the carbon fibre electrode 
remains stable after the onset of a reducing potential, confirming that it is the 
deterioration of the CAP-C electrode – due to the change in local pH, that ultimately 
leads to a decrease in electrode sensitivity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.7 Cyclic voltammograms detailing the response of a carbon fibre electrode towards 2 mM 
ruthenium before and after holding the electrode at -1.5 V for given time periods. Scan rate: 50 mV/s 
Inset: Carbon fiber electrode in the presence of phenolphthalein (1 mM, 0.1 M KCl) during electrolysis 
 
During electrolysis, the carbon fibre was also assessed in the presence of 
phenolphthalein (1 mM, 0.1 M KCl).  As the reducing potential was initiated at the 
carbon fibre electrode, images were captured during electrolysis at specific time 
periods to confirm the increase in local pH (Figure 5.3.7 Inset).             
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5.3.3 Alizarin Modified Electrode for Voltammetric pH Sensing 
 
In the following section, square wave voltammetry was used as the 
electrochemical probe of the system.  It was envisaged that monitoring the peak 
position of alizarin (1 mM in ethanol) would provide the diagnostic data for 
measuring the extent to which local pH changed as a consequence of electrolysis. In 
previous investigations it was possible to utilise the position of quinone peaks 
endogenous to the carbon surface as an indicator of pH. This requires a large 
population of the quinone which was generally created through the process of 
anodisation. The latter is clearly inappropriate for the CAP-C system and therefore a 
quinone indicator system had to be directly added to the film using conventional 
casting methods. Square wave voltammetry was used to probe the impact of pH on 
the position of the solution based alizarin. The redox reaction of alizarin is shown in 
Figure 5.3.8 below, where the peak potential should theoretically vary by 59.2 mV 
per pH unit according to the Nernst Equation (Bard and Faulkner, 2001).   
 
 
 
 
 
Figure 5.3.8 The electrochemical redox reaction of the alizarin 
 
The CAP binder could not be used in acquisition of the calibration data in this instance 
due to its pH sensitivity.  To overcome this issue, the CAP was substituted for 
polycarbonate (pH insensitive binder) and the composite film assembled as described 
in Section 5.2.3 and electrochemically anodised (+2 V, 300 s).  The carbon-
polycarbonate film’s response towards alizarin (1 mM, ethanol, 25 µL deposited each 
side) under a range of different pH regimes are shown in Figure 5.3.9.  
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Figure 5.3.9 Square wave voltammograms of the alizarin modified carbon-polycarbonate electrode 
towards a series of pH buffers 
 
The peak of the alizarin shifted to the more negative region as the pH of the solution 
increases to a more alkaline environment as expected, and the plot of peak potential 
against pH shows a good linear relationship with a shift of 48.9 mV per pH unit.  A 
calibration graph detailing peak position against pH (3-12) is detailed in Figure 5.3.10. 
The equation of the line was EpAliz / V = -0.0489 [pH] + 0.2178; R2 = 0.995; N = 10).   
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Figure 5.3.10 Relationship between the oxidation peak position of alizarin and solution pH 
 
One of the next objectives within this work was to modify the CAP-C electrode 
through the addition of alizarin for pH sensing within an unbuffered solution (0.1 M 
KCl).  A CAP-C electrode was modified through the drop casting of an aliquot of 
alizarin as described above with the carbon-polycarbonate.  The stability of the CAP-
C film was tested in the presence of 0.1 M KCl that had been adjusted to pH 3.51 
through the addition of 0.1 M HNO3.  The CAP-C-Alizarin film was then assessed after 
the imposition of a moderate reducing potential (-1 V, increments of 30 s) as shown 
in Figure 5.3.11.  After the application of the reducing potential the peak magnitude 
begins to decrease (detailed in Table 5.3.1). There is no significant shift in the 
potential of the oxidation peak – this can be attributed to the fact the reducing 
potential (-1 V) is not sufficiently negative to induce a marked increase in proton 
reduction and hence pH such the local pH re-establishes to the bulk pH (pH 3.51) 
almost immediately. Thus, when the actual scan is initiated after the reducing 
potential – the solution pH has returned and thus no peak shift. 
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Figure 5.3.11 Square wave voltammograms detailing the influence of the reducing potential (-1 V, 30 
s) on the alizarin modified CAP C films  
 
 
Table 5.3.1 Peak height measurement of the alizarin before and after various reduction times 
 Peak Position / V Peak Height / µA 
Preconditioning -0.47 47.39 
-1 V, 30 s -0.47 36.42 
-1 V, 60 s -0.48 31.31 
-1 V, 90 s   -0.48 27.27 
-1 V, 120 s -0.48 23.4 
-1 V, 150 s -0.48 20.14 
-1 V, 180 s -0.48 18.49 
-1 V, 210 s -0.48 16.24 
-1 V, 240 s -0.48 14.57 
-1 V, 270 s -0.48 12.81 
-1 V, 300 s -0.48 12.19 
 
Since the CAP-C-alizarin modified electrode showed a reasonable Nernst response 
under various pH regimes, it was necessary to test the performance of this electrode 
for the voltammetric sensing of local pH, before and after the commencement of 
hydrolysis.  The performance of the alizarin modified electrode was assessed by 
measuring the pH at the interface of the electrode in 0.1 M KCl.  The determined pH 
by the electrode before the commencement of the reducing potential is equal to 4.74 
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and is shown in Figure 5.3.12.  A further measurement of the pH was conducted after 
the reducing potential (-2 V, 30 s) and is equal to 9.86.  Additional scans were 
continued after the reducing step and show that after repetition the peak begins to 
disappear as the electrode is begins to disintegrate where the results are shown in 
Table 5.3.2.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.12 Square wave voltammograms detailing the influence of local pH on the alizarin peak 
position pre and post electrolysis 
 
 
Table 5.3.2 The measurement of pH in 0.1 M KCl by the CAP-C alizarin modified electrode  
 Peak Position / V Peak Height / µA 
Preconditioning -0.45 44.76 
-2 V, 30 s -0.7 11.15  
-2 V, 60 s -0.75 3.49  
-2 V, 90 s -0.76 2.19  
-2 V, 120 s -0.76 1.83  
-2 V, 150 s -0.76 1.37  
 
The peak position of the alizarin for both conditioning potentials (-1 V and -2 V) with 
increasing scan number is compared in Figure 5.3.13.  The relationship between the 
peak position of the alizarin and scan number for the lower conditioning potential (-
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1 V) is a relatively stable process with little shift in peak position, in contrast to the 
larger conditioning potential (-2 V) which shows a large shift towards the negative 
region as the local pH is increased at the surface of the CAP-C alizarin electrode.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.13 Plot of alizarin peak position against the scan number during electrolysis 
 
The next stage was to assess the impact of electrolysis on the electrode current at 
the different electrodes.  The electrodes assessed where; the carbon-polycarbonate 
electrode, the CAP-C-Alizarin electrode and the CAP-C-Alizarin electrode after 
dissolution, resulting in the loss of the sensing area.  All three electrodes were 
reduced at -2 V, and the effect on the current was measured using 
chronoamperometry (Figure 5.3.14).  After the imposition of the reducing potential 
the carbon-polycarbonate alizarin electrode remains stable and is unaffected by the 
electrolysis. This is in contrast to the CAP-C-alizarin electrode were the current drops 
very fast after the onset of reduction, after which the sensing window falls from the 
electrode as the CAP becomes unstable. This electrode was then rinsed and placed 
in a fresh solution of 0.1 M KCl and the process repeated.  The electrode is without a 
sensing window at this point- represented by the red line, where there is a very small 
amount of current, but not zero current, this is due to the remaining carbon that is 
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still exposed at the edge of the window where the working area of the electrode has 
fallen out.   
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 5.3.14 Effect of electrolysis on the measured current of each electrode tested; CAP-C-alizarin 
(blank line), CAP-C-alizarin no window (red line) and polycarbonate-C-alizarin (green line) 
 
5.3.4  Ion-Exchange Properties of the CAP-C film 
 
It was anticipated that the CAP-C film, upon electrochemical reduction could 
exhibit ion exchange activities with cations. The CAP polymer has, by nature of its 
composition, the capability of being transformed into an anionic film. There is an 
abundance of carboxylic acid groups on the structure (as per the phthalate residues) 
and thus while these would be expected to be protonated at low pH, the imposition 
of the reducing potential increases the pH and will simultaneously deprotonate the 
acid groups leading to a net negative charge. The latter can then pick up cationic 
species from the bulk solution. This is highlighted in Figure 5.3.15. The effect is 
relatively short lived unless a stable complex is formed and thus the cation will drift 
back into solution as the local pH is returned to the low pH of the bulk.    
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Figure 5.3.15 Ion exchange mechanism 
 
The CAP-C electrode was immersed in a solution of ruthenium hexamine (2 mM, 0.1 
M KCl) and held at -2 V for 1 second as shown in Figure 5.3.16 (green line).  The 
electrochemical signal becomes larger than the scan before reduction (black line) as 
expected.  As the conditioning potential continues for 10 seconds more (green line) 
the CAP binder begins to deteriorate exposing more of the carbon, however after 30 
seconds (purple line) much of the CAP-C has been lost as the electrode structure 
diminishes resulting in a loss in signal.  
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Figure 5.3.16 Cyclic voltammograms detailing the response of the CAP-C electrode to 2 mM 
Ruthenium before and after holding the electrode at -2 V for given time periods. Scan rate: 50 mV/s 
 
The still intact CAP-C film was then removed from the ruthenium solution, rinsed and 
placed in a fresh solution of 0.1 M KCl with no ruthenium hexamine present.  A series 
of cyclic voltammograms were initiated and are shown in Figure 5.3.17. Ruthenium 
hexamine peaks are still visible during the scan confirming that ion exchange into the 
polymer has occurred. As there is no additional reducing potential to maintain a high 
local pH, the internal voids with residual CAP-COO- Ru(NH3)63+ return to the bulk pH 
and the ruthenium hexamine slowly diffuses out into the solution – as evidenced by 
the successive reduction in the peak height.   
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Figure 5.3.17 Cyclic voltammograms detailing the response of the CAP-C films (post reduction in 2 
mM Ruthenium Hexamine) in fresh 0.1 M KCl.  Scan rate:50 mV/s 
 
This observation is interesting, as it was initially believed that when the conditioning 
potential was applied that the increase in signal was simply due to the increase the 
surface wettability and hence more active area and therefore a larger current.  
However, when the reducing potential (-2 V) is initiated, there is an immediate pH 
change at the interface and considering the CAP is full of acid groups, it effectively 
deprotonates the remainder - meaning the interface is now net negative.  The 
ruthenium complex is 2+ / 3+ and results in ion exchange into the film - hence the 
preconcentration effect and larger signal. In principle, this could serve as another 
means of drug delivery and in some respects, mirrors the early work with drug ion 
exchanged into polypyrrole films and delivered via cochlear implants (discussed 
previously in Section 1.4.2) (Richardson et al., 2009; Kaur et al., 2015).  It must be 
recognised that the delivery load will be much more limited than using the reservoir 
configuration previously described. 
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In order to confirm the potential for delivery of an actual drug – dopamine (10m M, 
pH7) was selected as a model. The CAP-C film’s direct voltammetric response 
towards increasing concentrations of dopamine (0-196 µM, 0.1 M KCl) are shown in 
Figure 5.3.18.   
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.18 Cyclic voltammetric response of the CAP-C towards increasing  
additions of dopamine (0-196 µM, 0.1 M KCl). Scan rate:50 mV/s   
 
Dopamine will have a net positive charge as a consequence of the protonation of 
primary amino group (pKa ~11) and therefore should have the potential to ion 
exchange into the film after imposing the reduction potential (Figure 5.3.19 A) in 
much the same way as the ruthenium hexamine (Figure 5.3.16). A similar decrease 
in dopamine peak magnitude was observed when the reduced electrode was 
removed, rinsed and tested in fresh 0.1 M KCl as shown in Figure 5.3.19 B. 
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Figure 5.3.19 (A) Cyclic voltammograms detailing the response of the CAP-C electrode towards 
dopamine (196 µM, pH 7) before and after holding the electrode at -2 V for given time periods. (B) 
Cyclic voltammograms detailing the response of the CAP-C films (post reduction) in 0.1 M KCl.  Scan 
rate: 50 mV/s 
 
5.3.5  Enhancement of Electrode Response  
 
Surface modification of an electrode substrate is often employed to improve 
the electron transfer kinetics, various surface interactions and overall sensing 
performance.  In this this case, the use of Graphene Oxide (GO) is electrochemically 
characterised using model redox probes, specifically potassium ferrocyanide and 
ruthenium hexamine to evaluate the ability of GO modifiers to enhance the HER 
process. 
The CAP-C film’s response towards ferrocyanide before and after the deposition of 
Graphene Oxide (GO) was investigated in a similar manner to the work previously 
reported in Chapter 4. Modification of the CAP-C film was achieved through the 
selective deposition of GO which had been previously sonicated in deionized water 
(1 mg / mL).  An aliquot of GO suspended in solution (0.005 mg) was accurately drop 
cast onto the electrode surface (2.5 µL each side) and allowed to dry under ambient 
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conditions. Cyclic voltammograms detailing the response to ferrocyanide are shown 
in Figure 5.3.20. The improvement in the CAP-C-GO electrode response resulting 
from the GO modification can be attributed to the increase in the availability of 
carboxylic acid groups and edge plane sites that present themselves with the addition 
of GO (cf. Section 4.3.4). It is important to acknowledge that the GO in this instance 
is serving much the same purpose as electrochemical anodisation but without the 
need to strong alkaline solutions and thus preserving the integrity of the CAP-C film.  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3.20 Cyclic voltammograms detailing the response of the CAP-C towards ferrocyanide (2 mM, 
0.1 M KCl), before (red line) and after (green line) the addition of graphene oxide (0.3125 µg / mm2 
GO) 
 
A similar response was observed after the CAP-C film was modified via the addition 
of Iron (II,II) oxide nano powder.  The unmodified film displays a poor response 
towards ferrocyanide, after which a solution of Fe3O4 was prepared in deionised 
water as described above (1 mg/ mL).  A small amount of the Fe3O4 solution (0.03 
mg) was dropped onto the electrode (15 µL each side) and left to dry.  The CAP-C film 
responses towards ferrocyanide before and after Fe3O4 modification are shown in 
Figure 5.3.21. 
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Figure 5.3.21. Cyclic voltammograms detailing the response of the CAP-C towards ferrocyanide (2 mM, 
0.1 M KCl), before (red line) and after (green line) the addition of Iron (II, II) oxide nano powder (1.875 
µg / mm2 Fe3O4) 
 
Modification of the CAP-C film through the addition of Fe3O4 nano particles displays 
very poor electrode kinetics towards ferrocyanide with a broad oxidation peak and 
no observable reduction peak.  This can be explained by the structure of the CAP-C 
film, where the carbon nanoparticles are effectively trapped within the polymer 
binder and therefore only small areas of the surface of the carbon particles are 
exposed as a sensing area. The CAP-C film’s response towards increasing additions of 
Fe3O4 (0.005 mg to 0.03 mg) was then assessed in the presence of ruthenium 
hexamine (2 mM, 0.1 M KCl) and is recorded in Figure 5.3.22.  
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Figure 5.3.22 Cyclic voltammograms detailing the CAP-C film’s response towards ruthenium 
hexamine (2 mM, 0.1 M KCl) with increasing additions of Fe3O4 
 
Each subsequent addition of Fe3O4 was found to increase the electrode sensitivity 
towards ruthenium hexamine and can be attributed to the increased presence of 
metal oxide particle facilitating electron transfer.  The central interest however lies in 
the ability of the modified electrode to improve the dynamics of the hydrogen 
evolution reaction. 
 
Linear sweep voltammograms of the unmodified CAP-C against the CAP-C-GO and 
CAP-C-Fe3O4 are detailed in Figure 5.3.23.  The responses to proton reduction show 
that the GO and Fe3O4 modifiers perform more favourably than the CAP-C alone.  For 
the modified electrodes, the potential at which reduction occurs is less negative as 
supported by the linear sweep voltammograms.  Although the modification of GO 
and Fe3O4 present an interesting approach for successful electrode modification and 
these preliminary findings are positive, the fabrication aspects, reproducibility and 
stability were poor and thus they were not used. 
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Figure 5.3.23 Linear sweep voltammograms of the unmodified, Fe3O4 modified and GO modified    
CAP-C films in 0.1 M KCl. Scan rate: 50 mV/s. 
 
The GO modified electrode (green line) is offset from the other two electrodes during 
the linear sweep, due to the capacitance background of the GO on the electrode.  
However, it should be noted that during reduction (-0.3 V, green line), is not H+ 
reduction – it is quinone reduction.  The reduction of H+ at GO occurs at -0.6 V, which 
is a much more improved response that the CAP-C electrode alone.  
 
5.4 Conclusions  
 
The dissolution of a conductive composite film through the application of a 
specified potential trigger is described. Nano carbon loaded polymer films were 
chosen such that they would retain conductivity and thus the imposition of a suitable 
cathodic potential would begin to generate hydrogen. It has been demonstrated that 
a change in local pH, brought about by the application of a reducing potential was 
able to induce the solubilisation of the CAP-C film. In application, the 
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electrochemically controllable film could be incorporated within existing drug 
delivery technology where the removal of the binder would allow the passage of the 
drug through the pores left behind. 
 
Results from biocompatibility testing in accordance with of DIN EN ISO 10993-5:2009 
indicated that the CAP-C film did not cause any relevant toxicological or biological 
damage to the subconfluent monolayer of L929 cells under the test conditions.  
These results show promise for the further development of the conductive film to be 
investigated within drug delivery applications which interact with biological systems.  
The simplification of the CAP-C film in comparison to previous designs outlined in 
Chapter 4, show that the conductive film serves as a function to both control the local 
pH and initiate dissolution concurrently.  Although the CAP-C film was constructed as 
a film, the production of the film could also be modified to function as a conductive 
ink which offers desirable conductivity for a wide range of applications.  
 
During electrochemical characterisation, there was a marked improvement in 
electrochemical response towards the ruthenium hexamine in comparison to the 
ferrocyanide. The disparity can be attributed to the difference in the nature of the 
compounds and their interaction with the carbon surface. The ferrocyanide probe is 
a classic negatively charged inner sphere complex, whereas the ruthenium hails from 
a positive charged outer sphere system and it could be that electron transfer is 
preferentially faster at the latter. 
 
The modification of the CAP-C electrode through the addition of alizarin for pH 
sensing within an unbuffered solution was also assessed. The deposition of alizarin 
resulted in an unambiguous peak which enhanced the diagnostic capability of the 
quinone voltammetric signal allowing for the measurement of the local pH. The 
determined pH by the electrode before the commencement of the reducing potential 
was equal to 4.74 and after the reducing potential (-2 V, 30 s) the pH increased to 
9.86. 
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The film was modified through the addition of Iron (II,III) oxide nano powder and 
graphene oxide in order to increase the electrode response towards the chosen 
redox probes – ferrocyanide and ruthenium.  The responses to proton reduction 
show that the GO and Fe3O4 modifiers perform more favourably then the CAP-C 
alone.  For the modified electrodes, the potential at which reduction occurs is less 
negative as supported by the linear sweep voltammograms.  While this method of 
modification initially presented promising potential towards the sensing application, 
it was found that fabrication aspects – reproducibility and stability of the deposited 
nano particles where poor, thus the modification step was omitted. 
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Chapter 6 
 
Controlled Electrochemical Dissolution of pH Sensitive Carbon Composite 
Microneedle Arrays 
 
 
Abstract 
A new approach to the production of conductive microneedles is presented. The 
methodology proposed herein focuses on the formulation of nano particulate carbon 
along with pH sensitive cellulose acetate phthalate as a polymeric binder for the 
production of microneedle patches.  Under normal conditions (open circuit), the 
conductive coating remains intact but, through exploiting hydrogen evolution at the 
microneedle array, changes in local pH is shown to induce swelling within the needle 
structure.  The design and characterisation of the carbon composite microneedles, 
the ability to electrochemically manipulate the structural integrity of the needles and 
the surface modification of the carbon needles with palladium and cysteine is 
critically assessed from sensing and drug delivery perspectives. 
 
 
 
 
 
 
 
 
 
 
Part of the research described in this chapter has been published in Martin, A., McConville, 
A., Anderson, A., McLister, A., and Davis, J. Microneedle Manufacture: Assessing Hazards and 
Control Measures. Safety 2017, 3, 25. 
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6.1  Introduction  
 
Microneedle systems are increasingly being proclaimed as a technological 
advancement in drug delivery applications and can proffer a wealth of advantages 
over traditional needle based approaches (Prausnitz, 2004; Cheung and Das, 2014; 
Larrañeta et al., 2016).  These microneedle (MN) systems characteristically consist of 
an array of sub millimetre sized needles (50-900 µm) and, counter to traditional 
hypodermic inoculations, are suitably minute that the shallow puncture depth 
usually does not illicit a response from the dermal nerve network (Prausnitz, 2004; 
Birchall et al., 2011).  The virtually painless perforation of the skin barrier can 
facilitate the delivery of a substantial range of drug therapies and vaccines to the 
microcirculation below the stratum corneum and the generic nature of the approach 
has resulted in an exponential increase in publications (Cheung and Das, 2014).  
 
Naturally formed microneedle structures can be found in a range of species – plant, 
insect and animal and are used as defence mechanism to protect the host system 
from various predation threats.  A common example is the stinging hairs that are 
found on the stem and the underside of the leaves of a stinging nettle – a common 
weed found in almost all parts of the UK.  The stinging hair of Urtica dioica, is shown 
in the micrograph in Figure 6.1.1.  The stinging hair consists of one tapered, 
elongated stinging cell with a bulbous base, which is surrounded with sheathing 
pedestal cells at the stem (Fu et al., 2007; Cummings and Olsen, 2011).  Upon contact 
with an external trigger, the ball tip breaks off and transforms the stinging hair into 
a micron sized hypodermic needle capable of penetrating the skin and releasing its 
constituents resulting in the typical rash.  
 
 
 
 
166 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.1 SEM micrograph detailing the morphology of stinging nettle hairs 
 
Many of the primary models of microneedle systems have been fostered by designs 
taken from nature, which provides a very effective method of puncturing the skin. 
While nature has had many millennia to perfect her designs, laboratory based MN 
manufacture is rather more basic.  In general, there are five categories of MN system: 
solid, coated, hollow, dissolvable and swellable.  Each individual types has its own 
advantageous qualities and limitations which have been comprehensively reviewed 
(Cheung and Das, 2014; Larrañeta et al., 2016). As MN technologies have progressed, 
there has been a gradual accessibility of the technologies necessary to manufacture 
them.  The availability of silicone moulds enables rapid, low cost, soft lithographic 
construction of MNs within the standard laboratory setting (Prausnitz, 2004; Birchall 
et al., 2011; Cheung and Das, 2014; Larrañeta et al., 2016; McConville and Davis, 
2016). The procedures can be modified for formulating all forms of MNs - with the 
exception of hollow systems.  An example of a commercial silicon microneedle mould 
and the resulting microneedle array are shown in Figure 6.1.2 A.  A comparison 
between traditional hypodermic needle, suture needle and microneedle tips are 
highlighted in Figure 6.1.2 B. 
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Figure 6.1.2 (A) Micropoint™ 200x200x350 micron needle mould template and an example of the 
resulting polymer cast microneedle patch. (B) Comparison of conventional sharps alongside a 350 
micron microneedle patch.  (C) Configuration of CAP-C microneedle patch above a drug containing 
reservoir.  (D) Schematic of drug release mechanism after the initiation of a suitable reducing potential 
 
The aim of the methodology within this chapter has been to investigate the 
development of solid microneedles based on nano carbon that has been 
encapsulated within a polymer network (CAP) as shown in Figure 6.1.2 C.  This 
research follows on from the previous chapter, where the development of a 
conductive film of the same components was exploited as a pH sensitive and 
electrochemically controllable film.  The intention in this chapter is to further 
investigate the conductive polymer blend and, therefore, to construct 
electrochemically controllable microneedle arrays.  The MN arrays could, in principle, 
offer the capability for electrochemical procedures to be applied such that the 
microneedle patches could acquire sensing capabilities but, more significantly, could 
also be used to control drug release as shown in Figure 6.1.2 D. The latter is situated 
at the core of the approach as the electrochemical manipulation of the release 
mechanism could offer a novel approach in MN design.  
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The rationale implemented here is subject to the use of cellulose acetate phthalate 
(CAP) as the binding polymer used to preserve the structural integrity of the needle 
assembly. Contrary to more benign polymer systems used in MN production (i.e. 
polycarbonate or polystyrene (McConville and Davis, 2016)), CAP is soluble in higher 
pH environments and has previously been extensively used in a large variety of oral 
drug formulations (Kelley et al., 2012; Bertz et al., 2013; Hanafi, Nograles, Abdullah, 
Shamsudin and Rosli, 2013; Larrañeta et al., 2016; Wong et al., 2017a).  Manipulation 
of the pH responsiveness of the polymer for use in electrochemically controlled drug 
release has been discussed in Chapters 3 and 4. In the latter, it was used as a thin film 
encapsulating a drug payload (Ashleigh Anderson, McConville and Davis, 2015).  The 
core objective within this work was to use the CAP matrix as the binding agent in 
which nano carbon particles would be interspersed to produce a pH sensitive 
composite microneedle. The application of an appropriate reducing potential to the 
MN array would lead to the swelling or dissolution of the MNs due to changes in the 
local pH as a result of electrolysis.  The latter is linked to the hydrogen evolution 
reaction (HER) by which an increase in local pH at the electrode occurs as an after 
effect of the reduction process (Ashleigh Anderson, McConville and Davis, 2015).  
Therefore, it could be foreseen that, were the HER reaction to be applied direct to 
the MN array, the increase in local pH would occur, leading to the swelling (and 
subsequent dissolution) of the CAP polymer that composes the needle structure.  
Hence, were drugs to be encapsulated within the polymer composite complex at the 
time of construction, then the electrochemically initiated swelling could permit 
control over their release.  
 
The final incorporation of the proposed electrochemically driven approach is shown 
within a MN system and is highlighted in Figure 6.1.3.  There is rapidly growing 
interest in the use of dissolvable and swellable MN systems for drug release (Lahiji, 
Dangol and Jung, 2015; Thakur et al., 2016; Ita, 2017b) and though the construction 
method is comparable to that investigated in this work, the release is markedly 
different as the release process for those systems is inherently passive.  Within this 
work it the objective was to investigate whether the addition of nano carbon particles 
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could expedite the development of a controlled release mechanism and to critically 
assess the merits and restrictions that these systems would present for transdermal 
drug delivery. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.1.3.  Overview of the proposed electrochemically initiated release mechanism 
 
6.2  Experimental Details  
6.2.1  Materials  
 
Chemical reagents were of the highest grade available and used without any 
additional purification.  All electrochemical measurements were carried out at 22 oC 
± 2oC in Britton Robinson (BR) buffer (pH 3-9, adjusted to the appropriate pH value 
via the addition of sodium hydroxide).  Nano carbon powder was supplied by Sigma 
Aldrich with a mean particle size of 100 nm. Silicone MPatch™ microneedle templates 
were purchased from Micropoint Technologies Pte Ltd. (CleanTech Loop, Singapore). 
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6.2.2  Electrochemical Setup  
 
Electrochemical analysis and set up was performed using a µAutolab 
computer controlled potentiostat (Eco-Chemie, Utrecht, The Netherlands).   The 
initial measurements involved a three electrode configuration comprising of carbon-
polymer composite MN working electrode, a counter electrode in the form of a 
platinum wire and a standard silver/silver chloride (3 M NaCl, BAS Technicol UK) 
reference electrode. 
 
6.2.3   Sensor Design and Modification  
CAP/Carbon Microneedle Fabrication: Production of the MNs was generally 
achieved through the simple mixing and dispersion of the nano carbon (Sigma-
Aldrich) within the polymer (50/50 wt%) that had previously been dissolved in a 
suitable solvent such as cyclohexanone. The silicone moulds were obtained from 
Micropoint Technologies Pte Ltd. (CleanTech Loop, Singapore) and typically 
comprised of a 10 x 10 MN array. The needle dimensions used in the studies were 
either 200 x 200 x 350 micron or 200 x 200 x 700 micron.  During investigations, silicon 
moulds were also produced inhouse using a SLYGARD 184 Silcone Eleastomer Kit.  
The elastomer and curing agent were mixed at a ratio of 10 parts to 1 and gently 
stirred until a viscous mixture was achieved.  The mixture was left to settle until all 
bubbles had disappeared from the solution.  The PDMS solution was then applied to 
a polycarbonate microneedle array with dimensions 200 x 200 x 400 micron and 
inspected to ensure full coverage of the needles.  The PDMS mould was baked in the 
oven under vacuum for two hours at 80 oC and then left to set for 48 hours at room 
temperature.   When the PDMS was fully cured, the microneedle substrate was then 
carefully removed, and the finished mould is shown in Figure 6.2.1 below.  The 
moulds were cleaned by sonication in methanol and the polymer-carbon mixture 
added and the solvent allowed to evaporate. The use of a vacuum oven (under 
ambient temperature) was found to greatly improve the speed of the production 
process and needle quality through accelerating the removal of trapped solvent. 
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Figure 6.2.1 In-house manufactured PDMS 200 x 200 x 400 µm microneedle mould and the resulting 
CAP-C microneedle array 
 
Toluidine Blue O /CAP/Carbon Microneedle Fabrication: Production of the Toluidine 
Blue O (TBO) loaded composite MNs was achieved by first dissolving TBO (5 wt%) in 
a solution of cyclohexanone.  CAP was then added to the TBO solution and left to stir 
until full dissolution was achieved, at this point the nano carbon (Sigma Aldrich) was 
added to the TBO/polymer solution (50/50 wt%).  The TBO/CAP/C solution was then 
cast onto the microneedle moulds with dimensions of 200 x 200 x 700 micron.  The 
moulds were then held under vacuum (at ambient temperature) as described in the 
methodology above, then removed and allowed to dry at room temperature for 48 
hours.  The microneedles were then carefully removed from the moulds and rinsed 
thoroughly to remove interfacial TBO. 
 
Microneedle Modification. The nano CAP-carbon microneedles were sputtered with 
a thin layer of Palladium using an 80:20 Pd/Au target at 30 mA for 3 minutes (Emitech 
K500X Sputter Coater, Quorum Technologies Ltd, England). X-ray photoelectron 
spectroscopy (XPS) of the Palladium samples before and after modification with 
cysteine was performed using an Axis Ultra DLD spectrometer (Kratos Analytical, 
Japan) using monochromated Al Ja X-rays (15 kV and 10 mA) with an operating 
pressure lower than 6x10-8 Pa. A hybrid lens mode was used during analysis and 
charge neutralisation was achieved using an immersion lens with a filament current 
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of between 1.7 and 2.1 mA at a charge balance voltage of between 3.0 and 3.6 V. 
Three spots were analysed per sample and wide energy survey scans (0–1300 eV 
binding energy) as well as high resolution spectra for Pd3d, C1s, N1s and O1s and 
S2p. Pass-energy was 160 eV for the wide energy survey scans and 20 eV for the high-
resolution spectra.  
Alginate Gel Preparation: Alginic acid sodium salt was added to a solution of 
ferrocyanide (2 mM, 0.1 M KCl) to produce a 1.5% w/v viscous solution.  The solution 
(typically 10 mL) was left to stir for 4 hours at 45 °C, after which a solution of 0.2 M 
calcium chloride (5 mL, deionised water) was added drop wise to the alginate/ferro 
solution and left overnight to ensure cross-linking was complete. 
Gelatin Preparation: Gelatin (2 g) was added to 0.1M KCl (typically 18 mL) and was 
stirred for 2 h at 40 °C until the solution was full dissolved.  The pH of the gel was 
measured to ensure that release was not initiated from the pH environment of the 
gel.  The gelatin solution was then transferred into a petri dish and left to set. 
 
6.3  Results and Discussion 
6.3.1  Characterisation of CAP Microneedle Array 
 
CAP is an ideal candidate for enteric coatings as it contains many 
carboxylic acid groups and has a pKa of around 5.28 (Rando et al., 2006).  Thus, when 
it is exposed to the lower pH conditions of the stomach, the carboxylic acid groups 
will not be fully dissociated and therefore the CAP will be resistant to dissolution. As 
the pH is increased to that of the intestine (pH 7-8), deprotonation is near complete 
resulting in the polymer chains having greater hydrophilicity and hence solubility. 
Scanning electron micrographs detailing the structure of a MN array (700 µm) cast 
from a solution of CAP alone are highlighted in Figure 6.3.1.   
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Figure 6.3.1 (A) Electron micrograph of a 10 x 10 microneedle array formed from the solution casting 
of CAP. (B) Individual morphology of a 400 x 400 x 700 micron CAP microneedle 
 
Scanning electron micrographs detailing the structure of a MN array (height: 350 µm) 
cast from a solution of CAP without any additional components are highlighted in 
Figure 6.3.2.  Well defined tips were attained which were found to be stable in 
solutions where the pH is acid/neutral. The microneedle array was then exposed to 
pH 8 buffer and the successive images recorded after 1, 3 and 5-minute intervals. The 
MN structure gradually dissolves and confirms the pH sensitivity of the system as 
indicated in the electron micrographs (B-D). 
100µm 
200µm 
A 
B 
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Figure 6.3.2 Scanning electron micrographs of the cellulose acetate phthalate microneedles upon 
exposure to pH 8 Britton Robinson buffer. Recorded at (A) 0 minutes (B) 1minute (C) 3 minutes and 
(D) 5 minutes.  Microneedles: 200 x 200 x 350 µm 
 
6.3.2  Characterisation of Carbon Nano Powder-CAP Microneedle Array 
 
The process was repeated but using the nano carbon CAP (CAP-C) 
formulation. The electron micrographs detailed in Figure 6.3.3 highlight a markedly 
increased surface roughness which can be attributed to the particulate nature of the 
nano carbon particles (mean diameter 100 nm).  
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Figure 6.3.3 Scanning electron micrographs of the cellulose acetate phthalate-nano carbon 
microneedles upon exposure to pH 8 britton robinson buffer. Recorded at (A) 0 minutes (B) 1 minute 
(C) 3 minutes and (D) 5 minutes. Microneedle: 200 x 200 x 350 µm. 
 
 
The microstructure of the carbon nano particles are shown in Figure 6.3.4 A and the 
aggregation of the nano carbon particles with the CAP binder is highlighted in Figure 
6.3.4 B, where a platelet type structure predominates. The MNs are however distinct 
and behave in a similar fashion to those composed purely of CAP. 
 
 
 
 
 
 
 
 
 
Figure 6.3.4 Electron micrographs of the (A) Carbon nanoparticles and (B) Cellulose acetate 
phthalate-nano carbon microstructure 
A B 
A B 
C D 
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Electrochemical Characterisation 
 
Cyclic voltammograms detailing the response of the CAP-C MN array (200 x 200 x 350 
µm) towards ferrocyanide and ruthenium hexamine (each solution containing 2 mM 
redox probe, 0.1 M KCl, 50 mV/s) are highlighted in Figures 6.3.5 A and B 
respectively. In both cases, well defined peaks are attained, however, there is 
noticeable nonconformity from the ideal peak separations of 59 mV. This can be 
accredited to the composite characteristics of the MN array and a similar 
performance has been observed with composite Pd-polystyrene microneedle 
(McConville and Davis, 2016).  Nevertheless, the capability of the needles to perform 
as functional electrochemical sensors is evident.   
 
 
 
 
 
 
 
 
 
 
 
 
Figures 6.3.5 Cyclic voltammograms detailing the response of the cellulose acetate phthalate-nano 
carbon microneedles to ferrocyanide (A) and ruthenium hexamine (B). Each redox probe present at 2 
mM in 0.1 M KCl. Scan rate: 50 mV/s 
 
6.3.3 Optimisation of Microneedle Response 
 
Palladium is commonly employed to improve the HER process (Zhang et al., 
2016b; Lin and Lasia, 2017) and has been applied in the manner of clusters and 
coatings with graphite (Bhowmik, Kundu and Barman, 2016), carbon nanotubes 
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(Ramakrishna et al., 2016), graphene (Ghasemi et al., 2015; Cardoso et al., 2017b) 
and numerous metal alloy systems (Zhuang et al., 2015; Jović et al., 2017) for use in 
fuel cell applications.  The principal methodology here is not to exploit the hydrogen 
being generated but rather to utilize the change in local pH that occurs as a result of 
the electrolysis.  Given that carbon is a quite poor substrate for the HER process, it 
was believed that the deposition of the Pd on the MN array would allow a much more 
effective response.   
 
The CAP-C microneedles were then sputtered with a thin layer of Palladium using an 
80:20 Pd/Au target at 30 mA for 3 minutes (Emitech K500X Sputter Coater, Quorum 
Technologies Ltd, England). This was done to further improve the electrochemical 
behavior in relation to enhancing the hydrogen evolution reaction, which would be 
necessary to promote swelling of the needles. The Pd sputtered microneedle array’s 
response towards ferrocyanide (2 mM, 0.1 M KCl) at varying scan rates is detailed in 
Figure 6.3.6.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.6.  Cyclic voltammograms detailing the response of the CAP-C-Pd modified microneedles 
to 2 mM Ferrocyanide at various scan rates 
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It was observed that the Pd layer enhanced the electrochemical performance as 
shown by the improvement in the peak definition and separation. Further 
optimization was carried through the adsorption of a cysteine layer onto the Pd 
surface as per the work by Macfie (2012) and Feliciano-Ramos (2010) and colleagues 
(Feliciano-Ramos et al., 2010; Macfie et al., 2012). Cyclic voltammograms detailing 
the response of the cysteine modified Pd-CAP-C microneedles towards ferrocyanide 
are compared with the simple CAP-C and Pd-CAP-C needles in Figure 6.3.7 A.  The 
peak definition of the former is much improved after the cysteine modification step.  
The addition of the cysteine onto Pd layers was verified through XPS analysis and 
comparison of the S2p peak before and after modification as indicated in Figure 6.3.7 
B.   
 
Figure 6.3.7 (A) Cyclic voltammograms comparing the response of the cellulose acetate phthalate-
nano carbon microneedles to 2 mM Ferrocyanide before and after modification with palladium and 
cysteine. Scan rate: 50 mV/s. (B) XPS spectra highlighting the modification of palladium with cysteine 
 
It was predicted that the application of the large reducing potential required to 
commence HER would also have reduced the Pd-thiol bond, which has been 
previously demonstrated with gold electrodes (Salvarezza and Carro, 2017), and thus 
the cysteine modification step was excluded.  The advantage of employing the Pd 
layer can be seen in the linear sweep voltammograms shown in Figure 6.3.8 where 
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two difference sets of MN arrays (CAP-C and CAP-C-Pd) where compared under two 
distinct pH environments. It is evident that the Pd coating provides a significant 
catalytic effect on the hydrogen evolution reaction. 
 
 
 
 
 
 
 
 
 
 
 
  
 
Figure 6.3.8 Linear sweep voltammograms of the unmodified and Pd coated microneedles in pH 3 
and pH 7 Britton Robinson buffer. Scan rate: 50 mV/s 
 
 
6.3.4  Microneedle Response Pre and Post Electrolysis 
 
In order to evaluate the effect of a reducing potential directly at the MN 
substrate, the Pd sputtered MNs were assessed before the commencement of 
electrolysis, where distinct oxidation and reduction peaks are observed in Figure 
6.3.9.  A reducing potential of -2 V was then applied in 10 second increments 
following which a CV was recorded.  Post reduction, the peaks become gradually 
broader and it is difficult to define specific peak potentials.  This can be attributed to 
the fact that as the reducing potential is applied, the binding CAP polymer slowly 
begins to dissolve thereby exposing more carbon particles resulting in a larger signal.  
This effect continues until full dissolution of the sensing area of the MN array occurs 
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thus resulting the signal deteriorating. As dissolution of the CAP binder progresses, 
connection the structural integrity of the system is compromised as the carbon 
particles become isolated leading to a reduction in the overall signal. 
 
Figure 6.3.9 Cyclic voltammograms detailing the response of the cellulose acetate phthalate-nano 
carbon-palladium microneedles to 2 mM ferrocyanide (A) before and (B) after holding the electrode 
at -2 V for given time periods. Scan rate: 50 mV/s 
 
Transdermal Mimics – Simulated Drug Delivery 
 
The next step was to evaluate the ability to control the swelling or dissolution of the 
MN arrays. A skin mimic system based on calcium crosslinked alginate gel was 
formulated which contained 2 mM Ferrocyanide, the set-up is detailed in Figure 
6.3.10  and follows the basic procedure developed by McConville and Davis, 2016. 
The pH of the redox loaded gel was adjusted prior to the addition of the calcium 
crosslinker to ensure that the gel matrix itself did not lead to the dissolution of the 
microneedles. A methodology was proposed to mimic the skin’s stratum corneum, 
and was adapted from previous work demonstrated by the Donnelly Group, where a 
thin layer of parafilm was stretched over the gel in order to closely mimic MN 
insertion into the skin (Larrañeta et al., 2014).  The Pd sputtered microneedles were 
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then pressed onto the parafilm layer (100 µm) through the application of thumb 
pressure, with the needle tips penetrating through the polymer film into the gel 
beneath. A reference electrode (3 M NaCl Ag | AgCl) and Pt counter were then 
incorporated through the parafilm to complete the cell.  Ferrocyanide was 
incorporated within the gel to act as an in situ redox probe that could be utilized to 
evaluate the structural integrity of the microneedle.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.10 Representation of the skin mimic assembly highlighting the use of ferrocyanide as a 
probe to determine in situ the integrity of the needles and the subsequent effects of imposing a 
cathodic potential 
 
Pd sputtered MNs where compared against cysteine sputtered MNs in the 
ferrocyanide loaded gel to determine the optimum mode of modification as shown 
in Figure 6.3.11.  In this case the Pd sputtered MNs were chosen for further 
investigation. Due to the implications of the reducing potential that could potentially 
result in the reduction the Pd-thiol bond, the cysteine modification step was omitted. 
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Figure 6.3.11 Cyclic voltammograms comparing the response of the CAP-C microneedles to 2 mM 
ferrocyanide (within the gel) before and after modification with palladium and cysteine. Scan rate: 50 
mV/s 
 
It was envisaged that the application of a cathodic potential would lead to an increase 
in pH and result in the swelling or dissolution of the CAP binder. As the latter makes 
up the core structure of the needle array, the surface area of the needles would be 
transformed. The latter could consequently be measured through variations in the 
peak magnitude of the ferrocyanide within the gel. Cyclic voltammograms were 
recorded prior to the commencement of the cathodic potential as a control measure. 
The ferrocyanide voltammograms were recorded before and after each cathodic 
step. Cyclic voltammograms presenting the performance of the MN array within the 
ferrocyanide loaded alginate layer before and after the application of a potential of -
2 V are shown Figure 6.3.12.  Prior to the application of the negative potential, the 
voltammetric response of the MN array to ferrocyanide is consistent with that 
observed in Figure 6.3.11.  
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Figure 6.3.12 Cyclic voltammograms detailing the response of the cellulose acetate phthalate-nano 
carbon-palladium microneedles to 2 mM Ferrocyanide before and after holding the electrode at -2 V 
for given time periods. Scan rate: 50 mV/s 
 
The voltammetric profile however transforms markedly upon initiating hydrogen 
evolution with a loss of peak definition.  The absence of peak definition be accredited 
to amplified resistance within the bulk of the needle assembly because of the CAP 
swelling and expanding the three-dimensional separation among the carbon 
particles. The swelling and dissolution of the MN was corroborated through 
surveying the needle morphology following the application of the cathodic potential 
at various time intervals.  Electron micrographs detailing the influence of holding the 
electrode at negative potentials (-1 V, -1.5 V and -2 V) on the dissolution of the 
microneedle assembly are shown in Figure 6.3.13.  In each case - the electrode was 
held for a period of 30 s. The dissolution of the assembly is perceptible at -1.5 V and 
is complete after holding at -2 V for 30 s. It is evident, from examining the cyclic 
voltammograms, that the resistance enlarges considerably upon the application of 
the cathodic potential for very brief cycles demonstrating that swelling occurs 
relatively promptly, but dissolution necessitates much more vigorous conditions. The 
continual response detailed in Figure 6.3.12 after the perceptible dissolution of the 
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needle (indicated in Figure 6.3.13 D) is accredited to the remaining electroactivity of 
the base plate. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.13 Scanning electron micrographs of the cellulose acetate phthalate-nano carbon 
microneedles after imposing the reducing potential. (A) Open circuit (B) -1 V for 30 s (C) -1.5 V for 30 
s (D) -2 V for 30 s. Microneedle: 200 x 200 x 700 µm 
 
It must be taken into account however that, provided that the needles are suitably 
shallow, residual needle fragments are likely to be removed from the skin through 
normal skin shedding in the external layers which would typically happen over a 
period of weeks (Baran and Maibach, 2010).  The biocompatibility studies of the CAP-
C material - detailed in Chapter 5, deliver some encouraging insights into the possible 
use of the material with no evident skin irritation nor cytotoxicity nevertheless these 
need to be regarded with some caution – especially where the devices may be used 
for long term purposes where sensitisation may transpire. 
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6.3.5  Model Drug Release 
 
Prior to the commencement of the controlled electrochemical release 
studies, the modified CAP-C MNs were inserted into a gelatin matrix preloaded with 
phenolphthalein (1 mM, 0.1 M KCl). The latter remains colourless in acidic conditions 
and turns pink when exposed to pH environments greater than pH 7. A sample of the 
gel was tested as a control, an aliquot of 0.1 M NaOH was added to the gel to confirm 
that the phenolphthalein had been adequately dispersed within the gel.   The MNs 
were then pressed into the gelatin. Visual inspection of the gel interface (Figure 
6.3.14) confirmed that the needles penetrate the gel and are intact. The MNs were 
then removed from the gel and the site of insertion remained colourless.   
 
 
 
 
 
 
 
Figure 6.3.14 Cross-section of MN array piercing through gelatin 
 
A reducing potential of -2 V was applied to the CAP-C MNs for increments of 10 s, 
after which the MN arrays were removed, and the puncture site inspected.  After the 
initiation of the cathodic potential to the MNs, there will be an increase in pH directly 
at the needle site thus changing to colour of the phenolphthalein loaded gel from 
colourless to pink.  After each reducing increment, the microneedles where removed 
and inspected as shown in Figure 6.3.15. 
 
 
 
 
186 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6.3.15 Images captured of the phenolphthalein loaded gel (A) Before reduction (B) -2 V, 20 s 
(C) -2 V, 40 s (D) -2 V, 60 s 
 
The next step was to assess the efficacy of the release method with a model drug – 
Toluidine Blue O (TBO).  The CAP-C was added to a solution of TBO in cyclohexanone 
and stirred until a viscous solution was achieved.  TBO was chosen as the release 
agent as it could be easily monitored through visual inspection. Thus, the initiation 
of the reducing potential would release the entrapped TBO and it was expected that 
it would slowly permeate through the gelatin matrix.  Prior to the commencement of 
electrolysis, the MNs were pierced into pH adjusted gelatin (pH 4.02) and removed 
to ensure there were no observable traces of released TBO.  Electrochemical release 
was induced through holding the potential at −2 V, at 10 s increments (up to 50 s) 
and then visually inspected after the application of each cathodic cycle (Figure 
6.3.16).  Although a strong blue colour was observed upon changing the pH, there is 
a possibility that there is release of TBO from the baseplate which is in contact with 
the gelatin.  To ensure the TBO was released exclusively from the needles, the MN 
array was first pierced through a layer of parafilm, which acted as a skin mimic, 
before being placed in the gel in order to separate the baseplate from the gelatin. 
Therefore, after the application of the reducing potential to the microneedle array 
A B 
C D 
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as shown in Figure 6.3.16, any blue colour observed in the gel can be attributed to 
the release from the microneedles exclusively.  
 
 
 
 
 
 
 
 
 
 
Figure 6.3.16 CAP-C MNs loaded with TBO before and after the commencement of electrolysis for 
varying times. (A) Before electrolysis (B) – 2 V, 20 s (C) – 2 V, 40 s (D) – 2 V, 60 s (E) – 2 V, 80 s (F) – 2 
V, 100 s 
 
Drug Delivery Candidates 
In recent years, the development of microneedles for drug and vaccine delivery has 
been extensively studied.  In vivo studies using MN arrays have demonstrated the 
successful delivery of several drug candidates, including; insulin delivery (Cegla, 
2015; Xie, Li and Yu, 2015), low molecular weight heparin (Gomaa et al., 2012) and 
human growth hormone delivery (Lee et al., 2011).  Each category of microneedles 
has been comprehensively studied for a number of different applications, examples 
of which are detailed in Table 6.3.1.   
At the present time, there are a number of companies that are currently developing 
MN-based products which include : 3M (USA), Becton - Dickinson (BD) Technologies 
(USA), Nanopass Technologies (Israel), Valeritas (USA) and Lohmann Therapie – 
Systeme AG (Germany / USA) the largest manufacturer of transdermal patches.  
Currently, there are no MN array-based drug delivery products on the market.  
Nanopass technologies have developed a combination microneedle system equipped 
with four hallow silicon microneedles which can be attached to a syringe driver.  This 
A D 
B E 
C F 
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MN-based medical system is not a true MN array for drug delivery, rather it is a 
delivery system combined with microneedles (no release from microneedles) which 
aids the delivery of a drug from a syringe driver through the stratum corneum.   
Table 6.3.1 Drug delivery from MN systems and their applications 
MN Type MN Material 
Drug 
Loaded 
Drug 
Content 
Delivered 
Application Reference 
Dissolving 
polymeric MN 
array 
Poly (methyl 
vinyl ether / 
maleic Acid)  
(PMVE / MA) 
Ibuprofen 
sodium 
33 mg over 
24 hr. 
Non-steroidal 
anti-
inflammatory 
drugs 
(NSAIDs) 
(McCrudde
n et al., 
2014) 
Dissolving 
polymeric MN 
array 
Poly 
(vinylpyrrolidone
) (PVP) and 
Poly(methyl vinyl 
ether/ maleic 
acid) (PMVE 
/MA) 
Aspirin 
 
 
 
 
Lisinopril 
dihydrate 
 
 
 
Atorvastatin 
calcium 
trihydrate 
3924 ± 1011 
μg 
 
 
 
687.9 ± 101.
3 μg 
 
 
 
126.3 ± 18.1 
μg 
 
 
NSAID 
 
 
Angiotensin-
converting-
enzyme 
inhibitor 
(ACE 
inhibitor) 
 
 
Statin 
 
 
(Quinn et 
al., 2015) 
Dissolving MN 
patch 
Sodium 
carboxymethyl 
cellulose (SCMC) 
Anti -
calcitonin 
gene – 
related 
peptide 
(CGRP8-37) 
1.42 + 0.65 
µg 
Analgesic 
effects for 
localized 
neuropathic 
pain 
(Xie et al., 
2017) 
Dissolving MN 
patch 
Hydroxypropyl 
cellulose (HPC) 
Cyclosporin A 
(CyA) 
34 + 6.5 µg 
after 60 min. 
Treatment of 
psoriasis 
(Jeong et 
al., 2018) 
Tip-loaded 
dissolving 
microneedles 
MN Tips -  
hydroxy-propyl-
methyl-cellulose 
(HPMC) 
Baseplate – 
carboxy-methyl 
cellulose (CMC) 
Donepezil 
hydrochloride 
(DPH) 
179.9 µg 
Alzheimer’s 
disease 
(Kim et al., 
2016) 
Tip-dissolving 
microneedles 
Polyvinylpyrrolid
one (PVP) 
Meloxicam 
(MX) 
272.96 µg  NSAIDs 
(Chen et 
al., 2017) 
Hydrogel-
forming 
microneedles 
with 
integrated 
drug film 
15% w/w 
Gantrez S-97, 
7.5% w/w PEG, 
10,000 and 3% 
w/w Na2CO3 
Donepezil 
hydrochloride 
(DPH) 
854.71 ± 
122.71 µg 
Alzheimer’s 
disease 
(Kearney et 
al., 2016) 
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It is envisaged that the MN array patch system within this work could be utilised to 
deliver high potency and low yield drug candidates, such as buprenorphine and 
fentanyl.  Transdermal fentanyl patches have long been established for the effective 
treatment of chronic pain associated with cancer (Cachia and Ahmedzai, 2011; 
Othman, Mohamad and Sayed, 2016).  This novel approach to delivery using drug 
loaded MN arrays may potentially lead to a reduction in opioid abuse as previously 
discussed in Section 1.1.  There is also potential for the MN needle arrays to combat 
some of the issues surrounding patient compliance.  Cognitive impairment is a 
significant issue in geriatric patients who have been diagnosed with Alzheimer’s 
disease (AD) (Lima et al., 2016).  The transdermal route for delivery is particularly 
useful in this case as it does not require the patient to remember to take their 
medication and provides stable dosage over an extended period of time.   
 
It is also important to highlight the factors which can limit the delivery of drug within 
this methodology.  For example, an issue would be the delivery of pH sensitive 
compounds such as proteins which, due to the exposure of the high pH environment 
during electrolysis could lead to denaturation.  Also, crucially as the device is using a 
negative potential, issues may arise if the drug loaded within the MN array contains 
nitro functional groups which could, in principle, be converted to the nitroso, 
hydroxylamine or amine group.   
 
Due to the lack of commercially available microneedle products, and their relative 
infancy of development, there are currently no regulatory requirements documented 
for MN array systems.  No doubt this concern will be addressed in the forthcoming 
years when companies who intend to commercialise MN technologies proceed with 
commercialisation procedures, after issues with scale up production methods have 
been successfully addressed.  
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6.4 Conclusions  
 
The applied potentials used in this work are significantly negative and have 
been selected on the basis of allowing gross characteristics to be observed with 
relative ease for the intention of confirming proof of concept.  The use of more 
moderate potentials would certainly reduce the degree of pH modification and thus, 
rather than initiating a rapid release, could permit a much more controlled rate of 
dosage devoid of the rapid deterioration of the microneedle structure.  The result of 
using less negative potentials also lessens the potential migration of nano carbon/Pd 
particles into the skin.  The approach reported underlines a new route through which 
microneedle structures could be controlled in situ and thereby offer alternative 
means of controlling dosage.  
 
 The micro moulding method undoubtedly offers a facile means of constructing high 
quality microneedles which, through astute selection of the casting constituents, 
could possibly be translated to numerous of sensing and drug delivery applications. 
The nano-carbon assemblies are conductive and present effective electrochemical 
properties which could be employed in analytical situations. The modification with 
Pd is simply accomplished through using standard sputtering techniques employed 
for coating SEM samples, however the Pd sputtering treatment can deliver 
substantial improvement to the voltammetric performance. The core impact of the 
work illustrated however is centred on the ability to electrochemically control the 
integral structure of the microneedle through regulating the cathodic potential 
directed to the needles themselves. It is easy to envision the integration of an 
appropriate drug candidate within the carbon-CAP solution at the time of casting. 
Drug yield will however be a matter of concern given the restrictions in the 
dimensions of the microneedle structure. This is a common issue encountered during 
the development of most microneedle systems and it is expected that the MN 
assembly developed in this work would only intended for low yield - high potency 
agents.  The application of the cathodic potential, while essential to initiate the 
polymer swelling, may, in principle, result in the reduction of functional groups within 
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the drug – for example nitro groups – thereby excluding such reagents from use in 
the MN system.  The likelihood of disintegration and the loss of carbon/Pd 
particulates should also be considered.  
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Chapter 7 
 
Smart Sutures – A Novel Approach to Electrochemical Drug Release  
from Micro-Wires 
 
Abstract 
 
 
The work described within this chapter assesses the use of a gold microwire loaded 
with cellulose acetate phthalate encapsulated drug droplets as a novel approach for 
the electrochemically driven drug release from a suture.  The imposition of hydrogen 
evolution reaction at the wire leads to an increase in the local pH and the subsequent 
dissolution of the pH sensitive cellulose acetate phthalate polymer binder and 
release of the drug.  Precise control over the electrochemically induced dissolution-
release mechanism has the potential to give rise to the further development of smart 
suture design where more responsive and accurate dosing could be achieved. 
 
 
 
 
 
 
 
 
 
 
 
Part of the research described in this chapter has been published in Morelli, F., Anderson, A., 
McLister, A., Fearon, J. J., & Davis, J. (2017). Electrochemically driven reagent release from 
an electronic suture. Electrochemistry Communications, 81(May), 70–73.  
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7.1   Introduction  
 
Sutures are an instrumental tool in the mending and physical restoration of 
major wounds, injuries or lacerations where they present a facile means of joining 
apposing tissues and, in effect, can assist in wound healing (Seitz et al., 2015; Dennis, 
Sethu, Nayak, Mohan, Y. Y. Morsi, et al., 2016a; Alshomer et al., 2017; Wu et al., 
2017).  While the general technique of wound closure has altered little over the 
years, the materials selected in the manufacture of sutures have advanced 
significantly.  Biodegradability, physical structure and chemical composition are the 
main features subject to modification or adaption and there is an abundance of 
commercially available forms (Alshomer et al., 2017; Wu et al., 2017).  Sutures which 
possess antimicrobial properties are now commonplace and have been employed as 
a consequence of the enduring issues surrounding surgical site infection (SSI) (Wu et 
al., 2017).  The latter are commonly recognised as being the most regularly 
encountered postoperative complication and correspond to 15–20% of all 
nosocomial infections that develop after surgery (Owens and Stoessel, 2008; De 
Angelis et al., 2010).  It has been established that sutures loaded with antimicrobial 
agents (such as triclosan or silver nanoparticles) decrease recurrence of infection and 
aid wound healing (Catanzano et al., 2014; Zhang et al., 2014; Gallo et al., 2016; 
Yamashita et al., 2016; Alshomer et al., 2017; Wu et al., 2017).  The mechanical 
properties of sutures can be tailored to meet the functional requirements of the 
wound site and can be achieved by braiding or coating the surface of the suture 
material.  A commercially available braided black silk suture is shown in Figure 7.1.1.  
Regardless of design, conventional sutures are characteristically based on a thread-
like arrangement to supply the mechanical strength necessary to bind the wound 
edges together and, subsequently, the antimicrobial attributes are consistently 
supplied through passive contact with the adjacent tissue (Alshomer et al., 2017). 
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Figure 7.1.1 Electron micrograph of braided black silk suture 
 
Taking into the account the growing concerns over antimicrobial resistance, there is 
a necessity for additional advances in suture design where the latter can provide a 
more functional role – either through imparting diagnostic telemetry of the wound 
healing rate or allowing the direct delivery of drugs to the infection location. The aim 
of this chapter is to assess the use of a gold–silver composite thread as a structure 
through which the electronically controlled release of a chemical agent from a suture 
could be achieved. Previous work by Kim and colleagues (2012) investigated the 
development of a microfabricated strip sensor equipped with sensory feedback 
modules and actuation capabilities which has given way to a step change in suture 
design (Kim et al., 2012b). The current investigation has likewise sought to advance 
the controlled actuation mechanism through a potentially straight forward, though 
more adaptable and easily employed electrochemical route. The under lying principle 
involves the loading of the model drug (Toluidine Blue O, TBO) within cellulose 
acetate phthalate (CAP) binder droplets which have spread and distributed along the 
length of a gold microwire (25-100 μm diameter) as illustrated in Figure 7.1.2. The 
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CAP polymer binder is pH responsive  as noted in previous chapters (Kelley et al., 
2011; Dasan and Rekha, 2012; Bertz et al., 2013; Hanafi, Nograles, Abdullah, 
Shamsudin, Rosli, et al., 2013; Ashayer-Soltani, Hunt and Thomas, 2016; Wong et al., 
2017b). Similarly, it was envisaged that the application of a reducing potential (-1 V 
to -2 V) at the gold electrode microwire would lead to an increase in the local pH and 
the CAP binder should dissolve and in doing so release the entrapped drug (A. 
Anderson, McConville and Davis, 2015).  The gold wire itself does not possess the 
required tensile strength to draw the wound edges together but it can be reinforced 
by braiding the wire within a conventional suture thread.  During investigations, a 
commercial silver thread was employed to improve mechanical suture strength and 
served as a second electrode in the electrochemical set up.  This work assesses the 
electrochemical response of several mechanisms and examines the capability of the 
proposed release mechanism.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.1.2 Proposed controlled release methodology 
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7.2  Experimental Details  
7.2.1  Materials  
 
Chemical reagents were of the highest grade available and used without any 
additional purification.  All electrochemical measurements were carried out at 22oC 
± 2oC in Britton Robinson (BR) buffer (pH 3-9, adjusted to the appropriate pH value 
via the addition of sodium hydroxide).  Cellulose acetate phthalate and Toluidine Blue 
O were supplied by Sigma Aldrich.  Gold and silver wires were supplied by Goodfellow 
Ltd (Huntingdon, UK).  Conductive silver thread (0.4 Ω/cm) was supplied by Kitronik 
Ltd (Nottingham, UK). 
 
 
7.2.2  Electrochemical Setup 
 
Electrochemical analysis and set up was performed using a µAutolab 
computer controlled potentiostat (Eco-Chemie, Utrecht, The Netherlands).   The 
initial electrochemical measurements involved a three electrode configuration, 
comprised of a conductive wire working electrode, a platinum wire counter electrode 
and a standard silver/silver chloride (3 M NaCl, BAS Technicol UK) reference 
electrode.  A two electrode set-up was used in further experiments which employed 
a conductive silver thread, utilised as a combined counter-reference electrode. The 
conductive silver thread (0.4 Ω/cm) is comprised of 96 singular filaments, each 
coated with a micron-thick layer of silver. The production procedure involves a 
primary twist comprising 16 filaments of cotton. Two primary twists are then wound 
together to form the secondary twist and finally three of the latter are combined to 
yield the final thread consisting of 96 filaments and is approximately 18 denier.   
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7.2.3   Sensor Design and Modification  
 
The Toluidine Blue O (TBO) (5 wt%) was first dissolved in a solution of 
acetonitrile and the CAP was added to this mixture and left to stir until the CAP was 
fully dissolved and incorporated within the solution. The TBO/CAP mixture was then 
dropped and spread along the length of the gold wire. Although it was originally 
anticipated that addition of the TBO/CAP mixture to the gold would have led to an 
evenly coated film, the polymer spontaneously merged into isolated droplets along 
the length of the wire as an effect of surface poor wetting as indicated in Figure 7.2.1.  
 
 
 
 
 
Figure 7.2.1 Image of the CAP-TBO modified gold wire 
 
This coating procedure was repeated up to 4 times to enhance the yield of TBO. The 
modification steps and the configuration of the gold – polymer composite electrode 
with the combined counter-reference electrode are detailed in Figure 7.2.2.  
Electrochemical release was initiated through holding the potential of the coated 
wire at potentials ranging from -1 V to -2 V for a given period (typically 10 s) in line 
with the previous methodology followed within Chapter 6, to induce polymer 
swelling and dissolution of the protective CAP binder.  The released TBO was then 
sampled by recording the absorbance spectrum (200-800 nm) in a 1 cm3 volume 
cuvette.   
 
 
 
198 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.2.2Modification steps of gold wire 
 
7.3  Results and Discussion 
Characterisation of the Thread Reference Electrode 
 
The potentiometric response of the silver thread to a range of chloride 
concentrations was tested in a range of chloride solutions (1 mM to 1 M). A plot of 
average potential against the Log of the chloride concentration was found to be 
linear and exhibited Nernstian behaviour (E/V = -0.060 log[Cl-] + 0.0103; N = 4; R2 = 
0.999) with a 60 mV shift with each decade shift in chloride concentration as shown 
in Figure 7.3.1.  
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Figure 7.3.1 Silver thread reference potentiometric response to chloride concentration 
 
7.3.1   Characterisation of Gold Wire and Toluidine Blue O Coating 
 
The practicality of employing cellulose acetate phthalate as the controlled 
release polymer was briefly evaluated using gelatin as the simulated tissue matrix. 
Toluidine Blue O was utilised as a model drug as its release could be readily observed 
through visual examination or, as reported later, through UV–vis spectroscopy (λmax 
= 591 nm, ε = 2.98 × 103 L−1 mol cm−1). The first step was to thoroughly rinse the 
coated wire to remove any interfacial TBO, to ensure that the only dye present was 
trapped within the polymer matrix.  The thread was then submersed in specific pH 
adjusted gelatin and left in the sample for 48 h.  The results from the pH - time study 
are shown in Figure 7.3.2 A-F, where it is evident that the TBO layer remains intact 
at pH 6 and where the blue coloration only appears when the TBO coating is exposed 
to alkaline conditions. 
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Figure 7.3.2 A-F Release of Toluidine Blue O from cellulose acetate polymer coating on thread 
immersed in gelatin of varying pH (A–F) 
 
During the time study, it was observed that the dissolution of the CAP occurred very 
slowly from neutral or mildly alkaline (pH 8) where the outwards diffusion of the TBO 
into the gelatin matrix was observed after 48 hours. The CAP/TBO droplets arranged 
on the gold wire (100 μm) are presented in Figure 7.3.3 A, although their visible 
arrangement is overstated for clarity. The construction of the conductive thread is 
shown in Figure 7.3.3 B and it can be observed that while each individual fibre has 
been silver coated, however upon closer inspection, it can be seen that there are 
some areas where the underlying cotton is exposed.   
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Figure 7.3.3 (A) Gold microwire (100 μm) modified with CAP/TBO droplets. (B) Electron micrograph 
of the silver suture thread 
 
This aligns with earlier reports of electroless deposition of silver on fabrics and can 
be anticipated where the plating suspension has not been successful with nucleation 
on specific areas or perhaps where the thread braiding has inhibited adequate 
penetration (Ashayer-Soltani, Hunt and Thomas, 2016; Liu, Hu and Yang, 2016; Lui et 
al., 2017).  Nonetheless, the silver deposition undoubtedly spreads along the length 
of the thread and is suitably consistent to maintain conductivity when twisted or 
sewn, which is ideal for the intended application.  It should be noted that the core 
rationale for the commercialisation of the thread was directed at developing ‘e-
fabrics’ and wearable electronics and was constructed exclusively for sewn and 
woven purposes. The capability of the thread to function as a feasible 
reference/counter electrode was evaluated through comparing the potentiometric 
response to chloride ion whereby a Nernstian response (−59 mV) was obtained. 
 
 
 
B 
A 
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7.3.2  Toluidine Blue O Release in pH Buffer 
 
Quantitative assessments of TBO release from the microwire were conducted 
using UV-Vis spectroscopy.   A section of wire, previously coated in the CAP/TBO 
solution, was thoroughly rinsed to remove any residual TBO and placed in pH 4.75 
buffer and left for 1 hour.  A blank scan was initiated and revealed that no TBO was 
released into the background solution as shown in Figure 7.3.4 (green line).   The 
process was repeated with a new section of wire and placed in a buffer solution at 
pH 9.75 and was subjected to the same conditions.  Upon completion of the scan, it 
was evident that the higher pH environment had indeed initiated successful release 
of the TBO into the solution (blue line).  
 
 
 
 
 
 
 
 
 
 
Figure 7.3.4 Spectra detailing the absence of TBO in pH 4.75 buffer (green line) and the emergence 
of TBO in pH 9.75 buffer (blue line) 
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Tensile Strength Testing 
The tensile strength of the conductive silver thread was tested and was found to be 
1.6 N/Tex (% RSD = 9.1; N = 6) which behaved favourable when measured against a 
conventional Vicryl® braided suture (0.57 N/Tex) (Kelley et al., 2011). It could then 
be envisaged that the electronic thread structural support to bring together the 
apposing wound edges together and facilitate closure.  The electrochemical response 
of a gold microwire (50 μm diameter) in the presence of ferrocyanide (2 mM, 0.1 M 
KCl) is detailed in Figure 7.3.5 utilising a conventional three-electrode set up with a 
3 M NaCl half cell reference and a platinum wire served as a counter electrode. 
 
 
 
 
 
 
 
  
 
 
 
 
Figure 7.3.5 Cyclic voltammograms detailing the response of a gold wire (50 μm) towards ferrocyanide 
(2 mM, 0.1 M KCl, 5 mV/s) using three-electrode (solid line) and two-electrode (dashed line) 
configurations. Silver thread was used as the combined reference counter in the two electrode 
(prototype suture) investigation 
 
The voltammetric profile generates a sigmoidal cyclic voltammogram distinctive of 
microelectrode performance (Stephen Fletcher and Horne, 1999), as expected due 
to the small dimensions of the gold microwire.  It was observed that after altering 
the cell configuration to a two-electrode set up where the silver thread was used as 
a combined counter-reference electrode – as would be the situation in the final 
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electronic suture design, the voltammetric profile maintained the sigmoidal profile 
but has shifted to the lower end of the potential window.  The potential shift can be 
accredited to the fact that the thread is in the presence of bulk chloride 
concentration (0.1 M KCl) instead of the local concentration characteristic to the 3 M 
internal solution within the half cell. It is evident that the silver thread could be 
employed as a functional reference-counter electrode with the deposited silver 
offering a larger surface area in contrast to the gold wire working electrode. The 
reliance on the chloride concentration within the solution may be problematic when 
investigating the exploitation of the thread within sensing applications where 
disparities in the chloride concentration could result in uncertainty in assigning peak 
positions. Nevertheless, it is probable that the homeostatic regulation of chloride ion 
within the tissues (usually 0.1 M) would decrease the extent of any peak shift. It must 
be stated however that the release mechanism proposed here applies large reducing 
potentials that are not likely to be influenced by negligible shifts in the reference 
potential.   
 
7.3.3  Electrochemical Release 
 
Prior to the release studies, a calibration graph was constructed from a stock 
solution of TBO (1 mM, pH 7 buffer) to assess the spectral properties of the molecule 
and is shown in Figure 7.3.6. The calibration equation was then used to determine 
the amount of entrapped TBO that had been electrochemically released from CAP 
coated suture.   
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Figure 7.3.6 (A) UV Spectra detailing the additions of TBO (1 mM, pH 7 buffer).  (B) Relationship 
observed between peak height and increasing TBO concentration (8.3 µM to 55.1 µM, pH 7) 
 
 
The TBO/CAP modified suture was assembled along with the reference and counter 
electrodes and placed in a small quartz cuvette and held at varying reducing 
potentials and the subsequent release of the TBO into the solution of 0.1 M KCl was 
observed through UV spectroscopic analysis. As per the proposed methodology 
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outlined in Chapter 4, the application of a sufficient reducing potential at the working 
electrode, it is possible to increase the local pH thereby initiating the dissolution of 
the CAP binder and releasing the entrapped TBO.  
Larger negative potentials were applied as it was found that a reducing potential of   
-1 V was found to be too slow to initiate any dissolution of the CAP binder.  As 
illustrated in Figure 7.3.7 there is no evidence of TBO emergence after 5 minutes 
reduction at -1 V. 
 
 
 
 
 
 
 
 
 
Figure 7.3.7 Spectra detailing the absence of TBO before and after the commencement of hydrolysis, 
-1 V for 300 s 
 
After applying a reducing potential of -1.75 V, it is possible to observe the released 
TBO as shown in Figure 7.3.8 A, along with a quantitative examination of the drug 
yield per 10 s cycle shown in Figure 7.3.8B.  The absorbance peak of TBO at 591 nm 
intensifies after each reducing cycle, which presents a linear response during the 
preliminary reducing phase with each 10 s increment releasing around 2 μg of the 
TBO.  The concentration of TBO released will evidently depend on the manufacturing 
of the suture coating (Figure 7.389B inset) and the quantity of drug loading and, as 
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anticipated, there are some mild inconsistencies between each reducing potential 
due to the initial characterisation of manufacture presented here. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7.3.8 A) Spectra detailing the release of TBO after successive applications of a reducing 
potential (−1.75 V for 10 s increments) from a 5 cm length of 100 μm CAP coated gold wire. B) Yield 
of drug (μg) per 10 s reduction cycle. Inset: Typical yield per length of suture depending on coating 
 
 
7.4  Conclusions  
 
It is evident that the release of TBO can be electrochemically initiated through 
the application of an appropriate potential to the suture.  The size of the reducing 
potential must be necessarily large to induce rapid disruption of the pH sensitive 
binder (CAP), although it can be anticipated that this could be lessened through using 
less harsh negative potentials.  The crucial principle is that the potential is adequate 
to induce the hydrogen evolution. Regulating the time through which the potential 
is applied is another option. 
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The principal benefit of the system described here lies in the ability to meter the 
dosing of the model drug through generating a change in the local pH. It must also 
be noted that the change in local pH only continues while the electrode potential is 
maintained at large negative potentials and the natural buffer elements within the 
matrix will swiftly proceed to re-establish the pH to that of the bulk solution. The 
release mechanism can be manipulated to be relatively brief and will cease when the 
reducing potential is removed. One limiting issue with the technique is that it should 
be noted that the drug itself should not contain any reducible functionality (i.e. nitro 
groups) which may be unintentionally altered during the application of the reducing 
potential. Even though more rigorous methods of manufacture would enhance the 
reproducibility of delivery, it is clear that the current approach offers a versatile 
mechanism through which exploitation of the applied potential or the duration over 
which it is applied can easily control the release process.   
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Chapter 8 
 
Conclusions and Scope for Future Work 
 
8.1  Conclusions 
 
While many of the materials and mechanisms for controlled release are 
promising contenders for effective drug delivery, only a few have been used in 
combination with micro – nanofabrication technologies.  By linking the novel 
research from these ‘smart’ materials into appropriate micro devices, it may be 
possible to tune the specificity of drug loading and control over release during the 
delivery phase.  It is clear that patients suffering from chronic illnesses would be 
among the key recipients for the use controllable release systems, by delivering 
medication through a more discrete and more accessible route.  Currently, there is a 
pressing need to further develop current transdermal patch technologies and explore 
the potential for the addition of feedback systems, initiating the development of 
smart patch drug delivery systems.  The convenience of an electrochemically 
controlled smart device that could be worn by an outpatient could address many of 
the issues associated with delays in drug delivery and treatment regime adherence.  
These can offer much better outcomes especially when it comes to patient 
compliance where all too often, human error can lead to the treatment regime 
becoming ineffective and can compromise the overall condition of the patient.  
Innovations in the fabrication of electronic devices for drug delivery have now 
reached a size which can be similar to those present within the physiological 
environment of the body.  This outlook creates exciting prospects for combining 
microelectronics and biosensor technology to develop novel mechanisms with 
unparalleled ability and potential. The miniaturization of device size and design of 
these drug delivery systems means they have the ability to release a multifaceted 
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drug therapy profile in a controlled manner in order to optimize the therapeutic 
outcome of the drug treatments. These would have the capability to deliver a more 
efficient method to drug release by taking into account the quantity of drug to be 
delivered and at the correct time in response to an appropriate electrochemical 
trigger. It could also be invaluable in weaning patients off opioid medications in a 
much more controlled manner.  The outcome would be to develop a platform 
technology that is at the forefront of electronic delivery. 
 
Chapter 3 detailed the development and characterisation of a nanostructured 
conductive carbon-polycarbonate (C-PC) film capable of facilitating the controlled 
dissolution of enteric coatings.  Modification of the conductive film was achieved 
using laser treatment to create pores.  Electrochemical manipulation of the local pH 
within laser etched pores was shown to initiate the hydrolysis of the cellulous acetate 
phthalate film and facilitate the controlled release of a model drug.  Dexamethasone 
was chosen as an ideal model drug candidate for incorporation into enteric film. 
Dexamethasone has been widely used in clinical applications to treat a variety of 
conditions and its suitability to be used in transdermal form was confirmed.  The 
methodology presented proffers the opportunity to achieve local transdermal 
delivery of dexamethasone for the treatment of rheumatoid arthritis in a controlled 
manner.  Furthermore, an innovate approach to the design and operation of 
microfiber pH probe based on electrochemically generated quinoid moieties on the 
surface of the carbon fibre probe was critically appraised.   
 
Carbon fibre was selected as the base substrate onto which a CAP film was fixed onto 
within Chapter 4.  The carbon fibre mesh acted as a support for the CAP film, as well 
as a gate for a drug reservoir and, as the fibre is conductive, an electrode.  A novel 
approach employing controlled electrolysis was developed as a means through which 
the electrochemically initiated rupture and subsequent dissolution of a pH sensitive 
barrier film could be used as a controllable gateway for the release of candidate 
drugs.  The application of a reducing potential to the conductive carbon fibre 
substrate initiated the generation of hydrogen bubbles, along with a change in local 
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pH, and the former was shown to enable rapid removal of the cellulose acetate 
phthalate (CAP) film thereby inducing reagent release.   
The shift in pH at the electrode interface was confirmed through observing the peak 
position of the quinoid species on the surface of the anodised carbon fibre electrode.  
The peak position of these quinone species on the surface of the carbon fibre are pH 
dependent, this makes them an identifying marker of the local pH.  After the 
application of the reducing potential (-2 V, 5 s), there was a distinct shift in the peak 
process towards more negative potentials which are consistent with a change in the 
local pH to more alkaline conditions.  The localised pH was found to have increased 
from pH 3.19 to pH 8.26 based on holding the electrode at -2 V for 5 s. 
A reservoir approach was developed to determine the efficacy of the approach for 
the delivery of a model drug (methotrexate) to be transported to the delivery 
chamber via the application of the electrochemical trigger. After the commencement 
of electrolysis, the successful detection of the model drug within the delivery 
reservoir, thus confirming the suitability of the methodology for controlled release 
applications.   
Modification of the carbon fibre electrode through the selective deposition of 
conductive nanoparticles was investigated.  The addition of iron oxide and graphene 
oxide nanoparticles displayed superior HER activity compared to the unmodified CF 
due to the high dispersity and conductivity on the surface of the carbon fibre.  The 
addition of the nanoparticles, in principle, could enable the imposition of smaller 
cathodic potentials to induce more subtler pH changes.  The benefit of using the iron 
oxide is that the system is inherently biocompatible and could potentially be 
incorporated into a variety of electrochemically initiated drug release mechanisms, 
while further study is required to determine the full toxicological effects of graphene 
oxide.  
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Chapter 5 investigated a new approach to simplify the electrode construction process 
and served to determine if the CAP component could be directly incorporated with 
the conductive element.  In this methodology the carbon fibre filaments were 
substituted with nanoparticulate carbon particles which were bound together using 
the CAP polymer to form a conductive sheet.  In contrast to conventional carbon 
films, a novel element was introduced whereby the CAP component could be eroded 
under the imposition of a reducing potential.  Under normal conditions, the 
conductive coating remained intact but, upon imposing a reducing potential on the 
carbon composite layer, the pH at the interface was increased, which resulted in the 
solubilisation of the pH sensitive CAP binder components. 
Modification of the film using iron oxide and graphene oxide nanoparticles was 
undertaken and, in this respect, it shared similar principles to the approach 
investigated in Chapter 4. It was important to acknowledge that the GO in this 
instance served the same purpose as electrochemical anodisation but without the 
need to expose the film to strong alkaline solutions and thus preserving the integrity 
of the CAP-C film. The central interest however was the ability of the modified 
electrode to improve the dynamics of the hydrogen evolution reaction. The 
responses to proton reduction showed that the GO and Fe3O4 modifiers performed 
more favourably than the CAP-C alone.  For the modified electrodes, the potential at 
which reduction occurs was less negative. Although these preliminary findings were 
positive, the fabrication aspects, reproducibility and stability were poor and thus they 
were not used. 
The biocompatibility of the nano carbon-cellulose acetate composite was assessed 
in relation to skin irritation and cytotoxicity conducted by Bioserv Analytik Un 
Medizinprodukte GMBH (Rostock Germany).  The overall assessment indicated that 
the material did not cause any relevant toxicological or biological damage and 
possessed good overall biocompatibility.  The proposed mechanism has potential to 
work as an effective drug delivery method were, if a drug component were loaded 
into the film, controlled release of the therapeutic could be achieved, thus serving as 
an ideal candidate for incorporation into drug delivery and electrochemical 
microsystems.   
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Chapter 6 focused on the further investigation of the conductive polymer blend 
detailed in Chapter 5, which was employed to construct electrochemically 
controllable microneedle arrays.  Manipulation of the pH responsiveness of the 
polymer for use in electrochemically controlled drug release has been discussed in 
Chapters 3 and 4. In the latter, it was used as a thin film encapsulating a drug payload.  
Under normal conditions (open circuit), the conductive microneedle array remained 
intact but, through exploiting hydrogen evolution at the microneedle array, changes 
in local pH were shown to induce swelling within the needle structure. 
A skin mimic system based on crosslinked alginate gel, was formulated.  Ferrocyanide 
was incorporated within the gel to act as an in situ redox probe that could be utilized 
to evaluate the structural integrity of the microneedle.  A cathodic potential was 
applied directly to the microneedle array which lead to an increase in pH and swelling 
of the CAP binder.  Upon initiating hydrogen evolution, the microneedles were 
periodically scanned, and it was observed that the voltammetric profile of the 
ferrocyanide began to deteriorate.  The efficacy of the release method was also 
tested with a model drug – Toluidine Blue O (TBO).  The TBO loaded MNs were placed 
in a gelatin matrix and visually inspected after the application of each cathodic 
conditioning step.  A strong blue colour was observed upon removing the MNs after 
changing the pH, thus confirming the ability to release an entrapped agent on 
demand.   
 
Hence, were drugs to be encapsulated within the polymer composite complex at the 
time of construction, then the electrochemically initiated swelling could permit 
control over their release. The latter is situated at the core of the approach as the 
electrochemical manipulation of the release mechanism could offer a novel approach 
in MN design. Biocompatibility studies of the CAP-C material - detailed in Chapter 5, 
delivered some encouraging insights into the possible use of the material with no 
evident skin irritation nor cytotoxicity nevertheless these need to be regarded with 
some caution – especially where the devices may be used for long term purposes 
where sensitisation may transpire.   
 
214 
 
The release mechanism detailed in Chapter 7 followed on from previous chapters 
which have employed the application of a negative potential, where in this case the 
potential was applied to a gold microwire.  The gold microwire was loaded with 
cellulose acetate phthalate encapsulated drug droplets (TBO) as a novel approach for 
the electrochemically driven drug release from a suture. 
A conductive silver thread was utilised as a combined counter-reference electrode. 
The capability of the thread to function as a feasible reference/counter electrode was 
evaluated through comparing the potentiometric response to chloride ion whereby 
a Nernstian response (−59 mV) was obtained.  Electrochemical release was initiated 
through holding the potential of the coated wire at potentials ranging from -1 V to -
2 V for a given period (typically 10 s) in line with the previous methodology followed 
within Chapter 6, to induce polymer swelling and dissolution of the protective CAP 
binder.  After each reducing cycle it was determined that around 2 μg of the TBO was 
released from the gold wire.  It is clear that the current approach offers a versatile 
mechanism through which exploitation of the applied potential or the duration over 
which it is applied can easily control the release process, thus proffering a novel 
approach to electrochemically controlled drug release from micro wires. 
 
 
8.2  Scope for Future Work 
 
The focus of the present thesis is directed towards electrochemical 
approaches to drug delivery given the compatibility with modern electronics which 
should, in principle, provide opportunities for the delivery devices to become much 
smaller and less obtrusive with greater dose control and much more rapid response 
times.  Through the development of functional materials whose properties can be 
controlled, it is possible, to create advanced systems that could deliver a drug, 
antidote or treatment upon activation by an electrochemical trigger.  These “smart” 
materials could ultimately be incorporated into a micro device or smart patch that 
would be capable of acting autonomously to deliver a drug therapy. 
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The further development of transdermal systems will also see the addition of 
complex electronic systems into the device itself, where considerations surrounding 
power requirements and the finished product size will have to be considered for 
future ‘smart’ delivery systems to achieve their full potential. 
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